<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Nitric oxide donors for cervical ripening and induction of labour - Ghosh, A - 2016 | Cochrane Library</title> <meta content="Nitric oxide donors for cervical ripening and induction of labour - Ghosh, A - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006901.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Nitric oxide donors for cervical ripening and induction of labour - Ghosh, A - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006901.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006901.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Nitric oxide donors for cervical ripening and induction of labour" name="citation_title"/> <meta content="Arpita Ghosh" name="citation_author"/> <meta content="Brighton and Sussex University Hospitals NHS Trust" name="citation_author_institution"/> <meta content="arpitagmc@yahoo.com" name="citation_author_email"/> <meta content="Katherine R Lattey" name="citation_author"/> <meta content="St Mary's Hospital" name="citation_author_institution"/> <meta content="Anthony J Kelly" name="citation_author"/> <meta content="Brighton and Sussex University Hospitals NHS Trust" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD006901.pub3" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/12/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006901.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006901.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006901.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Nitric Oxide Donors; Administration, Intravaginal; Cervical Ripening [*drug effects, physiology]; Dinoprostone; Labor, Induced [*methods]; Misoprostol; Oxytocics; Randomized Controlled Trials as Topic; Urinary Catheterization" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006901.pub3&amp;doi=10.1002/14651858.CD006901.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="f00EizoA";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006901\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006901\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ja","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006901.pub3",title:"Nitric oxide donors for cervical ripening and induction of labour",firstPublishedDate:"Dec 5, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=f00EizoA&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006901.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006901.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006901.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006901.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006901.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006901.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006901.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006901.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006901.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006901.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1494 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006901.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/full#CD006901-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/full#CD006901-sec-0112"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/full#CD006901-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/full#CD006901-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/full#CD006901-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/full#CD006901-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/full#CD006901-sec-0061"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/full#CD006901-sec-0106"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/table_n/CD006901StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/table_n/CD006901StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Nitric oxide donors for cervical ripening and induction of labour</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/information#CD006901-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Arpita Ghosh</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/information#CD006901-cr-0003">Katherine R Lattey</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006901.pub3/information#CD006901-cr-0004">Anthony J Kelly</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/information/en#CD006901-sec-0120">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 December 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006901.pub3">https://doi.org/10.1002/14651858.CD006901.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006901-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006901-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006901-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006901-abs-0008">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006901-abs-0001" lang="en"> <section id="CD006901-sec-0001"> <h3 class="title" id="CD006901-sec-0001">Background</h3> <p>Sometimes it is necessary to bring on labour artificially because of safety concerns for the mother or baby. This review is one of a series of reviews of methods of labour induction using a standardised protocol. </p> </section> <section id="CD006901-sec-0002"> <h3 class="title" id="CD006901-sec-0002">Objectives</h3> <p>To determine the effects of NO donors (isosorbide mononitrate (ISMN), isosorbide dinitrate (ISDN), nitroglycerin and sodium nitroprusside) for third trimester cervical ripening or induction of labour, in comparison with placebo or no treatment or other treatments from a predefined hierarchy. </p> </section> <section id="CD006901-sec-0003"> <h3 class="title" id="CD006901-sec-0003">Search methods</h3> <p>We searched Cochrane Pregnancy and Childbirth's Trials Register (15 August 2016) and the reference lists of trial reports. </p> </section> <section id="CD006901-sec-0004"> <h3 class="title" id="CD006901-sec-0004">Selection criteria</h3> <p>Clinical trials comparing NO donors for cervical ripening or labour induction with other methods listed above it on a predefined list of methods of labour induction. Interventions include NO donors (isosorbide mononitrate, isosorbide dinitrate, nitroglycerin and sodium nitroprusside) compared with other methods listed above it on a predefined list of methods of labour induction. </p> </section> <section id="CD006901-sec-0005"> <h3 class="title" id="CD006901-sec-0005">Data collection and analysis</h3> <p>This review is part of a series of reviews focusing on methods of induction of labour, based on a generic protocol. Three review authors independently assessed trials for inclusion, assessed risk of bias and extracted data. In this update, the quality of the evidence for the main comparison was assessed using the GRADE approach. </p> </section> <section id="CD006901-sec-0006"> <h3 class="title" id="CD006901-sec-0006">Main results</h3> <p>We included 23 trials (including a total of 4777 women). Included studies compared NO donors with placebo, vaginal prostaglandin E2 (PGE2), intracervical PGE2, vaginal misoprostol and intracervical Foley catheter. The majority of the included studies were assessed as being at low risk of bias. </p> <p><b>Nitric oxide versus placebo</b> </p> <p>There was no evidence of a difference for any of the primary outcomes analysed: vaginal delivery not achieved in 24 hours (risk ratio (RR) 0.97, 95% confidence interval (CI) 0.83 to 1.15; one trial, 238 women; <i>low‐quality evidence</i> ), uterine hyperstimulation with fetal heart rate (FHR) changes (RR 0.09, 95% CI 0.01 to 1.62; two trials, 300 women; <i>low‐quality evidence</i> ), caesarean section (RR 0.99, 95% CI 0.88 to 1.11; nine trials, 2624 women; <i>moderate‐quality evidence</i> ) or serious neonatal morbidity/perinatal death (average RR 1.61, 95% CI 0.08 to 33.26; two trials, 1712 women; <i>low‐quality evidence</i>). There were no instances of serious maternal morbidity or death (one study reported this outcome). </p> <p>There was a reduction in an unfavourable cervix at 12 to 24 hours in women treated with NO donors (average RR 0.78, 95% CI 0.67 to 0.90; four trials, 762 women), and this difference was observed in both subgroups of standard release and slow release formulation. Women who received NO donors were less likely to experience uterine hyperstimulation without FHR rate changes (RR 0.05, 95% CI 0.00 to 0.80; one trial, 200 women), and more likely to experience side effects, including nausea, headache and vomiting. </p> <p><b>Nitric oxide donors versus vaginal prostaglandins</b> </p> <p>There was no evidence of any difference between groups for uterine hyperstimulation with FHR changes or caesarean section (RR 0.97, 95% CI 0.78 to 1.21; three trials, 571 women). Serious neonatal morbidity and serious maternal morbidity were not reported. There were fewer women in the NO donor group who did not achieve a vaginal delivery within 24 hours (RR 0.63, 95% CI 0.47 to 0.86; one trial, 400 primiparae women). </p> <p><b>Nitric oxide donors versus intracervical prostaglandins</b> </p> <p>One study reported a reduction in the number of women who had not achieved a vaginal delivery within 24 hours with NO donors (RR 0.63, 95% CI 0.47 to 0.86; one trial, 400 women). This result should be interpreted with caution as the information was extracted from an abstract only and a full report of the study is awaited. No differences were observed between groups for uterine hyperstimulation with FHR changes (RR 0.33, 95% CI 0.01 to 7.74; one trial, 42 women) or serious neonatal morbidity/perinatal death (RR 0.33, 95% CI 0.01 to 7.74; one trial, 42 women). Fewer women in the NO donor group underwent a caesarean section in comparison to women who received intracervical prostaglandins (RR 0.63, 95% CI 0.44 to 0.90; two trials, 442 women). No study reported on the outcome serious maternal morbidity or death. </p> <p><b>Nitric oxide donors versus vaginal misoprostol</b> </p> <p>There was a reduction in the rate of uterine hyperstimulation with FHR changes with NO donors (RR 0.07, 95% CI 0.01 to 0.37; three trials, 281 women). There were no differences in caesarean section rates (RR 1.00, 95% CI 0.82 to 1.21; 761 women; six trials) and no cases of serious neonatal morbidity/perinatal death were reported. One study found that women in the NO donor group were more likely to not deliver within 24 hours (RR 5.33, 95% CI 1.62 to 17.55; one trial, 150 women). Serious maternal morbidity or death was not reported. </p> <p>In terms of secondary outcomes, there was an increase in cervix unchanged/unfavourable with NO (RR 3.43, 95% CI 2.07 to 5.66; two trials, 151 women) and an increase in the need for oxytocin augmentation with NO induction (RR 2.67, 95% CI 1.31 to 5.45; 7 trials; 767 women), although there was evidence of significant heterogeneity which could not be fully explained. Uterine hyperstimulation without FHR was lower in the NO group, as was meconium‐stained liquor, Apgar score less than seven at five minutes and analgesia requirements. </p> <p><b>Nitric oxide donors versus intracervical catheter</b> </p> <p>There was no evidence on any difference between the effects of NO and the use of a Foley catheter for induction of labour for caesarean section (RR 1.00, 95% CI 0.39 to 2.59; one trial, 80 women). No other primary outcomes were reported. One study of 75 participants did not contribute any data to the review. </p> <p>For all comparisons, women who received NO donors were more likely to experience side effects such as headache, nausea or vomiting. </p> </section> <section id="CD006901-sec-0007"> <h3 class="title" id="CD006901-sec-0007">Authors' conclusions</h3> <p>Available data suggests that NO donors can be a useful tool in the process of induction of labour causing the cervix to be more favourable in comparison to placebo. However, additional data are needed to assess the true impact of NO donors on all important labour process and delivery outcomes. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006901-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006901-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD006901-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD006901-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006901-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD006901-abs-0007">日本語</a> </li> <li class="section-language"> <a class="" href="full/ru#CD006901-abs-0004">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006901-abs-0002" lang="en"> <h3>Nitric oxide donors for cervical ripening and induction of labour</h3> <p><b>What is the issue?</b> </p> <p>Sometimes it is necessary to bring on labour artificially in the third trimester because of safety concerns for the mother or her baby. Most commonly used cervical ripening or induction agents also cause uterine activity or contraction, which requires close monitoring of mother and baby within a hospital environment. </p> <p><b>Why is this important?</b> </p> <p>Nitric oxide (NO) donor agents such as isosorbide mononitrate, Isosorbide dinitrate, nitroglycerin and sodium nitroprusside are thought to bring on ripening of the cervix (neck of the womb) without producing contractions and could be used in an outpatient setting. There are increasing data to support their use for this purpose. </p> <p><b>What evidence did we find?</b> </p> <p>We searched for evidence on 15th August 2016 and identified a further 13 studies. The review now includes a total of 23 studies involving 4777 women. The five main primary outcomes (after the administration of NO donors) included: vaginal delivery not achieved within 24 hours; uterine hyperstimulation with changes in the fetal heart rate; caesarean section; serious neonatal morbidity/perinatal death; and serious maternal morbidity or death. The evidence for the five primary outcomes was mainly found to be of low quality. There was no evidence of a difference for any of the primary outcomes analysed. There was evidence from four trials to suggest that NO donors were superior to placebo in bringing on ripening of the cervix. Women who received NO donors were also more likely to experience side effects such as headache, nausea or vomiting. </p> <p><b>What does this mean?</b> </p> <p>NO donor leads to little or no difference on the majority of labour process and delivery outcomes. However, there was some evidence to suggest that it probably helps in causing the cervix to be more favourable at 12 to 24 hours after administration. Additional studies are needed to see the true impact of NO donors in bringing on induction of labour and its effect on caesarean section rates. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006901-sec-0112" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006901-sec-0112"></div> <h3 class="title" id="CD006901-sec-0113">Implications for practice</h3> <section id="CD006901-sec-0113"> <p>Available data suggest that nitric oxide (NO) donors can be a useful tool in the process of induction of labour causing the cervix to be more favourable in comparison to placebo. However, further complex interventional trials are needed to study its true effect on labour process and delivery outcomes. </p> </section> <h3 class="title" id="CD006901-sec-0114">Implications for research</h3> <section id="CD006901-sec-0114"> <p>More studies are required to examine how NO donors may work alongside established induction of labour protocols, especially those based in outpatient settings. There is also a need to further develop a more robust set of outcome measures which allow the efficacy of the cervical ripening phase of the induction process to be effectively evaluated. </p> <p>An ideal study to determine the effect of NO donor would involve complex intervention. In this, women could be randomised into two groups, one receiving placebo + prostaglandin E2 (PGE2) and another receiving NO donor + PGE2 regardless of the favourability of the cervix. Then the need for oxytocin, length of the labour and delivery outcomes to be assessed. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006901-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006901-sec-0015"></div> <div class="table" id="CD006901-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Nitric oxide donors versus placebo for cervical ripening and induction of labour</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Nitric oxide donors for cervical ripening and induction of labour</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> pregnant women undergoing cervical ripening and induction of labour<br/> <b>Setting:</b> outpatient and inpatient settings in India, UK, Sweden, Sri Lanka, France and Iran <br/> <b>Intervention:</b> nitric oxide donors<br/> <b>Comparison:</b> placebo/no intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo/no intervention (all women)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with (1.1) Nitric oxide donors</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal delivery not achieved in 24 hours</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.97<br/> (0.83 to 1.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>238<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>711 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>689 per 1000<br/> (590 to 817) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Uterine hyperstimulation with FHR changes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.09<br/> (0.01 to 1.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>300<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3 per 1000<br/> (1 to 54) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.99<br/> (0.88 to 1.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2624<br/> (9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>280 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>277 per 1000<br/> (246 to 311) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious neonatal morbidity/perinatal death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.61<br/> (0.08 to 33.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1712<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>5 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000<br/> (0 to 39) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious maternal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1362<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were no events for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>FHR:</b> Fetal heart rate; <b>RCT:</b> randomised controlled trial; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Only one study with few events, small sample size and wide confidence interval. </p> <p><sup>2</sup> High risk of bias for allocation concealment and blinding. </p> <p><sup>3</sup> Only two studies with few or no events, small sample size and wide confidence interval. </p> <p><sup>4</sup> High risk of bias for allocation concealment, blinding and selective outcome reporting. </p> <p><sup>5</sup> Confidence intervals do not overlap (opposite directions of effect) and I<sup>2</sup> = 48%. </p> <p><sup>6</sup> Only two studies with few events and wide confidence intervals. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006901-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006901-sec-0016"></div> <section id="CD006901-sec-0017"> <h3 class="title" id="CD006901-sec-0017">Description of the condition</h3> <p>It is often necessary to bring on labour artificially because of safety concerns for the mother or baby. This review is one of a series of reviews of methods of labour induction using a standardised protocol. For more detailed information on the rationale for this methodological approach, please refer to the currently published 'generic' protocol (<a href="./references#CD006901-bbs2-0055" title="HofmeyrGJ , AlfirevicZ , KellyAJ , KavanaghJ , ThomasJ , NeilsonJP , et al. Methods for cervical ripening and labour induction in late pregnancy: generic protocol. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD002074] ">Hofmeyr 2009</a>). The generic protocol describes how a number of standardised reviews were combined to compare various methods of preparing the cervix of the uterus and inducing labour. The initial series of 21 reviews were developed simultaneously (<a href="./references#CD006901-bbs2-0039" title="AlfirevicZ , AflaifelN , WeeksA . Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD001338.pub3] ">Alfirevic 2014</a>; <a href="./references#CD006901-bbs2-0041" title="BoulvainM , StanC , IrionO . Membrane sweeping for induction of labour. Cochrane Database of Systematic Reviews2005, Issue 1. [DOI: 10.1002/14651858.CD000451.pub2] ">Boulvain 2005</a>; <a href="./references#CD006901-bbs2-0043" title="BoulvainM , IrionO , DowswellT , ThorntonJG . Induction of labour at or near term for suspected fetal macrosomia. Cochrane Database of Systematic Reviews2016, Issue 5. [DOI: 10.1002/14651858.CD000938.pub2] ">Boulvain 2016</a>; <a href="./references#CD006901-bbs2-0044" title="BrickerL , LuckasM . Amniotomy alone for induction of labour. Cochrane Database of Systematic Reviews2000, Issue 4. [DOI: 10.1002/14651858.CD002862] ">Bricker 2000</a>; <a href="./references#CD006901-bbs2-0051" title="FrenchL . Oral prostaglandin E2 for induction of labour. Cochrane Database of Systematic Reviews2001, Issue 2. [DOI: 10.1002/14651858.CD003098] ">French 2001</a>; <a href="./references#CD006901-bbs2-0052" title="HapangamaD , NeilsonJP . Mifepristone for induction of labour. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD002865.pub2] ">Hapangama 2009</a>; <a href="./references#CD006901-bbs2-0054" title="HofmeyrGJ , GülmezogluAM , PileggiC . Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD000941] ">Hofmeyr 2003</a>; <a href="./references#CD006901-bbs2-0056" title="HowarthGR , BothaDJ . Amniotomy plus intravenous oxytocin for induction of labour. Cochrane Database of Systematic Reviews2001, Issue 3. [DOI: 10.1002/14651858.CD003250] ">Howarth 2001</a>; <a href="./references#CD006901-bbs2-0057" title="HuttonE , MozurkewichE . Extra‐amniotic prostaglandin for induction of labour. Cochrane Database of Systematic Reviews2001, Issue 2. [DOI: 10.1002/14651858.CD003092] ">Hutton 2001</a>; <a href="./references#CD006901-bbs2-0059" title="JozwiakM , BloemenkampWM , KellyA , MolBWJ , IrionO , BoulvainM . Mechanical methods for induction of labour. Cochrane Database of Systematic Reviews2012, Issue 3. [DOI: 10.1002/14651858.CD001233.pub2] ">Jozwiak 2012</a>; <a href="./references#CD006901-bbs2-0060" title="KavanaghJ , KellyAJ , ThomasJ . Sexual intercourse for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2001, Issue 2. [DOI: 10.1002/14651858.CD003093] ">Kavanagh 2001</a>; <a href="./references#CD006901-bbs2-0061" title="KavanaghJ , KellyAJ , ThomasJ . Breast stimulation for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD003392.pub2] ">Kavanagh 2005</a>; <a href="./references#CD006901-bbs2-0062" title="KavanaghJ , KellyAJ , ThomasJ . Corticosteroids for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD003100.pub2] ">Kavanagh 2006a</a>; <a href="./references#CD006901-bbs2-0063" title="KavanaghJ , KellyAJ , ThomasJ . Hyaluronidase for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD003097.pub2] ">Kavanagh 2006b</a>; <a href="./references#CD006901-bbs2-0064" title="KellyAJ , KavanaghJ , ThomasJ . Relaxin for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2001, Issue 2. [DOI: 10.1002/14651858.CD003103] ">Kelly 2001a</a>; <a href="./references#CD006901-bbs2-0065" title="KellyAJ , KavanaghJ , ThomasJ . Castor oil, bath and/or enema for cervical priming and induction of labour. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD003099.pub2] ">Kelly 2013b</a>; <a href="./references#CD006901-bbs2-0067" title="LuckasM , BrickerL . Intravenous prostaglandin for induction of labour. Cochrane Database of Systematic Reviews2000, Issue 4. [DOI: 10.1002/14651858.CD002864] ">Luckas 2000</a>; <a href="./references#CD006901-bbs2-0072" title="SmithCA . Homoeopathy for induction of labour. Cochrane Database of Systematic Reviews2003, Issue 4. [DOI: 10.1002/14651858.CD003399] ">Smith 2003</a>; <a href="./references#CD006901-bbs2-0073" title="SmithCA , CrowtherCA , GrantSJ . Acupuncture for induction of labour. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD002962.pub3] ">Smith 2013</a>; <a href="./references#CD006901-bbs2-0075" title="ThomasJ , KellyAJ , KavanaghJ . Oestrogens alone or with amniotomy for cervical ripening or induction of labour. Cochrane Database of Systematic Reviews2001, Issue 4. [DOI: 10.1002/14651858.CD003393] ">Thomas 2001</a>; <a href="./references#CD006901-bbs2-0076" title="ThomasJ , FaircloughA , KavanaghJ , KellyAJ . Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD003101.pub3] ">Thomas 2014</a>). </p> <p>Induction of labour occurs in approximately 20% of pregnancies in the UK. The ideal agent for induction of labour would induce cervical ripening without causing uterine contractions (<a href="./references#CD006901-bbs2-0047" title="CalderAA . Nitric oxide: another factor in cervical ripening. Human Reproduction1998;13:250‐1. ">Calder 1998</a>). Currently, most commonly used cervical ripening or induction agents result in uterine activity or contractions, or both. These necessitate close monitoring of mother and baby within a hospital environment. Cervical ripening without uterine contractility could occur safely in an outpatient setting and it may be expected that this would result in greater maternal satisfaction and lower costs. </p> </section> <section id="CD006901-sec-0018"> <h3 class="title" id="CD006901-sec-0018">Description of the intervention</h3> <p>Nitric oxide (NO) is thought to be an essential mediator in the process of cervical ripening (<a href="./references#CD006901-bbs2-0048" title="ChwaliszK , GarfieldRE . Nitric oxide as the final mediator of cervical ripening. Human Reproduction1998;13:245‐52. ">Chwalisz 1998</a>). There is increasing evidence that the use of NO donors (including isosorbide mononitrate (ISMN), isosorbide dinitrate (ISDN), nitroglycerin and sodium nitroprusside) allow cervical ripening to occur in the absence of uterine contractions and this may be performed in an outpatient environment (<a href="./references#CD006901-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a>; <a href="./references#CD006901-bbs2-0003" title="BullarboM , ErikssonO , AnderschB , GranstromL , NorstromA , ErkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196:50.e1‐50.e5. BullarboM , NorstromA , AnderschB , EkerhovdE . Isosorbide mononitrate induces increased cervical expression of cyclooxygenase‐2, but not of cyclooxygenase‐1, at term. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2007;130(2):160‐4. ">Bullarbo 2007</a>; <a href="./references#CD006901-bbs2-0004" title="ChanrachakulB , HerabutyaY , PunyavachiraP . Potential efficacy of nitric oxide for cervical ripening on pregnancy at term. International Journal of Gynecology &amp; Obstetrics2000;71:217‐9. ChanrachakulB , HerabutyaY , PunyavachiraP . Randomised comparison of glyceryl trinitrate and prostaglandin E2 for cervical ripening at term. Obstetrics and Gynecology2000;96:549‐53. ChanrachakulB , HerbutyaY . Phase II to determine the potential efficacy and safety of nitric oxide for cervical ripening in pregnancy at term. XVI FIGO World Congress of Obstetrics &amp; Gynecology (Book 4); 2000 Sept 3‐8; Washington DC, USA. 2000:68‐9. ">Chanrachakul 2000</a>; <a href="./references#CD006901-bbs2-0005" title="ChanrachakulB , HerabutyaY , PunyavachiraP . Randomized trial of isosorbide mononitrate versus misoprostol for cervical ripening at term. International Journal of Gynecology &amp; Obstetrics2002;78:139‐45. ">Chanrachakul 2002</a>; <a href="./references#CD006901-bbs2-0013" title="OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The &quot;PRIM&quot; study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. American Journal of Obstetrics and Gynecology2006;194(4):1012‐21. OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for pre‐induction cervical ripening at term [abstract]. BJOG: an international journal of obstetrics and gynaecology2005;112(4):512. OsmanI , MackenzieF , NorrieJ , GreerA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for preinduction cervical ripening at term [abstract]. Journal of Obstetrics and Gynaecology2004;24(Suppl 1):S67. OsmanI , NormanJ , MackenzieF , MurrayH , NorrieJ , GreerI . The &quot;PRIM&quot; study: a randomised comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening prior to the induction of labour at term [abstract]. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S184. ">Osman 2006</a>; <a href="./references#CD006901-bbs2-0017" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD006901-bbs2-0019" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>). </p> </section> <section id="CD006901-sec-0019"> <h3 class="title" id="CD006901-sec-0019">How the intervention might work</h3> <p>The major physiological effect of NO (a free radical gas with a half‐life of less than four seconds) is the relaxation of smooth muscle (<a href="./references#CD006901-bbs2-0046" title="BuhimschiI , YallampalliC , DongY . Involvement of nitric‐oxide‐cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy. American Journal of Obstetrics and Gynecology1995;172:1577‐84. ">Buhimschi 1995</a>). NO itself is endogenously supplied from L‐arginine through the action of the nitric oxide synthase (NOS) (<a href="./references#CD006901-bbs2-0040" title="ArnoldWP , MittalCK , KatsukiS , MuradF . Nitric oxide activates guanylate cyclase and increases guanosine 3':5'‐cyclic monophosphate levels in various tissue preparations. Proceedings of the National Academy of Sciences of the United States of America1977;74:3203‐7. ">Arnold 1977</a>), which has been identified as being present in the human cervix (<a href="./references#CD006901-bbs2-0074" title="TelferJ , LyallF , NormanJ . Identification of nitric oxide synthase in human uterus. Human Reproduction1995;10:19‐23. ">Telfer 1995</a>). This NO product reacts with soluble guanylate cyclase, the product of which raises the concentration of intracellular cyclic guanosine monophosphate (cGMP). cGMP causes the dephosphorylation of myosin light chains within the smooth muscle structure leading to its relaxation. Significantly, the cervix is largely composed of connective tissue, including smooth muscle. Previous studies have confirmed that this smooth muscle component of the cervix has a functional role in cervical ripening (<a href="./references#CD006901-bbs2-0045" title="BrymanI , NorströmA , LindblomB . Influence of prostaglandins and adrenoceptor agonists on contractile activity in the human cervix at term. Obstetrics &amp; Gynecology1986;67:574‐8. ">Bryman 1986</a>). Several animal experiments have independently come to the conclusion that NO is an important mediator in the cervical ripening process (<a href="./references#CD006901-bbs2-0047" title="CalderAA . Nitric oxide: another factor in cervical ripening. Human Reproduction1998;13:250‐1. ">Calder 1998</a>; <a href="./references#CD006901-bbs2-0048" title="ChwaliszK , GarfieldRE . Nitric oxide as the final mediator of cervical ripening. Human Reproduction1998;13:245‐52. ">Chwalisz 1998</a>). Specifically, when the NO donor sodium nitroprusside was applied to the cervixes of pregnant guinea pigs, ripening occurred in the same way as during normal labour, but significantly labour itself was not induced (<a href="./references#CD006901-bbs2-0070" title="QingS , BierH , GarfiledR . Local application of nitric oxide (NO) donors induces cervical ripening. Journal of the Society of Gynaecological Investigation1996;3:462. ">Qing 1996</a>). Further to this, and in opposition to the adverse effects of prostaglandin use, NO also inhibits myometrial contraction and promotes uterine blood flow (<a href="./references#CD006901-bbs2-0050" title="EkerhordE , BrannstromM , DelboD , NorstromA . Nitric oxide mediated inhibition of contractile activity in the human cervix. Molecular Human Reproduction1998;4:915‐20. ">Ekerhord 1998</a>; <a href="./references#CD006901-bbs2-0058" title="IzurniH , YallampallC , CarfieldR . Gestational changes in L‐arginine‐induced relaxation of pregnant rat and human myometrial smooth muscle. American Journal of Obstetrics and Gynecology1993;169(5):1327‐37. ">Izurni 1993</a>). NO donors have even been proposed as realistic tocolytic agents in the management of preterm labour (<a href="./references#CD006901-bbs2-0066" title="LeesC , CampbellS , JaunaaxE , BrownR , RamseyB , CibbD . Arrest of pre‐term labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet1994;343:1325‐6. ">Lees 1994</a>; <a href="./references#CD006901-bbs2-0069" title="NormanJ , WardI , MartinW , CameronA , McGrathJ , CreerI . Effects of cGMP and the nitric oxide donors glyceryl trinitrate and sodium nitroprusside on contractions in vitro of isolated myometrial tissue from pregnant women. Journal of Repoductive Fertility1997;110:249‐54. ">Norman 1997</a>). </p> <p>NO donors have successfully been used for cervical ripening, not for pre‐induction ripening, but to ripen the cervix in preparation for first trimester surgical termination of pregnancy (<a href="./references#CD006901-bbs2-0077" title="ThompsonA , LumanC , CameronA . Nitric oxide donors induce ripening of the human uterine cervix: a randomised control trial. British Journal of Obstetrics and Gynaecology1997;104:1054‐7. ">Thompson 1997</a>), where they have been shown to have fewer adverse effects than prostaglandins (<a href="./references#CD006901-bbs2-0078" title="ThompsonA , LunanC , LedinghamM , HowatR , CameronI , GreerI . Randomised trial of nitric oxide donors versus prostaglandins for cervical ripening before first trimester termination of pregnancy. Lancet1998;352:1093‐6. ">Thompson 1998</a>). </p> </section> <section id="CD006901-sec-0020"> <h3 class="title" id="CD006901-sec-0020">Why it is important to do this review</h3> <p>There is increasing focus on agents that allow safe initiation of the labour process without uterine contractions and where possible away from a hospital environment. NO donors may represent such a group of agents. This review allows us to examine the efficacy of these agents for induction of labour. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006901-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006901-sec-0021"></div> <p>To determine the effects of NO donors (ISMN, ISDN, nitroglycerin and sodium nitroprusside) for third trimester cervical ripening or induction of labour, in comparison with placebo or no treatment or other treatments from a predefined hierarchy. </p> <p>This review is part of a series of review focusing on induction of labour. Within all previous reviews there has been no distinction between cervical ripening and later stages of the induction process. The primary aim of all induction agents is to induce the labour not solely to produce cervical ripening. NO donors in some ways only aim to produce cervical ripening, but for the purpose of this review they have been examined alongside other similar agents and we have used similar outcomes to all the other reviews in the series. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006901-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006901-sec-0022"></div> <section id="CD006901-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006901-sec-0024"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials comparing NO donors for cervical ripening or labour induction to other methods listed above it on a predefined list of methods of labour induction (<i>see</i><a href="#CD006901-sec-0022">Methods</a>). Cluster trials were eligible for inclusion. Quasi‐randomised and cross‐over trials were not eligible for inclusion. </p> </section> <section id="CD006901-sec-0025"> <h4 class="title">Types of participants</h4> <p>Pregnant women due for third trimester induction of labour, carrying a viable fetus.</p> </section> <section id="CD006901-sec-0026"> <h4 class="title">Types of interventions</h4> <p>NO donors (isosorbide mononitrate (ISMN), isosorbide dinitrate (ISDN), nitroglycerin and sodium nitroprusside) compared to other methods listed above it on a predefined list of methods of labour induction (<i>see</i><a href="#CD006901-sec-0022">Methods</a>). </p> <p>For the purposes of most of the comparisons, the main agent used was ISMN. Hence unless specified in the analysis all included studies used this agent, and it was administered in single or multiple doses using a standard release formulation. In one trial a slow‐release compound was used and this was analysed within a separate subgroup within this comparison. Another trial used isosorbide dinitrate as a NO donor. </p> <p>Studies were analysed as a whole group (all women), and also according to status of the cervix, membrane status and parity, as specified in the generic protocol <a href="./references#CD006901-bbs2-0055" title="HofmeyrGJ , AlfirevicZ , KellyAJ , KavanaghJ , ThomasJ , NeilsonJP , et al. Methods for cervical ripening and labour induction in late pregnancy: generic protocol. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD002074] ">Hofmeyr 2009</a>. </p> <section id="CD006901-sec-0027"> <h5 class="title">Primary comparisons</h5> <p> <ol id="CD006901-list-0001"> <li> <p>NO donors versus placebo/no treatment.</p> </li> <li> <p>NO donors versus vaginal prostaglandin E2 (PGE2).</p> </li> <li> <p>NO donors versus intracervical PGE2.</p> </li> <li> <p>NO donors versus vaginal misoprostol.</p> </li> <li> <p>NO donors versus intracervical Foley catheter.</p> </li> </ol> </p> </section> </section> <section id="CD006901-sec-0028"> <h4 class="title">Types of outcome measures</h4> <p>Clinically relevant outcomes for trials of methods of cervical ripening and labour induction have been prespecified by two authors of labour induction reviews (Justus Hofmeyr and Zarko Alfirevic). </p> <section id="CD006901-sec-0029"> <h5 class="title">Primary outcomes</h5> <p>Five primary outcomes were chosen as being most representative of the clinically important measures of effectiveness and complications..<br/> 1. Vaginal delivery not achieved within 24 hours (or period specified by trial authors).<br/> 2. Uterine hyperstimulation with fetal heart rate (FHR) changes.<br/> 3. Caesarean section.<br/> 4. Serious neonatal morbidity or perinatal death (e.g. seizures, birth asphyxia defined by trialists, neonatal encephalopathy, disability in childhood).<br/> 5. Serious maternal morbidity or death (e.g. uterine rupture, admission to intensive care unit, septicaemia). </p> <p>Perinatal and maternal morbidity and mortality are composite outcomes. This is not an ideal solution because some components are clearly less severe than others. It is possible for one intervention to cause more deaths, but less severe morbidity. However, in the context of labour induction at term this is unlikely. All of these events are rare, and a modest change in their incidence is easier to detect if composite outcomes are presented. We have explored the incidence of individual components as secondary outcomes (<i>see</i> below). </p> </section> <section id="CD006901-sec-0030"> <h5 class="title">Secondary outcomes</h5> <p>Secondary outcomes relate to measures of effectiveness, complications and satisfaction.</p> <section id="CD006901-sec-0031"> <h6 class="title">Measures of effectiveness</h6> <p>6. Cervix unfavourable/unchanged after 12 to 24 hours.<br/> 7. Oxytocin augmentation. </p> </section> <section id="CD006901-sec-0032"> <h6 class="title">Complications</h6> <p>8. Uterine hyperstimulation without FHR changes.<br/> 9. Uterine rupture.<br/> 10. Epidural analgesia.<br/> 11. Instrumental vaginal delivery.<br/> 12. Meconium‐stained liquor.<br/> 13. Apgar score less than seven at five minutes.<br/> 14. Neonatal intensive care unit admission.<br/> 15. Neonatal encephalopathy.<br/> 16. Perinatal death.<br/> 17. Disability in childhood.<br/> 18. Maternal side effects (all).<br/> 19. Maternal nausea.<br/> 20. Maternal vomiting.<br/> 21. Maternal diarrhoea.<br/> 22. Other maternal side effects.<br/> 23. Postpartum haemorrhage (as defined by the trial authors).<br/> 24. Serious maternal complications (e.g. intensive care unit admission, septicaemia but excluding uterine rupture).<br/> 25. Maternal death. </p> </section> <section id="CD006901-sec-0033"> <h6 class="title">Measures of satisfaction</h6> <p>26. Woman not satisfied.<br/> 27. Caregiver not satisfied. </p> <p>'Uterine rupture' includes all clinically significant ruptures of unscarred or scarred uteri. We have excluded trivial scar dehiscence noted incidentally at the time of surgery. </p> <p>Additional outcomes may appear in individual reviews.</p> <p>While we have sought all the above outcomes, we have included only those with data in the analysis tables. </p> <p>The terminology of uterine hyperstimulation is problematic (<a href="./references#CD006901-bbs2-0049" title="CurtisP , EvansS , ResnickJ . Uterine hyperstimulation. The need for standard terminology. Journal of Reproductive Medicine1987;32:91‐5. ">Curtis 1987</a>). In the reviews, we use the term 'uterine hyperstimulation without FHR changes' to include uterine tachysystole (more than five contractions per 10 minutes for at least 20 minutes) and uterine hypersystole/hypertonus (a contraction lasting at least two minutes) and 'uterine hyperstimulation with FHR changes' to denote uterine hyperstimulation syndrome (tachysystole or hypersystole with FHR changes such as persistent decelerations, tachycardia or decreased short‐term variability). </p> <p>We have included outcomes in the analysis: if reasonable measures were taken to minimise observer bias; and data were available for analysis according to original allocation. </p> <p>In more recent reviews and updates the following outcomes have been added.</p> <p>28. Neonatal infection.<br/> 29. Neonatal antibiotics.<br/> 30. Chorioamnionitis.<br/> 31. Endometritis.<br/> 32. Maternal antibiotics. </p> <p>In addition, in view of the nature of the trials and the intervention studied, we have examined some additional outcomes in this review. These include the following. </p> <p>33. Additional induction agents required.<br/> 34. Initiation of cervical ripening to delivery interval (in days). </p> </section> </section> </section> </section> <section id="CD006901-sec-0034"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> <section id="CD006901-sec-0035"> <h4 class="title">Electronic searches</h4> <p>We searched Cochrane Pregnancy and Childbirth’s Trials Register by contacting their Information Specialist (15 August 2016)<b>.</b> </p> <p>The Register is a database containing over 22,000 reports of controlled trials in the field of pregnancy and childbirth. For full search methods used to populate Pregnancy and Childbirth’s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth</a> in the Cochrane Library and select the ‘<i><b>Specialized Register</b> </i> ’ section from the options on the left side of the screen. </p> <p>Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is maintained by their Information Specialist and contains trials identified from: </p> <p> <ol id="CD006901-list-0002"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set which has been fully accounted for in the relevant review sections (<a href="./references#CD006901-bbs1-0001" title="">Included studies</a>; <a href="./references#CD006901-bbs1-0002" title="">Excluded studies</a>; <a href="./references#CD006901-bbs1-0003" title="">Studies awaiting classification</a>). </p> </section> <section id="CD006901-sec-0036"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of trial reports by hand.</p> <p>We did not apply any language or date restrictions.</p> </section> </section> <section id="CD006901-sec-0037"> <h3 class="title" id="CD006901-sec-0037">Data collection and analysis</h3> <p>To avoid duplication of data the labour induction methods have been listed in a specific order, from one to 27. Each review includes comparisons between one of the methods (from two to 28), with only those methods above it on the list. Thus, the review of intravenous oxytocin (4) includes only comparisons with intracervical prostaglandins (3), vaginal prostaglandins (2) or placebo (1). Methods identified in the future will be added to the end of the list. The current list is as follows: </p> <p> <ol id="CD006901-list-0003"> <li> <p>placebo/no treatment;</p> </li> <li> <p>vaginal prostaglandins (<a href="./references#CD006901-bbs2-0076" title="ThomasJ , FaircloughA , KavanaghJ , KellyAJ . Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD003101.pub3] ">Thomas 2014</a>); </p> </li> <li> <p>intracervical prostaglandins (<a href="./references#CD006901-bbs2-0042" title="BoulvainM , KellyAJ , IrionO . Intracervical prostaglandins for induction of labour. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD006971] ">Boulvain 2008</a>); </p> </li> <li> <p>intravenous oxytocin (<a href="./references#CD006901-bbs2-0038" title="AlfirevicZ , KellyAJ , DowswellT . Intravenous oxytocin alone for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD003246.pub2] ">Alfirevic 2009</a>); </p> </li> <li> <p>amniotomy (<a href="./references#CD006901-bbs2-0044" title="BrickerL , LuckasM . Amniotomy alone for induction of labour. Cochrane Database of Systematic Reviews2000, Issue 4. [DOI: 10.1002/14651858.CD002862] ">Bricker 2000</a>); </p> </li> <li> <p>intravenous oxytocin with amniotomy (<a href="./references#CD006901-bbs2-0056" title="HowarthGR , BothaDJ . Amniotomy plus intravenous oxytocin for induction of labour. Cochrane Database of Systematic Reviews2001, Issue 3. [DOI: 10.1002/14651858.CD003250] ">Howarth 2001</a>); </p> </li> <li> <p>vaginal misoprostol (<a href="./references#CD006901-bbs2-0054" title="HofmeyrGJ , GülmezogluAM , PileggiC . Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD000941] ">Hofmeyr 2003</a>); </p> </li> <li> <p>oral misoprostol (<a href="./references#CD006901-bbs2-0039" title="AlfirevicZ , AflaifelN , WeeksA . Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD001338.pub3] ">Alfirevic 2014</a>); </p> </li> <li> <p>mechanical methods including extra‐amniotic Foley catheter (<a href="./references#CD006901-bbs2-0059" title="JozwiakM , BloemenkampWM , KellyA , MolBWJ , IrionO , BoulvainM . Mechanical methods for induction of labour. Cochrane Database of Systematic Reviews2012, Issue 3. [DOI: 10.1002/14651858.CD001233.pub2] ">Jozwiak 2012</a>); </p> </li> <li> <p>membrane sweeping (<a href="./references#CD006901-bbs2-0041" title="BoulvainM , StanC , IrionO . Membrane sweeping for induction of labour. Cochrane Database of Systematic Reviews2005, Issue 1. [DOI: 10.1002/14651858.CD000451.pub2] ">Boulvain 2005</a>); </p> </li> <li> <p>extra‐amniotic prostaglandins (<a href="./references#CD006901-bbs2-0057" title="HuttonE , MozurkewichE . Extra‐amniotic prostaglandin for induction of labour. Cochrane Database of Systematic Reviews2001, Issue 2. [DOI: 10.1002/14651858.CD003092] ">Hutton 2001</a>); </p> </li> <li> <p>intravenous prostaglandins (<a href="./references#CD006901-bbs2-0067" title="LuckasM , BrickerL . Intravenous prostaglandin for induction of labour. Cochrane Database of Systematic Reviews2000, Issue 4. [DOI: 10.1002/14651858.CD002864] ">Luckas 2000</a>); </p> </li> <li> <p>oral prostaglandins (<a href="./references#CD006901-bbs2-0051" title="FrenchL . Oral prostaglandin E2 for induction of labour. Cochrane Database of Systematic Reviews2001, Issue 2. [DOI: 10.1002/14651858.CD003098] ">French 2001</a>); </p> </li> <li> <p>mifepristone (Hapangama 2009);</p> </li> <li> <p>estrogens (<a href="./references#CD006901-bbs2-0075" title="ThomasJ , KellyAJ , KavanaghJ . Oestrogens alone or with amniotomy for cervical ripening or induction of labour. Cochrane Database of Systematic Reviews2001, Issue 4. [DOI: 10.1002/14651858.CD003393] ">Thomas 2001</a>); </p> </li> <li> <p>corticosteroids (<a href="./references#CD006901-bbs2-0062" title="KavanaghJ , KellyAJ , ThomasJ . Corticosteroids for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD003100.pub2] ">Kavanagh 2006a</a>); </p> </li> <li> <p>relaxin (<a href="./references#CD006901-bbs2-0064" title="KellyAJ , KavanaghJ , ThomasJ . Relaxin for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2001, Issue 2. [DOI: 10.1002/14651858.CD003103] ">Kelly 2001a</a>); </p> </li> <li> <p>hyaluronidase (<a href="./references#CD006901-bbs2-0063" title="KavanaghJ , KellyAJ , ThomasJ . Hyaluronidase for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD003097.pub2] ">Kavanagh 2006b</a>); </p> </li> <li> <p>castor oil, bath, and/or enema (<a href="./references#CD006901-bbs2-0065" title="KellyAJ , KavanaghJ , ThomasJ . Castor oil, bath and/or enema for cervical priming and induction of labour. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD003099.pub2] ">Kelly 2013b</a>); </p> </li> <li> <p>acupuncture (<a href="./references#CD006901-bbs2-0073" title="SmithCA , CrowtherCA , GrantSJ . Acupuncture for induction of labour. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD002962.pub3] ">Smith 2013</a>); </p> </li> <li> <p>breast stimulation (<a href="./references#CD006901-bbs2-0061" title="KavanaghJ , KellyAJ , ThomasJ . Breast stimulation for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD003392.pub2] ">Kavanagh 2005</a>); </p> </li> <li> <p>sexual intercourse (<a href="./references#CD006901-bbs2-0060" title="KavanaghJ , KellyAJ , ThomasJ . Sexual intercourse for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2001, Issue 2. [DOI: 10.1002/14651858.CD003093] ">Kavanagh 2001</a>); </p> </li> <li> <p>homoeopathic methods (<a href="./references#CD006901-bbs2-0072" title="SmithCA . Homoeopathy for induction of labour. Cochrane Database of Systematic Reviews2003, Issue 4. [DOI: 10.1002/14651858.CD003399] ">Smith 2003</a>); </p> </li> <li> <p><b>nitric oxide</b>; </p> </li> <li> <p>buccal or sublingual misoprostol (<a href="./references#CD006901-bbs2-0068" title="MuzonziniG , HofmeyrGJ . Buccal or sublingual misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2004, Issue 4. [DOI: 10.1002/14651858.CD004221.pub2] ">Muzonzini 2004</a>); </p> </li> <li> <p>hypnosis;</p> </li> <li> <p>other methods for induction of labour.</p> </li> </ol> </p> <p>For methods used in the previous version of this review, <i>see</i><a href="./references#CD006901-bbs2-0080" title="KellyAJ , MunsonC , MindenL . Nitric oxide donors for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2011, Issue 6. [DOI: 10.1002/14651858.CD006901.pub2] ">Kelly 2011</a>. </p> <p>For this update, the following methods were used for assessing the reports that were identified as a result of the updated search. </p> <p>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> <section id="CD006901-sec-0038"> <h4 class="title">Selection of studies</h4> <p>Three review authors independently assessed for inclusion all the potential studies we identified as a result of the search strategy. We resolved any disagreement through discussion. </p> </section> <section id="CD006901-sec-0039"> <h4 class="title">Data extraction and management</h4> <p>We used a standardised form to extract data. For eligible studies, all three review authors extracted the data using the agreed form. We resolved discrepancies through discussion. We entered data into Review Manager software (<a href="./references#CD006901-bbs2-0071" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and checked for accuracy. </p> <p>When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details. </p> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> </section> <section id="CD006901-sec-0040"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>All three review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006901-bbs2-0053" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We resolved any disagreement by discussion. </p> <section id="CD006901-sec-0041"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD006901-list-0004"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.   </p> </li> </ul> </p> </section> <section id="CD006901-sec-0042"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assess whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD006901-list-0005"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.   </p> </li> </ul> </p> </section> <section id="CD006901-sec-0043"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered studies to be at low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to have affected the results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD006901-list-0006"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel;</p> </li> <li> <p>low, high or unclear risk of bias for outcome assessors.</p> </li> </ul> </p> </section> <section id="CD006901-sec-0044"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD006901-list-0007"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD006901-sec-0045"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or was supplied by the trial authors, we re‐included missing data in the analyses which we undertook. </p> <p>We assessed methods as:</p> <p> <ul id="CD006901-list-0008"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD006901-sec-0046"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD006901-list-0009"> <li> <p>low risk of bias (where it is clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD006901-sec-0047"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described for each included study any important concerns we have about other possible sources of bias. </p> <p>We assessed whether each study was free of other problems that could put it at risk of bias: </p> <p> <ul id="CD006901-list-0010"> <li> <p>low risk of other bias;</p> </li> <li> <p>high risk of other bias;</p> </li> <li> <p>unclear whether there is risk of other bias.</p> </li> </ul> </p> </section> <section id="CD006901-sec-0048"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="./references#CD006901-bbs2-0053" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it is likely to impact on the findings.  We explored the impact of the level of bias through undertaking sensitivity analyses ‐ <i>see</i><a href="#CD006901-sec-0060">Sensitivity analysis</a>. </p> </section> <section id="CD006901-sec-0049"> <h5 class="title">Assessment of the quality of the evidence using the GRADE approach</h5> <p>For this update, we assessed the quality of the evidence using the GRADE approach as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE handbook</a> in order to assess the quality of the body of evidence relating to the following outcomes for the main comparison NO donors versus placebo. </p> <p> <ol id="CD006901-list-0011"> <li> <p>Vaginal delivery not achieved within 24 hours (or period specified by trial authors).</p> </li> <li> <p>Uterine hyperstimulation with FHR changes.</p> </li> <li> <p>Caesarean section.</p> </li> <li> <p>Serious neonatal morbidity or perinatal death (e.g. seizures, birth asphyxia defined by trialists, neonatal encephalopathy, disability in childhood). </p> </li> <li> <p>Serious maternal morbidity or death (e.g. uterine rupture, admission to intensive care unit, septicaemia). </p> </li> </ol> </p> <p>We used the <a href="http://www.guidelinedevelopment.org/" target="_blank">GRADEpro</a> Guideline Development Tool to import data from Review Manager 5.3 (<a href="./references#CD006901-bbs2-0071" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) in order to create a ’Summary of findings’ table. A summary of the intervention effect and a measure of quality for each of the above outcomes was produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. </p> </section> </section> <section id="CD006901-sec-0050"> <h4 class="title">Measures of treatment effect</h4> <section id="CD006901-sec-0051"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we present results as summary risk ratio (RR) with 95% confidence intervals (CI).  </p> </section> <section id="CD006901-sec-0052"> <h5 class="title">Continuous data</h5> <p>No continuous data were analysed in this review. In future updates, if available, we will use the mean difference if outcomes are measured in the same way between trials. We will use the standardised mean difference to combine trials that measure the same outcome, but use different methods.   </p> </section> </section> <section id="CD006901-sec-0053"> <h4 class="title">Unit of analysis issues</h4> <p>Cross‐over trials were not eligible for inclusion due to the nature of their design. No cluster‐randomised controlled trials were included in the review. In future updates of this review, if cluster‐randomised trials became available, we plan to include them. </p> <section id="CD006901-sec-0054"> <h5 class="title">Cluster‐randomised trials</h5> <p>If identified in future updates, we will include cluster‐randomised trials in the analyses along with individually‐randomised trials. We will adjust their sample sizes or standard errors using the methods described in the <i>Handbook [Section 16.3.4 or 16.3.6]</i> using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit. </p> </section> </section> <section id="CD006901-sec-0055"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. We explored the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. </p> <p>For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD006901-sec-0056"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if the Tau² is greater than zero and either an I² was greater than 30% or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. </p> </section> <section id="CD006901-sec-0057"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates of this review, if there are 10 or more studies in a meta‐analysis, we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If we detect asymmetry visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD006901-sec-0058"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using Review Manager software (<a href="./references#CD006901-bbs2-0071" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if we detected substantial statistical heterogeneity, we used random‐effects meta‐analysis to produce an overall summary, if we considered an average treatment effect across trials was clinically meaningful. We treated the random‐effects summary as the average of the range of possible treatment effects and discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials. </p> <p>Where we used random‐effects analyses, we presented the results as the average treatment effect with its 95% CI, and the estimates of Tau² and I². </p> </section> <section id="CD006901-sec-0059"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where we identified substantial heterogeneity, we investigated it using subgroup analyses and sensitivity analyses. We considered whether an overall summary was meaningful, and if it was, used random‐effects analysis to produce it. </p> <p>We carried out the following subgroup analyses.</p> <p> <ol id="CD006901-list-0012"> <li> <p>Slow release versus standard release (<a href="./references#CD006901-fig-0008" title="">Analysis 1.6</a>; <a href="./references#CD006901-fig-0024" title="">Analysis 1.22</a>) </p> </li> <li> <p>One type of NO donor versus a different NO donor (Analyses 7 to 24)</p> </li> </ol> </p> <p>We carried out subgroup analyses for all outcomes in the above analyses.</p> <p>We assessed subgroup differences by interaction tests available within RevMan (<a href="./references#CD006901-bbs2-0071" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We reported the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> <section id="CD006901-sec-0060"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analysis on the basis of trial quality.</p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006901-sec-0061" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006901-sec-0061"></div> <section id="CD006901-sec-0062"> <h3 class="title">Description of studies</h3> <section id="CD006901-sec-0063"> <h4 class="title">Results of the search</h4> <p>In total, we considered 36 trials. We excluded 13 (for details, <i>see</i><a href="./references#CD006901-sec-0124" title="">Characteristics of excluded studies</a>), and included 23 (involving a total of 4777 women) (for details, <i>see</i><a href="./references#CD006901-sec-0123" title="">Characteristics of included studies</a>). </p> </section> <section id="CD006901-sec-0064"> <h4 class="title">Included studies</h4> <p> <ol id="CD006901-list-0013"> <li> <p>Ten studies compared nitric oxide (NO) donors with placebo (<a href="./references#CD006901-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a>; <a href="./references#CD006901-bbs2-0002" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. NormanJ . Pharmacokinetics of nitric oxide donors administered per vaginam in the third trimester of pregnancy. National Research Register (www.controlled‐trials.com) (accessed 26 July 2001). ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27:30‐5. ">Bollapragada 2009</a>; <a href="./references#CD006901-bbs2-0003" title="BullarboM , ErikssonO , AnderschB , GranstromL , NorstromA , ErkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196:50.e1‐50.e5. BullarboM , NorstromA , AnderschB , EkerhovdE . Isosorbide mononitrate induces increased cervical expression of cyclooxygenase‐2, but not of cyclooxygenase‐1, at term. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2007;130(2):160‐4. ">Bullarbo 2007</a>; <a href="./references#CD006901-bbs2-0008" title="HaghighiL , MoukhahS , GoshtasbiA . Comparing the effect of oral and vaginal isosorbide dinitrate in pre‐induction cervical ripening in term pregnancy: A controlled clinical trial. Advanced Biomedical Research2015;4:129. MoukhahS , AhmadiF . Preinduction cervical ripening using oral and vaginal isosorbide dinitrate in patients with term pregnancy: A randomized clinical trial. Koomesh2016;17(4):863‐70. ">Haghighi 2015</a>; <a href="./references#CD006901-bbs2-0010" title="KrishnamurthyR , PallaveeP , GhoseS . Evaluation of isosorbide mononitrate for preinduction of cervical ripening: A randomized placebo‐controlled trial. Journal of Family and Reproductive Health2015;9:75‐81. ">Krishnamurthy 2015</a>; <a href="./references#CD006901-bbs2-0012" title="NicollAE , MackenzieF , GreerIA , NormanJE . Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics. American Journal of Obstetrics and Gynecology2001;184:958‐64. ">Nicoll 2001</a>; <a href="./references#CD006901-bbs2-0015" title="RameezMF , GoonewardeneIM . Nitric oxide donor isosorbide mononitrate for pre‐induction cervical ripening at 41 weeks' gestation: a randomized controlled trial. Journal of Obstetrics and Gynaecology Research2007;33(4):452‐6. ">Rameez 2007</a>; <a href="./references#CD006901-bbs2-0019" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>; <a href="./references#CD006901-bbs2-0022" title="VidanagamageRS , GoonewardeneIM . The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial. Ceylon Medical Journal2011;56(3):91‐100. ">Vidanagamage 2011</a>; <a href="./references#CD006901-bbs2-0023" title="YazdizadehH , AbediP , NajarS , AngaliKA . The impact of isosorbide mononitrate on cervical ripening and labor induction in primiparous women with term pregnancy: A double‐blind, randomized, controlled trial. Iranian Journal of Nursing and Midwifery Research2013; Vol. 18, issue 3:246‐50. ">Yazdizadeh 2013</a>). </p> </li> <li> <p>Three studies compared NO donors with vaginal prostaglandin E2 (PGE2) (<a href="./references#CD006901-bbs2-0004" title="ChanrachakulB , HerabutyaY , PunyavachiraP . Potential efficacy of nitric oxide for cervical ripening on pregnancy at term. International Journal of Gynecology &amp; Obstetrics2000;71:217‐9. ChanrachakulB , HerabutyaY , PunyavachiraP . Randomised comparison of glyceryl trinitrate and prostaglandin E2 for cervical ripening at term. Obstetrics and Gynecology2000;96:549‐53. ChanrachakulB , HerbutyaY . Phase II to determine the potential efficacy and safety of nitric oxide for cervical ripening in pregnancy at term. XVI FIGO World Congress of Obstetrics &amp; Gynecology (Book 4); 2000 Sept 3‐8; Washington DC, USA. 2000:68‐9. ">Chanrachakul 2000</a>; <a href="./references#CD006901-bbs2-0013" title="OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The &quot;PRIM&quot; study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. American Journal of Obstetrics and Gynecology2006;194(4):1012‐21. OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for pre‐induction cervical ripening at term [abstract]. BJOG: an international journal of obstetrics and gynaecology2005;112(4):512. OsmanI , MackenzieF , NorrieJ , GreerA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for preinduction cervical ripening at term [abstract]. Journal of Obstetrics and Gynaecology2004;24(Suppl 1):S67. OsmanI , NormanJ , MackenzieF , MurrayH , NorrieJ , GreerI . The &quot;PRIM&quot; study: a randomised comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening prior to the induction of labour at term [abstract]. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S184. ">Osman 2006</a>; <a href="./references#CD006901-bbs2-0018" title="Romero‐GutierrezG , GonzalezOEB , Ponce‐Ponce de LeonA . Isosorbide and dinoprostone for induction of labor [Isosorbide y dinoprostona en induccion del trabajo de parto]. Ginecologia y Obstetricia de Mexico2011;79(5):285‐91. ">Romero‐Gutierrez 2011</a>). </p> </li> <li> <p>Seven studies compared NO donors with vaginal misoprostol (<a href="./references#CD006901-bbs2-0005" title="ChanrachakulB , HerabutyaY , PunyavachiraP . Randomized trial of isosorbide mononitrate versus misoprostol for cervical ripening at term. International Journal of Gynecology &amp; Obstetrics2002;78:139‐45. ">Chanrachakul 2002</a>; <a href="./references#CD006901-bbs2-0006" title="GuhaK , FatemaA , BiswasPK , HaqueE . Isosorbide mononitrate versus misoprostol for cervical ripening and induction of labour at term. Mymensingh Medical Journal : Mmj2015;24(2):346‐51. ">Guha 2015</a>; <a href="./references#CD006901-bbs2-0007" title="HaghighiL , HomamH , RaoofiZ , NajmiZ . Intravaginal isosorbide dinitrate or misoprostol for cervical ripening prior to induction of labour: A randomised controlled trial. Journal of Obstetrics and Gynaecology2013;33(3):272‐6. ">Haghighi 2013</a>; <a href="./references#CD006901-bbs2-0014" title="PercheS , GuerraM , ReynaE , HidalgoM , SantosJ , MejiaJ , et al. Vaginal isosorbide mononitrate or misoprostol for cervical ripening in term pregnancies. Clinica e Investigacion en Ginecologia y Obstetricia2009;36(6):203‐8. ">Perche 2009</a>; <a href="./references#CD006901-bbs2-0016" title="RazaqA . Isosorbide mononitrate versus misoprostol for cervical ripening. Al‐Kindy College Medical Journal2011;8(1):69‐74. ">Razaq 2011</a>; <a href="./references#CD006901-bbs2-0020" title="SharmaY , KumarS , MittalS , MisraR , DadhwalV . Evaluation of glyceryl trinitrate, misoprostol, and prostaglandin E2 gel for preinduction cervical ripening in term pregnancy. Journal of Obstetrics and Gynaecology Research2005;31(3):210‐5. ">Sharma 2005</a>; <a href="./references#CD006901-bbs2-0021" title="SolimanAT . A comparison of isosorbide mononitrate, misoprostol, and combination therapy for preinduction cervical ripening at term: a randomized controlled trial. Tanta Medical Journal2013;41(4):310‐7. ">Soliman 2013</a>). </p> </li> <li> <p>One study had three arms and compared NO donors with both intracervical PGE2 and vaginal misoprostol (<a href="./references#CD006901-bbs2-0020" title="SharmaY , KumarS , MittalS , MisraR , DadhwalV . Evaluation of glyceryl trinitrate, misoprostol, and prostaglandin E2 gel for preinduction cervical ripening in term pregnancy. Journal of Obstetrics and Gynaecology Research2005;31(3):210‐5. ">Sharma 2005</a>). </p> </li> <li> <p>One study had three arms and compared NO donors with vaginal misoprostol and with a combination of vaginal misoprostol and NO donor, which is a complex intervention. We have not included the data from this arm of the study in the review (<a href="./references#CD006901-bbs2-0021" title="SolimanAT . A comparison of isosorbide mononitrate, misoprostol, and combination therapy for preinduction cervical ripening at term: a randomized controlled trial. Tanta Medical Journal2013;41(4):310‐7. ">Soliman 2013</a>). </p> </li> <li> <p>One study compared NO donors with intracervical PGE2 only (<a href="./references#CD006901-bbs2-0009" title="KadianND . Comparison of nitric oxide donor isosorbide dinitrate (IDN) and dinoprostone for cervical ripening before induction of labor at term. BJOG: an international journal of obstetrics and gynaecology2008;115(s1):76. ">Kadian 2008</a>). </p> </li> <li> <p>Two studies compared NO donors with intracervical catheter (<a href="./references#CD006901-bbs2-0011" title="MovahedF , SeyedE , PakniatH , IranipourM , YazdiZ . Comparison of the effects of transcervical catheter, laminaria and isosorbide mononitrate on cervical ripening. Journal of Babol University of Medical Sciences2016;18(3):19‐24. ">Movahed 2016</a>; <a href="./references#CD006901-bbs2-0017" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>), however <a href="./references#CD006901-bbs2-0011" title="MovahedF , SeyedE , PakniatH , IranipourM , YazdiZ . Comparison of the effects of transcervical catheter, laminaria and isosorbide mononitrate on cervical ripening. Journal of Babol University of Medical Sciences2016;18(3):19‐24. ">Movahed 2016</a> did not contribute any data to the review. </p> </li> <li> <p>One study had three arms and compared standard dose ISMN and sustained release ISMN with placebo (<a href="./references#CD006901-bbs2-0022" title="VidanagamageRS , GoonewardeneIM . The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial. Ceylon Medical Journal2011;56(3):91‐100. ">Vidanagamage 2011</a>) (to allow inclusion of both intervention arms from this trial, we did not pool the results within the comparison). </p> </li> </ol> </p> <p><b>Where isosorbide mononitrate</b> (<b>ISMN) was used:</b> </p> <p> <ol id="CD006901-list-0014"> <li> <p>a dose of 40 mg was used in all but one study, where the dose was 60 mg (<a href="./references#CD006901-bbs2-0015" title="RameezMF , GoonewardeneIM . Nitric oxide donor isosorbide mononitrate for pre‐induction cervical ripening at 41 weeks' gestation: a randomized controlled trial. Journal of Obstetrics and Gynaecology Research2007;33(4):452‐6. ">Rameez 2007</a>). In one study, a sustained release formulation of 60 mg isosorbide mononitrate (ISMN) was used (<a href="./references#CD006901-bbs2-0022" title="VidanagamageRS , GoonewardeneIM . The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial. Ceylon Medical Journal2011;56(3):91‐100. ">Vidanagamage 2011</a>); </p> </li> <li> <p>a single dose was given in five studies (<a href="./references#CD006901-bbs2-0003" title="BullarboM , ErikssonO , AnderschB , GranstromL , NorstromA , ErkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196:50.e1‐50.e5. BullarboM , NorstromA , AnderschB , EkerhovdE . Isosorbide mononitrate induces increased cervical expression of cyclooxygenase‐2, but not of cyclooxygenase‐1, at term. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2007;130(2):160‐4. ">Bullarbo 2007</a>; <a href="./references#CD006901-bbs2-0005" title="ChanrachakulB , HerabutyaY , PunyavachiraP . Randomized trial of isosorbide mononitrate versus misoprostol for cervical ripening at term. International Journal of Gynecology &amp; Obstetrics2002;78:139‐45. ">Chanrachakul 2002</a>; <a href="./references#CD006901-bbs2-0012" title="NicollAE , MackenzieF , GreerIA , NormanJE . Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics. American Journal of Obstetrics and Gynecology2001;184:958‐64. ">Nicoll 2001</a>; <a href="./references#CD006901-bbs2-0017" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD006901-bbs2-0022" title="VidanagamageRS , GoonewardeneIM . The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial. Ceylon Medical Journal2011;56(3):91‐100. ">Vidanagamage 2011</a>); multiple planned doses were used in four studies (<a href="./references#CD006901-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a>; <a href="./references#CD006901-bbs2-0002" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. NormanJ . Pharmacokinetics of nitric oxide donors administered per vaginam in the third trimester of pregnancy. National Research Register (www.controlled‐trials.com) (accessed 26 July 2001). ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27:30‐5. ">Bollapragada 2009</a>; <a href="./references#CD006901-bbs2-0019" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>; <a href="./references#CD006901-bbs2-0023" title="YazdizadehH , AbediP , NajarS , AngaliKA . The impact of isosorbide mononitrate on cervical ripening and labor induction in primiparous women with term pregnancy: A double‐blind, randomized, controlled trial. Iranian Journal of Nursing and Midwifery Research2013; Vol. 18, issue 3:246‐50. ">Yazdizadeh 2013</a>); and multiple doses as required were used in six studies (<a href="./references#CD006901-bbs2-0006" title="GuhaK , FatemaA , BiswasPK , HaqueE . Isosorbide mononitrate versus misoprostol for cervical ripening and induction of labour at term. Mymensingh Medical Journal : Mmj2015;24(2):346‐51. ">Guha 2015</a>; <a href="./references#CD006901-bbs2-0010" title="KrishnamurthyR , PallaveeP , GhoseS . Evaluation of isosorbide mononitrate for preinduction of cervical ripening: A randomized placebo‐controlled trial. Journal of Family and Reproductive Health2015;9:75‐81. ">Krishnamurthy 2015</a>; <a href="./references#CD006901-bbs2-0014" title="PercheS , GuerraM , ReynaE , HidalgoM , SantosJ , MejiaJ , et al. Vaginal isosorbide mononitrate or misoprostol for cervical ripening in term pregnancies. Clinica e Investigacion en Ginecologia y Obstetricia2009;36(6):203‐8. ">Perche 2009</a>; <a href="./references#CD006901-bbs2-0020" title="SharmaY , KumarS , MittalS , MisraR , DadhwalV . Evaluation of glyceryl trinitrate, misoprostol, and prostaglandin E2 gel for preinduction cervical ripening in term pregnancy. Journal of Obstetrics and Gynaecology Research2005;31(3):210‐5. ">Sharma 2005</a>; <a href="./references#CD006901-bbs2-0019" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>; <a href="./references#CD006901-bbs2-0021" title="SolimanAT . A comparison of isosorbide mononitrate, misoprostol, and combination therapy for preinduction cervical ripening at term: a randomized controlled trial. Tanta Medical Journal2013;41(4):310‐7. ">Soliman 2013</a>); </p> </li> <li> <p>all but one study used the ISMN vaginally.</p> </li> </ol> </p> <p><b>Where isosorbide dinitrate</b> (<b>ISDN) was used:</b> </p> <p> <ol id="CD006901-list-0015"> <li> <p>a dose of 40 mg was used in four studies (<a href="./references#CD006901-bbs2-0007" title="HaghighiL , HomamH , RaoofiZ , NajmiZ . Intravaginal isosorbide dinitrate or misoprostol for cervical ripening prior to induction of labour: A randomised controlled trial. Journal of Obstetrics and Gynaecology2013;33(3):272‐6. ">Haghighi 2013</a>; <a href="./references#CD006901-bbs2-0008" title="HaghighiL , MoukhahS , GoshtasbiA . Comparing the effect of oral and vaginal isosorbide dinitrate in pre‐induction cervical ripening in term pregnancy: A controlled clinical trial. Advanced Biomedical Research2015;4:129. MoukhahS , AhmadiF . Preinduction cervical ripening using oral and vaginal isosorbide dinitrate in patients with term pregnancy: A randomized clinical trial. Koomesh2016;17(4):863‐70. ">Haghighi 2015</a>; <a href="./references#CD006901-bbs2-0009" title="KadianND . Comparison of nitric oxide donor isosorbide dinitrate (IDN) and dinoprostone for cervical ripening before induction of labor at term. BJOG: an international journal of obstetrics and gynaecology2008;115(s1):76. ">Kadian 2008</a>; <a href="./references#CD006901-bbs2-0013" title="OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The &quot;PRIM&quot; study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. American Journal of Obstetrics and Gynecology2006;194(4):1012‐21. OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for pre‐induction cervical ripening at term [abstract]. BJOG: an international journal of obstetrics and gynaecology2005;112(4):512. OsmanI , MackenzieF , NorrieJ , GreerA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for preinduction cervical ripening at term [abstract]. Journal of Obstetrics and Gynaecology2004;24(Suppl 1):S67. OsmanI , NormanJ , MackenzieF , MurrayH , NorrieJ , GreerI . The &quot;PRIM&quot; study: a randomised comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening prior to the induction of labour at term [abstract]. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S184. ">Osman 2006</a>), in three studies a maximum of two doses were used, in one a single dose of 40 mg was used (<a href="./references#CD006901-bbs2-0013" title="OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The &quot;PRIM&quot; study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. American Journal of Obstetrics and Gynecology2006;194(4):1012‐21. OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for pre‐induction cervical ripening at term [abstract]. BJOG: an international journal of obstetrics and gynaecology2005;112(4):512. OsmanI , MackenzieF , NorrieJ , GreerA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for preinduction cervical ripening at term [abstract]. Journal of Obstetrics and Gynaecology2004;24(Suppl 1):S67. OsmanI , NormanJ , MackenzieF , MurrayH , NorrieJ , GreerI . The &quot;PRIM&quot; study: a randomised comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening prior to the induction of labour at term [abstract]. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S184. ">Osman 2006</a>); </p> </li> <li> <p>a dose of 20 mg was used in one study (<a href="./references#CD006901-bbs2-0018" title="Romero‐GutierrezG , GonzalezOEB , Ponce‐Ponce de LeonA . Isosorbide and dinoprostone for induction of labor [Isosorbide y dinoprostona en induccion del trabajo de parto]. Ginecologia y Obstetricia de Mexico2011;79(5):285‐91. ">Romero‐Gutierrez 2011</a>) to a maximum of three doses; </p> </li> <li> <p>a dose of 20 mg used orally in the third arm of one trial (<a href="./references#CD006901-bbs2-0008" title="HaghighiL , MoukhahS , GoshtasbiA . Comparing the effect of oral and vaginal isosorbide dinitrate in pre‐induction cervical ripening in term pregnancy: A controlled clinical trial. Advanced Biomedical Research2015;4:129. MoukhahS , AhmadiF . Preinduction cervical ripening using oral and vaginal isosorbide dinitrate in patients with term pregnancy: A randomized clinical trial. Koomesh2016;17(4):863‐70. ">Haghighi 2015</a>) to a maximum of two doses. </p> </li> </ol> </p> <p><b>Where glyceryl trinitrate (GTN) was used:</b> </p> <p> <ul id="CD006901-list-0016"> <li> <p>a dose of 500 mcg was used in both studies (<a href="./references#CD006901-bbs2-0004" title="ChanrachakulB , HerabutyaY , PunyavachiraP . Potential efficacy of nitric oxide for cervical ripening on pregnancy at term. International Journal of Gynecology &amp; Obstetrics2000;71:217‐9. ChanrachakulB , HerabutyaY , PunyavachiraP . Randomised comparison of glyceryl trinitrate and prostaglandin E2 for cervical ripening at term. Obstetrics and Gynecology2000;96:549‐53. ChanrachakulB , HerbutyaY . Phase II to determine the potential efficacy and safety of nitric oxide for cervical ripening in pregnancy at term. XVI FIGO World Congress of Obstetrics &amp; Gynecology (Book 4); 2000 Sept 3‐8; Washington DC, USA. 2000:68‐9. ">Chanrachakul 2000</a>; <a href="./references#CD006901-bbs2-0020" title="SharmaY , KumarS , MittalS , MisraR , DadhwalV . Evaluation of glyceryl trinitrate, misoprostol, and prostaglandin E2 gel for preinduction cervical ripening in term pregnancy. Journal of Obstetrics and Gynaecology Research2005;31(3):210‐5. ">Sharma 2005</a>). </p> </li> </ul> </p> <p><b>Additonal induction agents</b> </p> <p>In addition to the study medication, additional agents were used for cervical ripening prior to amniotomy and intravenous oxytocin in four studies. In five trials, this was additional doses of vaginal PGE2 (<a href="./references#CD006901-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a>; <a href="./references#CD006901-bbs2-0002" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. NormanJ . Pharmacokinetics of nitric oxide donors administered per vaginam in the third trimester of pregnancy. National Research Register (www.controlled‐trials.com) (accessed 26 July 2001). ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27:30‐5. ">Bollapragada 2009</a>; <a href="./references#CD006901-bbs2-0003" title="BullarboM , ErikssonO , AnderschB , GranstromL , NorstromA , ErkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196:50.e1‐50.e5. BullarboM , NorstromA , AnderschB , EkerhovdE . Isosorbide mononitrate induces increased cervical expression of cyclooxygenase‐2, but not of cyclooxygenase‐1, at term. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2007;130(2):160‐4. ">Bullarbo 2007</a>; <a href="./references#CD006901-bbs2-0013" title="OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The &quot;PRIM&quot; study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. American Journal of Obstetrics and Gynecology2006;194(4):1012‐21. OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for pre‐induction cervical ripening at term [abstract]. BJOG: an international journal of obstetrics and gynaecology2005;112(4):512. OsmanI , MackenzieF , NorrieJ , GreerA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for preinduction cervical ripening at term [abstract]. Journal of Obstetrics and Gynaecology2004;24(Suppl 1):S67. OsmanI , NormanJ , MackenzieF , MurrayH , NorrieJ , GreerI . The &quot;PRIM&quot; study: a randomised comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening prior to the induction of labour at term [abstract]. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S184. ">Osman 2006</a>; <a href="./references#CD006901-bbs2-0019" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>), and in two studies this additional ripening was effected using an intracervical extra amniotic Foley catheter (<a href="./references#CD006901-bbs2-0015" title="RameezMF , GoonewardeneIM . Nitric oxide donor isosorbide mononitrate for pre‐induction cervical ripening at 41 weeks' gestation: a randomized controlled trial. Journal of Obstetrics and Gynaecology Research2007;33(4):452‐6. ">Rameez 2007</a>; <a href="./references#CD006901-bbs2-0022" title="VidanagamageRS , GoonewardeneIM . The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial. Ceylon Medical Journal2011;56(3):91‐100. ">Vidanagamage 2011</a>). </p> <p><b>Trial setting</b> </p> <p>Five trials were conducted in an outpatient setting (<a href="./references#CD006901-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a>; <a href="./references#CD006901-bbs2-0002" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. NormanJ . Pharmacokinetics of nitric oxide donors administered per vaginam in the third trimester of pregnancy. National Research Register (www.controlled‐trials.com) (accessed 26 July 2001). ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27:30‐5. ">Bollapragada 2009</a>; <a href="./references#CD006901-bbs2-0003" title="BullarboM , ErikssonO , AnderschB , GranstromL , NorstromA , ErkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196:50.e1‐50.e5. BullarboM , NorstromA , AnderschB , EkerhovdE . Isosorbide mononitrate induces increased cervical expression of cyclooxygenase‐2, but not of cyclooxygenase‐1, at term. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2007;130(2):160‐4. ">Bullarbo 2007</a>; <a href="./references#CD006901-bbs2-0017" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD006901-bbs2-0019" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>). </p> <p>This information is summarised in <a href="./references#CD006901-sec-0123" title="">Characteristics of included studies</a>. </p> </section> <section id="CD006901-sec-0065"> <h4 class="title">Excluded studies</h4> <p>We excluded 13 studies (for details, <i>see</i><a href="./references#CD006901-sec-0124" title="">Characteristics of excluded studies</a>). </p> </section> </section> <section id="CD006901-sec-0066"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias assessments are summarised in <a href="#CD006901-fig-0001">Figure 1</a> and <a href="#CD006901-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD006901-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006901-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD006901-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006901-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD006901-sec-0067"> <h4 class="title">Allocation</h4> <p>Randomisation sequence was computer‐generated in nine studies (<a href="./references#CD006901-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a>; <a href="./references#CD006901-bbs2-0002" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. NormanJ . Pharmacokinetics of nitric oxide donors administered per vaginam in the third trimester of pregnancy. National Research Register (www.controlled‐trials.com) (accessed 26 July 2001). ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27:30‐5. ">Bollapragada 2009</a>; <a href="./references#CD006901-bbs2-0004" title="ChanrachakulB , HerabutyaY , PunyavachiraP . Potential efficacy of nitric oxide for cervical ripening on pregnancy at term. International Journal of Gynecology &amp; Obstetrics2000;71:217‐9. ChanrachakulB , HerabutyaY , PunyavachiraP . Randomised comparison of glyceryl trinitrate and prostaglandin E2 for cervical ripening at term. Obstetrics and Gynecology2000;96:549‐53. ChanrachakulB , HerbutyaY . Phase II to determine the potential efficacy and safety of nitric oxide for cervical ripening in pregnancy at term. XVI FIGO World Congress of Obstetrics &amp; Gynecology (Book 4); 2000 Sept 3‐8; Washington DC, USA. 2000:68‐9. ">Chanrachakul 2000</a>; <a href="./references#CD006901-bbs2-0005" title="ChanrachakulB , HerabutyaY , PunyavachiraP . Randomized trial of isosorbide mononitrate versus misoprostol for cervical ripening at term. International Journal of Gynecology &amp; Obstetrics2002;78:139‐45. ">Chanrachakul 2002</a>; <a href="./references#CD006901-bbs2-0010" title="KrishnamurthyR , PallaveeP , GhoseS . Evaluation of isosorbide mononitrate for preinduction of cervical ripening: A randomized placebo‐controlled trial. Journal of Family and Reproductive Health2015;9:75‐81. ">Krishnamurthy 2015</a>; <a href="./references#CD006901-bbs2-0013" title="OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The &quot;PRIM&quot; study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. American Journal of Obstetrics and Gynecology2006;194(4):1012‐21. OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for pre‐induction cervical ripening at term [abstract]. BJOG: an international journal of obstetrics and gynaecology2005;112(4):512. OsmanI , MackenzieF , NorrieJ , GreerA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for preinduction cervical ripening at term [abstract]. Journal of Obstetrics and Gynaecology2004;24(Suppl 1):S67. OsmanI , NormanJ , MackenzieF , MurrayH , NorrieJ , GreerI . The &quot;PRIM&quot; study: a randomised comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening prior to the induction of labour at term [abstract]. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S184. ">Osman 2006</a>; <a href="./references#CD006901-bbs2-0017" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD006901-bbs2-0019" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>; <a href="./references#CD006901-bbs2-0021" title="SolimanAT . A comparison of isosorbide mononitrate, misoprostol, and combination therapy for preinduction cervical ripening at term: a randomized controlled trial. Tanta Medical Journal2013;41(4):310‐7. ">Soliman 2013)</a>. Random number tables were used in six studies (<a href="./references#CD006901-bbs2-0003" title="BullarboM , ErikssonO , AnderschB , GranstromL , NorstromA , ErkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196:50.e1‐50.e5. BullarboM , NorstromA , AnderschB , EkerhovdE . Isosorbide mononitrate induces increased cervical expression of cyclooxygenase‐2, but not of cyclooxygenase‐1, at term. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2007;130(2):160‐4. ">Bullarbo 2007</a>; <a href="./references#CD006901-bbs2-0012" title="NicollAE , MackenzieF , GreerIA , NormanJE . Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics. American Journal of Obstetrics and Gynecology2001;184:958‐64. ">Nicoll 2001</a>; <a href="./references#CD006901-bbs2-0014" title="PercheS , GuerraM , ReynaE , HidalgoM , SantosJ , MejiaJ , et al. Vaginal isosorbide mononitrate or misoprostol for cervical ripening in term pregnancies. Clinica e Investigacion en Ginecologia y Obstetricia2009;36(6):203‐8. ">Perche 2009</a>; <a href="./references#CD006901-bbs2-0018" title="Romero‐GutierrezG , GonzalezOEB , Ponce‐Ponce de LeonA . Isosorbide and dinoprostone for induction of labor [Isosorbide y dinoprostona en induccion del trabajo de parto]. Ginecologia y Obstetricia de Mexico2011;79(5):285‐91. ">Romero‐Gutierrez 2011</a>; <a href="./references#CD006901-bbs2-0022" title="VidanagamageRS , GoonewardeneIM . The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial. Ceylon Medical Journal2011;56(3):91‐100. ">Vidanagamage 2011</a>; <a href="./references#CD006901-bbs2-0023" title="YazdizadehH , AbediP , NajarS , AngaliKA . The impact of isosorbide mononitrate on cervical ripening and labor induction in primiparous women with term pregnancy: A double‐blind, randomized, controlled trial. Iranian Journal of Nursing and Midwifery Research2013; Vol. 18, issue 3:246‐50. ">Yazdizadeh 2013)</a> and sequence generation method was 'unclear' in eight studies (<a href="./references#CD006901-bbs2-0006" title="GuhaK , FatemaA , BiswasPK , HaqueE . Isosorbide mononitrate versus misoprostol for cervical ripening and induction of labour at term. Mymensingh Medical Journal : Mmj2015;24(2):346‐51. ">Guha 2015</a>; <a href="./references#CD006901-bbs2-0007" title="HaghighiL , HomamH , RaoofiZ , NajmiZ . Intravaginal isosorbide dinitrate or misoprostol for cervical ripening prior to induction of labour: A randomised controlled trial. Journal of Obstetrics and Gynaecology2013;33(3):272‐6. ">Haghighi 2013</a>; <a href="./references#CD006901-bbs2-0008" title="HaghighiL , MoukhahS , GoshtasbiA . Comparing the effect of oral and vaginal isosorbide dinitrate in pre‐induction cervical ripening in term pregnancy: A controlled clinical trial. Advanced Biomedical Research2015;4:129. MoukhahS , AhmadiF . Preinduction cervical ripening using oral and vaginal isosorbide dinitrate in patients with term pregnancy: A randomized clinical trial. Koomesh2016;17(4):863‐70. ">Haghighi 2015</a>; <a href="./references#CD006901-bbs2-0009" title="KadianND . Comparison of nitric oxide donor isosorbide dinitrate (IDN) and dinoprostone for cervical ripening before induction of labor at term. BJOG: an international journal of obstetrics and gynaecology2008;115(s1):76. ">Kadian 2008</a>; <a href="./references#CD006901-bbs2-0011" title="MovahedF , SeyedE , PakniatH , IranipourM , YazdiZ . Comparison of the effects of transcervical catheter, laminaria and isosorbide mononitrate on cervical ripening. Journal of Babol University of Medical Sciences2016;18(3):19‐24. ">Movahed 2016</a>; <a href="./references#CD006901-bbs2-0015" title="RameezMF , GoonewardeneIM . Nitric oxide donor isosorbide mononitrate for pre‐induction cervical ripening at 41 weeks' gestation: a randomized controlled trial. Journal of Obstetrics and Gynaecology Research2007;33(4):452‐6. ">Rameez 2007</a>; <a href="./references#CD006901-bbs2-0016" title="RazaqA . Isosorbide mononitrate versus misoprostol for cervical ripening. Al‐Kindy College Medical Journal2011;8(1):69‐74. ">Razaq 2011</a>; <a href="./references#CD006901-bbs2-0020" title="SharmaY , KumarS , MittalS , MisraR , DadhwalV . Evaluation of glyceryl trinitrate, misoprostol, and prostaglandin E2 gel for preinduction cervical ripening in term pregnancy. Journal of Obstetrics and Gynaecology Research2005;31(3):210‐5. ">Sharma 2005</a>). One study stated that randomisation occurred in blocks, but no mention of the method of sequence generation was made (<a href="./references#CD006901-bbs2-0015" title="RameezMF , GoonewardeneIM . Nitric oxide donor isosorbide mononitrate for pre‐induction cervical ripening at 41 weeks' gestation: a randomized controlled trial. Journal of Obstetrics and Gynaecology Research2007;33(4):452‐6. ">Rameez 2007</a>). </p> <p>Allocation concealment was performed by using centrally‐dispensed (pharmacy) packs of study medication including suitable dummies in one study (<a href="./references#CD006901-bbs2-0002" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. NormanJ . Pharmacokinetics of nitric oxide donors administered per vaginam in the third trimester of pregnancy. National Research Register (www.controlled‐trials.com) (accessed 26 July 2001). ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27:30‐5. ">Bollapragada 2009</a>). Sequentially‐numbered, opaque and sealed envelopes were used in eight studies (<a href="./references#CD006901-bbs2-0003" title="BullarboM , ErikssonO , AnderschB , GranstromL , NorstromA , ErkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196:50.e1‐50.e5. BullarboM , NorstromA , AnderschB , EkerhovdE . Isosorbide mononitrate induces increased cervical expression of cyclooxygenase‐2, but not of cyclooxygenase‐1, at term. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2007;130(2):160‐4. ">Bullarbo 2007</a>; <a href="./references#CD006901-bbs2-0007" title="HaghighiL , HomamH , RaoofiZ , NajmiZ . Intravaginal isosorbide dinitrate or misoprostol for cervical ripening prior to induction of labour: A randomised controlled trial. Journal of Obstetrics and Gynaecology2013;33(3):272‐6. ">Haghighi 2013</a>; <a href="./references#CD006901-bbs2-0010" title="KrishnamurthyR , PallaveeP , GhoseS . Evaluation of isosorbide mononitrate for preinduction of cervical ripening: A randomized placebo‐controlled trial. Journal of Family and Reproductive Health2015;9:75‐81. ">Krishnamurthy 2015</a>; <a href="./references#CD006901-bbs2-0012" title="NicollAE , MackenzieF , GreerIA , NormanJE . Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics. American Journal of Obstetrics and Gynecology2001;184:958‐64. ">Nicoll 2001</a>; <a href="./references#CD006901-bbs2-0013" title="OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The &quot;PRIM&quot; study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. American Journal of Obstetrics and Gynecology2006;194(4):1012‐21. OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for pre‐induction cervical ripening at term [abstract]. BJOG: an international journal of obstetrics and gynaecology2005;112(4):512. OsmanI , MackenzieF , NorrieJ , GreerA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for preinduction cervical ripening at term [abstract]. Journal of Obstetrics and Gynaecology2004;24(Suppl 1):S67. OsmanI , NormanJ , MackenzieF , MurrayH , NorrieJ , GreerI . The &quot;PRIM&quot; study: a randomised comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening prior to the induction of labour at term [abstract]. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S184. ">Osman 2006</a>; <a href="./references#CD006901-bbs2-0015" title="RameezMF , GoonewardeneIM . Nitric oxide donor isosorbide mononitrate for pre‐induction cervical ripening at 41 weeks' gestation: a randomized controlled trial. Journal of Obstetrics and Gynaecology Research2007;33(4):452‐6. ">Rameez 2007</a>; <a href="./references#CD006901-bbs2-0021" title="SolimanAT . A comparison of isosorbide mononitrate, misoprostol, and combination therapy for preinduction cervical ripening at term: a randomized controlled trial. Tanta Medical Journal2013;41(4):310‐7. ">Soliman 2013</a>; <a href="./references#CD006901-bbs2-0022" title="VidanagamageRS , GoonewardeneIM . The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial. Ceylon Medical Journal2011;56(3):91‐100. ">Vidanagamage 2011</a>). One study used sealed envelopes (<a href="./references#CD006901-bbs2-0014" title="PercheS , GuerraM , ReynaE , HidalgoM , SantosJ , MejiaJ , et al. Vaginal isosorbide mononitrate or misoprostol for cervical ripening in term pregnancies. Clinica e Investigacion en Ginecologia y Obstetricia2009;36(6):203‐8. ">Perche 2009</a>), and another study used coded drug boxes (<a href="./references#CD006901-bbs2-0023" title="YazdizadehH , AbediP , NajarS , AngaliKA . The impact of isosorbide mononitrate on cervical ripening and labor induction in primiparous women with term pregnancy: A double‐blind, randomized, controlled trial. Iranian Journal of Nursing and Midwifery Research2013; Vol. 18, issue 3:246‐50. ">Yazdizadeh 2013</a>). One study used a web‐based application to assign women and the allocation was reported as being unavailable to the research team (<a href="./references#CD006901-bbs2-0019" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>). Ten studies were unclear on how allocation was concealed (<a href="./references#CD006901-bbs2-0004" title="ChanrachakulB , HerabutyaY , PunyavachiraP . Potential efficacy of nitric oxide for cervical ripening on pregnancy at term. International Journal of Gynecology &amp; Obstetrics2000;71:217‐9. ChanrachakulB , HerabutyaY , PunyavachiraP . Randomised comparison of glyceryl trinitrate and prostaglandin E2 for cervical ripening at term. Obstetrics and Gynecology2000;96:549‐53. ChanrachakulB , HerbutyaY . Phase II to determine the potential efficacy and safety of nitric oxide for cervical ripening in pregnancy at term. XVI FIGO World Congress of Obstetrics &amp; Gynecology (Book 4); 2000 Sept 3‐8; Washington DC, USA. 2000:68‐9. ">Chanrachakul 2000</a>; <a href="./references#CD006901-bbs2-0005" title="ChanrachakulB , HerabutyaY , PunyavachiraP . Randomized trial of isosorbide mononitrate versus misoprostol for cervical ripening at term. International Journal of Gynecology &amp; Obstetrics2002;78:139‐45. ">Chanrachakul 2002</a>; <a href="./references#CD006901-bbs2-0006" title="GuhaK , FatemaA , BiswasPK , HaqueE . Isosorbide mononitrate versus misoprostol for cervical ripening and induction of labour at term. Mymensingh Medical Journal : Mmj2015;24(2):346‐51. ">Guha 2015</a>; <a href="./references#CD006901-bbs2-0008" title="HaghighiL , MoukhahS , GoshtasbiA . Comparing the effect of oral and vaginal isosorbide dinitrate in pre‐induction cervical ripening in term pregnancy: A controlled clinical trial. Advanced Biomedical Research2015;4:129. MoukhahS , AhmadiF . Preinduction cervical ripening using oral and vaginal isosorbide dinitrate in patients with term pregnancy: A randomized clinical trial. Koomesh2016;17(4):863‐70. ">Haghighi 2015</a>; <a href="./references#CD006901-bbs2-0009" title="KadianND . Comparison of nitric oxide donor isosorbide dinitrate (IDN) and dinoprostone for cervical ripening before induction of labor at term. BJOG: an international journal of obstetrics and gynaecology2008;115(s1):76. ">Kadian 2008</a>; <a href="./references#CD006901-bbs2-0011" title="MovahedF , SeyedE , PakniatH , IranipourM , YazdiZ . Comparison of the effects of transcervical catheter, laminaria and isosorbide mononitrate on cervical ripening. Journal of Babol University of Medical Sciences2016;18(3):19‐24. ">Movahed 2016</a>; <a href="./references#CD006901-bbs2-0016" title="RazaqA . Isosorbide mononitrate versus misoprostol for cervical ripening. Al‐Kindy College Medical Journal2011;8(1):69‐74. ">Razaq 2011</a>; <a href="./references#CD006901-bbs2-0017" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD006901-bbs2-0018" title="Romero‐GutierrezG , GonzalezOEB , Ponce‐Ponce de LeonA . Isosorbide and dinoprostone for induction of labor [Isosorbide y dinoprostona en induccion del trabajo de parto]. Ginecologia y Obstetricia de Mexico2011;79(5):285‐91. ">Romero‐Gutierrez 2011</a>; <a href="./references#CD006901-bbs2-0020" title="SharmaY , KumarS , MittalS , MisraR , DadhwalV . Evaluation of glyceryl trinitrate, misoprostol, and prostaglandin E2 gel for preinduction cervical ripening in term pregnancy. Journal of Obstetrics and Gynaecology Research2005;31(3):210‐5. ">Sharma 2005</a>). One study used open allocation (<a href="./references#CD006901-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a>). </p> </section> <section id="CD006901-sec-0068"> <h4 class="title">Blinding</h4> <p>Blinding was achieved by using suitable dummies in 10 studies (<a href="./references#CD006901-bbs2-0002" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. NormanJ . Pharmacokinetics of nitric oxide donors administered per vaginam in the third trimester of pregnancy. National Research Register (www.controlled‐trials.com) (accessed 26 July 2001). ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27:30‐5. ">Bollapragada 2009</a>; <a href="./references#CD006901-bbs2-0003" title="BullarboM , ErikssonO , AnderschB , GranstromL , NorstromA , ErkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196:50.e1‐50.e5. BullarboM , NorstromA , AnderschB , EkerhovdE . Isosorbide mononitrate induces increased cervical expression of cyclooxygenase‐2, but not of cyclooxygenase‐1, at term. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2007;130(2):160‐4. ">Bullarbo 2007</a>; <a href="./references#CD006901-bbs2-0007" title="HaghighiL , HomamH , RaoofiZ , NajmiZ . Intravaginal isosorbide dinitrate or misoprostol for cervical ripening prior to induction of labour: A randomised controlled trial. Journal of Obstetrics and Gynaecology2013;33(3):272‐6. ">Haghighi 2013</a>; <a href="./references#CD006901-bbs2-0010" title="KrishnamurthyR , PallaveeP , GhoseS . Evaluation of isosorbide mononitrate for preinduction of cervical ripening: A randomized placebo‐controlled trial. Journal of Family and Reproductive Health2015;9:75‐81. ">Krishnamurthy 2015</a>; <a href="./references#CD006901-bbs2-0012" title="NicollAE , MackenzieF , GreerIA , NormanJE . Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics. American Journal of Obstetrics and Gynecology2001;184:958‐64. ">Nicoll 2001</a>; <a href="./references#CD006901-bbs2-0013" title="OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The &quot;PRIM&quot; study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. American Journal of Obstetrics and Gynecology2006;194(4):1012‐21. OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for pre‐induction cervical ripening at term [abstract]. BJOG: an international journal of obstetrics and gynaecology2005;112(4):512. OsmanI , MackenzieF , NorrieJ , GreerA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for preinduction cervical ripening at term [abstract]. Journal of Obstetrics and Gynaecology2004;24(Suppl 1):S67. OsmanI , NormanJ , MackenzieF , MurrayH , NorrieJ , GreerI . The &quot;PRIM&quot; study: a randomised comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening prior to the induction of labour at term [abstract]. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S184. ">Osman 2006</a>; <a href="./references#CD006901-bbs2-0015" title="RameezMF , GoonewardeneIM . Nitric oxide donor isosorbide mononitrate for pre‐induction cervical ripening at 41 weeks' gestation: a randomized controlled trial. Journal of Obstetrics and Gynaecology Research2007;33(4):452‐6. ">Rameez 2007</a>; <a href="./references#CD006901-bbs2-0019" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>; <a href="./references#CD006901-bbs2-0021" title="SolimanAT . A comparison of isosorbide mononitrate, misoprostol, and combination therapy for preinduction cervical ripening at term: a randomized controlled trial. Tanta Medical Journal2013;41(4):310‐7. ">Soliman 2013</a>; <a href="./references#CD006901-bbs2-0023" title="YazdizadehH , AbediP , NajarS , AngaliKA . The impact of isosorbide mononitrate on cervical ripening and labor induction in primiparous women with term pregnancy: A double‐blind, randomized, controlled trial. Iranian Journal of Nursing and Midwifery Research2013; Vol. 18, issue 3:246‐50. ">Yazdizadeh 2013</a>). No dummies were used in two studies, but it was stated that the outcome assessor was unaware of allocation in both (<a href="./references#CD006901-bbs2-0004" title="ChanrachakulB , HerabutyaY , PunyavachiraP . Potential efficacy of nitric oxide for cervical ripening on pregnancy at term. International Journal of Gynecology &amp; Obstetrics2000;71:217‐9. ChanrachakulB , HerabutyaY , PunyavachiraP . Randomised comparison of glyceryl trinitrate and prostaglandin E2 for cervical ripening at term. Obstetrics and Gynecology2000;96:549‐53. ChanrachakulB , HerbutyaY . Phase II to determine the potential efficacy and safety of nitric oxide for cervical ripening in pregnancy at term. XVI FIGO World Congress of Obstetrics &amp; Gynecology (Book 4); 2000 Sept 3‐8; Washington DC, USA. 2000:68‐9. ">Chanrachakul 2000</a>; <a href="./references#CD006901-bbs2-0005" title="ChanrachakulB , HerabutyaY , PunyavachiraP . Randomized trial of isosorbide mononitrate versus misoprostol for cervical ripening at term. International Journal of Gynecology &amp; Obstetrics2002;78:139‐45. ">Chanrachakul 2002</a>). In six studies no details were given regarding blinding of any groups (<a href="./references#CD006901-bbs2-0006" title="GuhaK , FatemaA , BiswasPK , HaqueE . Isosorbide mononitrate versus misoprostol for cervical ripening and induction of labour at term. Mymensingh Medical Journal : Mmj2015;24(2):346‐51. ">Guha 2015</a>; <a href="./references#CD006901-bbs2-0009" title="KadianND . Comparison of nitric oxide donor isosorbide dinitrate (IDN) and dinoprostone for cervical ripening before induction of labor at term. BJOG: an international journal of obstetrics and gynaecology2008;115(s1):76. ">Kadian 2008</a>; <a href="./references#CD006901-bbs2-0011" title="MovahedF , SeyedE , PakniatH , IranipourM , YazdiZ . Comparison of the effects of transcervical catheter, laminaria and isosorbide mononitrate on cervical ripening. Journal of Babol University of Medical Sciences2016;18(3):19‐24. ">Movahed 2016</a>; <a href="./references#CD006901-bbs2-0014" title="PercheS , GuerraM , ReynaE , HidalgoM , SantosJ , MejiaJ , et al. Vaginal isosorbide mononitrate or misoprostol for cervical ripening in term pregnancies. Clinica e Investigacion en Ginecologia y Obstetricia2009;36(6):203‐8. ">Perche 2009</a>; <a href="./references#CD006901-bbs2-0016" title="RazaqA . Isosorbide mononitrate versus misoprostol for cervical ripening. Al‐Kindy College Medical Journal2011;8(1):69‐74. ">Razaq 2011</a>; <a href="./references#CD006901-bbs2-0020" title="SharmaY , KumarS , MittalS , MisraR , DadhwalV . Evaluation of glyceryl trinitrate, misoprostol, and prostaglandin E2 gel for preinduction cervical ripening in term pregnancy. Journal of Obstetrics and Gynaecology Research2005;31(3):210‐5. ">Sharma 2005</a>). Two studies were single blind study (<a href="./references#CD006901-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a>; <a href="./references#CD006901-bbs2-0017" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>). In one study, women were blinded but it is unclear if therapist was blinded as well (<a href="./references#CD006901-bbs2-0018" title="Romero‐GutierrezG , GonzalezOEB , Ponce‐Ponce de LeonA . Isosorbide and dinoprostone for induction of labor [Isosorbide y dinoprostona en induccion del trabajo de parto]. Ginecologia y Obstetricia de Mexico2011;79(5):285‐91. ">Romero‐Gutierrez 2011</a>). In one study the therapist was aware of the intervention given (<a href="./references#CD006901-bbs2-0022" title="VidanagamageRS , GoonewardeneIM . The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial. Ceylon Medical Journal2011;56(3):91‐100. ">Vidanagamage 2011</a>). One study was unblinded (<a href="./references#CD006901-bbs2-0008" title="HaghighiL , MoukhahS , GoshtasbiA . Comparing the effect of oral and vaginal isosorbide dinitrate in pre‐induction cervical ripening in term pregnancy: A controlled clinical trial. Advanced Biomedical Research2015;4:129. MoukhahS , AhmadiF . Preinduction cervical ripening using oral and vaginal isosorbide dinitrate in patients with term pregnancy: A randomized clinical trial. Koomesh2016;17(4):863‐70. ">Haghighi 2015</a>). </p> </section> <section id="CD006901-sec-0069"> <h4 class="title">Incomplete outcome data</h4> <p>There were no trials where there was evidence of significant levels of attrition bias, though six were assessed as unclear (<a href="./references#CD006901-bbs2-0008" title="HaghighiL , MoukhahS , GoshtasbiA . Comparing the effect of oral and vaginal isosorbide dinitrate in pre‐induction cervical ripening in term pregnancy: A controlled clinical trial. Advanced Biomedical Research2015;4:129. MoukhahS , AhmadiF . Preinduction cervical ripening using oral and vaginal isosorbide dinitrate in patients with term pregnancy: A randomized clinical trial. Koomesh2016;17(4):863‐70. ">Haghighi 2015</a>; <a href="./references#CD006901-bbs2-0009" title="KadianND . Comparison of nitric oxide donor isosorbide dinitrate (IDN) and dinoprostone for cervical ripening before induction of labor at term. BJOG: an international journal of obstetrics and gynaecology2008;115(s1):76. ">Kadian 2008</a>; <a href="./references#CD006901-bbs2-0014" title="PercheS , GuerraM , ReynaE , HidalgoM , SantosJ , MejiaJ , et al. Vaginal isosorbide mononitrate or misoprostol for cervical ripening in term pregnancies. Clinica e Investigacion en Ginecologia y Obstetricia2009;36(6):203‐8. ">Perche 2009</a>; <a href="./references#CD006901-bbs2-0018" title="Romero‐GutierrezG , GonzalezOEB , Ponce‐Ponce de LeonA . Isosorbide and dinoprostone for induction of labor [Isosorbide y dinoprostona en induccion del trabajo de parto]. Ginecologia y Obstetricia de Mexico2011;79(5):285‐91. ">Romero‐Gutierrez 2011</a>; <a href="./references#CD006901-bbs2-0020" title="SharmaY , KumarS , MittalS , MisraR , DadhwalV . Evaluation of glyceryl trinitrate, misoprostol, and prostaglandin E2 gel for preinduction cervical ripening in term pregnancy. Journal of Obstetrics and Gynaecology Research2005;31(3):210‐5. ">Sharma 2005</a>; <a href="./references#CD006901-bbs2-0023" title="YazdizadehH , AbediP , NajarS , AngaliKA . The impact of isosorbide mononitrate on cervical ripening and labor induction in primiparous women with term pregnancy: A double‐blind, randomized, controlled trial. Iranian Journal of Nursing and Midwifery Research2013; Vol. 18, issue 3:246‐50. ">Yazdizadeh 2013</a>). </p> </section> <section id="CD006901-sec-0070"> <h4 class="title">Selective reporting</h4> <p>Two studies were assessed as having a high risk of reporting bias as neither study clearly specified which outcomes would be reported (<a href="./references#CD006901-bbs2-0008" title="HaghighiL , MoukhahS , GoshtasbiA . Comparing the effect of oral and vaginal isosorbide dinitrate in pre‐induction cervical ripening in term pregnancy: A controlled clinical trial. Advanced Biomedical Research2015;4:129. MoukhahS , AhmadiF . Preinduction cervical ripening using oral and vaginal isosorbide dinitrate in patients with term pregnancy: A randomized clinical trial. Koomesh2016;17(4):863‐70. ">Haghighi 2015</a>; <a href="./references#CD006901-bbs2-0016" title="RazaqA . Isosorbide mononitrate versus misoprostol for cervical ripening. Al‐Kindy College Medical Journal2011;8(1):69‐74. ">Razaq 2011</a>). </p> </section> <section id="CD006901-sec-0071"> <h4 class="title">Other potential sources of bias</h4> <p>No other bias was identified in 10 of the studies (<a href="./references#CD006901-bbs2-0002" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. NormanJ . Pharmacokinetics of nitric oxide donors administered per vaginam in the third trimester of pregnancy. National Research Register (www.controlled‐trials.com) (accessed 26 July 2001). ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27:30‐5. ">Bollapragada 2009</a>; <a href="./references#CD006901-bbs2-0003" title="BullarboM , ErikssonO , AnderschB , GranstromL , NorstromA , ErkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196:50.e1‐50.e5. BullarboM , NorstromA , AnderschB , EkerhovdE . Isosorbide mononitrate induces increased cervical expression of cyclooxygenase‐2, but not of cyclooxygenase‐1, at term. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2007;130(2):160‐4. ">Bullarbo 2007</a>; <a href="./references#CD006901-bbs2-0005" title="ChanrachakulB , HerabutyaY , PunyavachiraP . Randomized trial of isosorbide mononitrate versus misoprostol for cervical ripening at term. International Journal of Gynecology &amp; Obstetrics2002;78:139‐45. ">Chanrachakul 2002</a>; <a href="./references#CD006901-bbs2-0006" title="GuhaK , FatemaA , BiswasPK , HaqueE . Isosorbide mononitrate versus misoprostol for cervical ripening and induction of labour at term. Mymensingh Medical Journal : Mmj2015;24(2):346‐51. ">Guha 2015</a>; <a href="./references#CD006901-bbs2-0007" title="HaghighiL , HomamH , RaoofiZ , NajmiZ . Intravaginal isosorbide dinitrate or misoprostol for cervical ripening prior to induction of labour: A randomised controlled trial. Journal of Obstetrics and Gynaecology2013;33(3):272‐6. ">Haghighi 2013</a>; <a href="./references#CD006901-bbs2-0012" title="NicollAE , MackenzieF , GreerIA , NormanJE . Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics. American Journal of Obstetrics and Gynecology2001;184:958‐64. ">Nicoll 2001</a>; <a href="./references#CD006901-bbs2-0013" title="OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The &quot;PRIM&quot; study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. American Journal of Obstetrics and Gynecology2006;194(4):1012‐21. OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for pre‐induction cervical ripening at term [abstract]. BJOG: an international journal of obstetrics and gynaecology2005;112(4):512. OsmanI , MackenzieF , NorrieJ , GreerA , NormanJE . The 'PRIM' study ‐ a randomised comparison of prostaglandin with isosorbide mononitrate for preinduction cervical ripening at term [abstract]. Journal of Obstetrics and Gynaecology2004;24(Suppl 1):S67. OsmanI , NormanJ , MackenzieF , MurrayH , NorrieJ , GreerI . The &quot;PRIM&quot; study: a randomised comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening prior to the induction of labour at term [abstract]. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S184. ">Osman 2006</a>; <a href="./references#CD006901-bbs2-0015" title="RameezMF , GoonewardeneIM . Nitric oxide donor isosorbide mononitrate for pre‐induction cervical ripening at 41 weeks' gestation: a randomized controlled trial. Journal of Obstetrics and Gynaecology Research2007;33(4):452‐6. ">Rameez 2007</a>; <a href="./references#CD006901-bbs2-0016" title="RazaqA . Isosorbide mononitrate versus misoprostol for cervical ripening. Al‐Kindy College Medical Journal2011;8(1):69‐74. ">Razaq 2011</a>; <a href="./references#CD006901-bbs2-0022" title="VidanagamageRS , GoonewardeneIM . The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial. Ceylon Medical Journal2011;56(3):91‐100. ">Vidanagamage 2011</a>), with the remaining studies assessed as unclear risk. </p> </section> </section> <section id="CD006901-sec-0072"> <h3 class="title" id="CD006901-sec-0072">Effects of interventions</h3> <p>See: <a href="./full#CD006901-tbl-0001"><b>Summary of findings for the main comparison</b> Nitric oxide donors versus placebo for cervical ripening and induction of labour</a> </p> <section id="CD006901-sec-0073"> <h4 class="title">Comparison 1: Nitric oxide versus placebo (10 studies, 2799 women)</h4> <section id="CD006901-sec-0074"> <h5 class="title">Primary outcomes</h5> <p>There was no evidence of a difference for any of the primary outcomes when NO donors were compared to placebo for induction of labour: vaginal delivery not achieved in 24 hours (risk ratio (RR 0.97, 95% confidence interval (CI) 0.83 to 1.15; one trial, 238 women, <i>low‐quality evidence</i>, <a href="./references#CD006901-fig-0003" title="">Analysis 1.1</a>); uterine hyperstimulation with fetal heart rate (FHR) changes (RR 0.09, 95% CI 0.01 to 1.62; two trials, 300 women, <i>low‐quality evidence,</i><a href="./references#CD006901-fig-0004" title="">Analysis 1.2</a>); caesarean section (RR 0.99, 95% CI 0.88 to 1.11; nine trials, 2624 women, <i>moderate‐quality evidence</i><a href="./references#CD006901-fig-0005" title="">Analysis 1.3</a>); or serious neonatal morbidity/perinatal death (average RR 1.61, 95% CI 0.08 to 33.26; I² = 48%, two trials, 1712 women, <i>low‐quality evidence,</i><a href="./references#CD006901-fig-0006" title="">Analysis 1.4</a>). There were no instances of serious maternal morbidity or death in the one study reporting this outcome (<a href="./references#CD006901-bbs2-0019" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>). </p> </section> <section id="CD006901-sec-0075"> <h5 class="title">Clinical subgroups</h5> <p>There was no evidence of a difference for any of the primary outcomes in any of the clinical subgroups examined: </p> <p> <ol id="CD006901-list-0017"> <li> <p>unfavourable cervix (<a href="./references#CD006901-fig-0025" title="">Analysis 2.1</a>; <a href="./references#CD006901-fig-0026" title="">Analysis 2.2</a>; <a href="./references#CD006901-fig-0027" title="">Analysis 2.3</a>; <a href="./references#CD006901-fig-0028" title="">Analysis 2.4</a>); </p> </li> <li> <p>intact membranes and unfavourable cervix (<a href="./references#CD006901-fig-0042" title="">Analysis 3.1</a>; <a href="./references#CD006901-fig-0043" title="">Analysis 3.2</a>; <a href="./references#CD006901-fig-0044" title="">Analysis 3.3</a>; <a href="./references#CD006901-fig-0045" title="">Analysis 3.4</a>); </p> </li> <li> <p>all primiparae (<a href="./references#CD006901-fig-0059" title="">Analysis 4.1</a>; <a href="./references#CD006901-fig-0061" title="">Analysis 4.3</a>; <a href="./references#CD006901-fig-0062" title="">Analysis 4.4</a>); </p> </li> <li> <p>all primiparae and unfavourable cervix (<a href="./references#CD006901-fig-0074" title="">Analysis 5.1</a>; <a href="./references#CD006901-fig-0076" title="">Analysis 5.3</a>; <a href="./references#CD006901-fig-0077" title="">Analysis 5.4</a>); </p> </li> <li> <p>all primiparae, intact membranes, unfavourable cervix (<a href="./references#CD006901-fig-0089" title="">Analysis 6.1</a>; <a href="./references#CD006901-fig-0090" title="">Analysis 6.2</a>; <a href="./references#CD006901-fig-0091" title="">Analysis 6.3</a>). </p> </li> </ol> </p> </section> <section id="CD006901-sec-0076"> <h5 class="title">Secondary outcomes</h5> <p>There was a reduction in the proportion of women with an unfavourable cervix at 12 to 24 hours in those women who were treated with NO donors compared to placebo ( average RR 0.78, 95% CI 0.67 to 0.90; Tau² = 0.02; I² =64%, four trials, 762 women, <a href="./references#CD006901-fig-0008" title="">Analysis 1.6</a>). A difference was also observed in each of the subgroups: in four studies (<a href="./references#CD006901-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a>; <a href="./references#CD006901-bbs2-0002" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. NormanJ . Pharmacokinetics of nitric oxide donors administered per vaginam in the third trimester of pregnancy. National Research Register (www.controlled‐trials.com) (accessed 26 July 2001). ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27:30‐5. ">Bollapragada 2009</a>; <a href="./references#CD006901-bbs2-0010" title="KrishnamurthyR , PallaveeP , GhoseS . Evaluation of isosorbide mononitrate for preinduction of cervical ripening: A randomized placebo‐controlled trial. Journal of Family and Reproductive Health2015;9:75‐81. ">Krishnamurthy 2015</a>; <a href="./references#CD006901-bbs2-0022" title="VidanagamageRS , GoonewardeneIM . The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial. Ceylon Medical Journal2011;56(3):91‐100. ">Vidanagamage 2011</a>), there was a reduction in the proportion of women with an unfavourable cervix at 12 to 24 hours in those women who were treated with NO donors compared to placebo in comparison to placebo (RR 0.80, 95% CI 0.73 to 0.87; I² = 63%, four trials, 659 women, <a href="./references#CD006901-fig-0008" title="">Analysis 1.6</a>.1); additionally, there was evidence of a similar reduction in the proportion of women with an unfavourable cervix when treated with a slow release formulation in one study (<a href="./references#CD006901-bbs2-0022" title="VidanagamageRS , GoonewardeneIM . The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial. Ceylon Medical Journal2011;56(3):91‐100. ">Vidanagamage 2011</a>) (RR 0.63, 95% CI 0.49 to 0.82, one trial, 103 women, <a href="./references#CD006901-fig-0008" title="">Analysis 1.6</a>.2). No evidence of a difference was observed between subgroups (Test for subgroup differences: Chi² = 1.69, df = 1 (P = 0.10), I² = 62.8%). </p> <p>There were no differences observed between groups in rates of oxytocin augmentation (RR 0.95, 95% CI 0.84 to 1.07; four trials, 1916 women, I² = 61% <a href="./references#CD006901-fig-0009" title="">Analysis 1.7</a>) and there was evidence of substantial heterogeneity. No woman in the NO donor group experienced uterine hyperstimulation without FHR rate changes (RR 0.05, 95% CI 0.00 to 0.80; one trial, 200 women, <a href="./references#CD006901-fig-0010" title="">Analysis 1.8</a>). </p> <p>Induction of labour with NO when compared to placebo was associated with an increase in all maternal side effects (RR 2.82, 95% CI 2.49 to 3.20; one trial, 1362 women; <a href="./references#CD006901-fig-0017" title="">Analysis 1.15</a>), nausea (average RR 2.44, 95% CI 1.47 to 4.05; three trials, 1782 women; I² = 55%), headache (average RR 6.59, 95% CI 3.97 to 10.95; six trials, 2085 women, <a href="./references#CD006901-fig-0019" title="">Analysis 1.17</a>), and vomiting (RR 2.42, 95% CI 1.54 to 3.81; one trial, 1362 women, <a href="./references#CD006901-fig-0020" title="">Analysis 1.18</a>). There was significant heterogeneity associated with the result for maternal headache, despite using a random‐effects model (Heterogeneity: Tau² = 0.23; Chi² = 19.91, df = 5 (P = 0.001); I² = 75%). However, this was due to the results from one study (<a href="./references#CD006901-bbs2-0002" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. NormanJ . Pharmacokinetics of nitric oxide donors administered per vaginam in the third trimester of pregnancy. National Research Register (www.controlled‐trials.com) (accessed 26 July 2001). ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27:30‐5. ">Bollapragada 2009</a>) and the heterogeneity disappears if the results from this trial are excluded, resulting in a greater effect of NO. Despite close scrutiny of this trial, it was not possible to understand why the result for this trial would be so different to the others in this comparison. </p> <p>When compared to placebo, the use of NO (in a standard release formulation) for induction of labour resulted in the use of less additional induction agents (average RR 0.73, 95% CI 0.58 to 0.92; five studies, 2077 women, <a href="./references#CD006901-fig-0024" title="">Analysis 1.22</a>). However, there was evidence of significant heterogeneity in this result (Heterogeneity: Tau² = 0.06; Chi² = 33.79, df = 4 (P &lt; 0.00001, I² = 88%). This is generated by one study (<a href="./references#CD006901-bbs2-0015" title="RameezMF , GoonewardeneIM . Nitric oxide donor isosorbide mononitrate for pre‐induction cervical ripening at 41 weeks' gestation: a randomized controlled trial. Journal of Obstetrics and Gynaecology Research2007;33(4):452‐6. ">Rameez 2007</a>). This study again is comparable to others in this group and hence it is unclear why this difference is seen. The same benefit was seen when a slow release formulation was used in one additional study (<a href="./references#CD006901-bbs2-0022" title="VidanagamageRS , GoonewardeneIM . The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial. Ceylon Medical Journal2011;56(3):91‐100. ">Vidanagamage 2011</a>), compared to placebo. </p> <p>No differences were observed for any of the other secondary outcomes analysed (<a href="./references#CD006901-fig-0009" title="">Analysis 1.7</a>; <a href="./references#CD006901-fig-0011" title="">Analysis 1.9</a>; <a href="./references#CD006901-fig-0012" title="">Analysis 1.10</a>; <a href="./references#CD006901-fig-0013" title="">Analysis 1.11</a>; <a href="./references#CD006901-fig-0014" title="">Analysis 1.12</a>; <a href="./references#CD006901-fig-0015" title="">Analysis 1.13</a>; <a href="./references#CD006901-fig-0016" title="">Analysis 1.14</a>; <a href="./references#CD006901-fig-0021" title="">Analysis 1.19</a>; <a href="./references#CD006901-fig-0022" title="">Analysis 1.20</a>; <a href="./references#CD006901-fig-0023" title="">Analysis 1.21</a>; <a href="./references#CD006901-fig-0024" title="">Analysis 1.22</a>). </p> <p>None of the following secondary outcomes were reported and analysed: uterine rupture; neonatal encephalopathy; disability in childhood; other maternal side effects; serious maternal complications; maternal death; caregiver not satisfied; neonatal infection; neonatal antibiotics; chorioamnionitis; endometritis; maternal antibiotics; initiation of cervical ripening to delivery interval (in days). </p> </section> <section id="CD006901-sec-0077"> <h5 class="title">Clinical subgroups</h5> <p>The results for the majority of secondary outcomes were the same in the clinical subgroups analysed. The only difference related to the maternal side effect of nausea, where no differences were observed between groups for the following clinical subgroups: </p> <p> <ol id="CD006901-list-0018"> <li> <p>intact membranes and unfavourable cervix (<a href="./references#CD006901-fig-0056" title="">Analysis 3.15</a>); </p> </li> <li> <p>all primiparae (<a href="./references#CD006901-fig-0071" title="">Analysis 4.13</a>); </p> </li> <li> <p>all primiparae and unfavourable cervix (<a href="./references#CD006901-fig-0086" title="">Analysis 5.13</a>); </p> </li> <li> <p>all primiparae, intact membranes, unfavourable cervix (<a href="./references#CD006901-fig-0100" title="">Analysis 6.12</a>). </p> </li> </ol> </p> </section> </section> <section id="CD006901-sec-0078"> <h4 class="title">Comparison 2: Nitric oxide versus vaginal prostaglandins (three studies, 578 women)</h4> <section id="CD006901-sec-0079"> <h5 class="title">Primary outcomes</h5> <p>There was no evidence of any difference between the effects of NO and vaginal prostaglandins for the two of the primary outcomes analysed: </p> <p> <ol id="CD006901-list-0019"> <li> <p>uterine hyperstimulation with FHR changes (RR 0.21, 95% CI 0.01 to 4.22; two trials, 508 women, (<a href="./references#CD006901-fig-0104" title="">Analysis 7.2</a>); </p> </li> <li> <p>caesarean section (RR 0.97, 95% CI 0.78 to 1.21; three trials, 571 women, <a href="./references#CD006901-fig-0106" title="">Analysis 7.4</a>). </p> </li> </ol> </p> <p>There were fewer women in the NO donor group who did not achieve a vaginal delivery within 24 hours in comparison to vaginal prostaglandins (<a href="./references#CD006901-fig-0103" title="">Analysis 7.1</a>). This result should be interpreted with caution as the information was extracted from an abstract only and a full report of the study is awaited. </p> <p>Serious neonatal morbidity and serious maternal morbidity were not reported in any of the trials for all women. </p> <p>There was no evidence of a difference for two of the primary outcomes (<i>uterine hyperstimulation with FHR changes and caesarean section</i>) in any of the other clinical subgroups examined: </p> <p> <ol id="CD006901-list-0020"> <li> <p>unfavourable cervix (<a href="./references#CD006901-fig-0116" title="">Analysis 8.1</a>; <a href="./references#CD006901-fig-0117" title="">Analysis 8.2</a>); </p> </li> <li> <p>intact membranes and unfavourable cervix (<a href="./references#CD006901-fig-0127" title="">Analysis 9.1</a>; <a href="./references#CD006901-fig-0128" title="">Analysis 9.2</a>); </p> </li> <li> <p>primiparae (<a href="./references#CD006901-fig-0136" title="">Analysis 10.2</a>; <a href="./references#CD006901-fig-0137" title="">Analysis 10.3</a>); </p> </li> <li> <p>all primiparae and unfavourable cervix (<a href="./references#CD006901-fig-0144" title="">Analysis 11.1</a>; <a href="./references#CD006901-fig-0145" title="">Analysis 11.2</a>); </p> </li> <li> <p>all primiparae, intact membranes, unfavourable cervix (<a href="./references#CD006901-fig-0152" title="">Analysis 12.1</a>; <a href="./references#CD006901-fig-0153" title="">Analysis 12.2</a>). </p> </li> </ol> </p> </section> <section id="CD006901-sec-0080"> <h5 class="title">Subgroup analysis</h5> <p>There was no evidence of any difference between the different types of NO donor used (glyceral trinitrate; isosorbide mononitrate; isosorbide dinitrate) for any of the primary outcomes analysed. </p> </section> <section id="CD006901-sec-0081"> <h5 class="title">Secondary outcomes</h5> <p>There were no cases of uterine hyperstimulation without FHR changes reported in the NO donor group compared to five cases in the vaginal prostaglandin group (RR 0.09, 95% CI 0.01 to 1.66; one trial, 110 women, <a href="./references#CD006901-fig-0105" title="">Analysis 7.3</a>). There were no differences observed between groups for any of the following outcomes: </p> <p> <ol id="CD006901-list-0021"> <li> <p>epidural analgesia (RR 1.04, 95% CI 0.91 to 1.18; one trial, 394 women, <a href="./references#CD006901-fig-0110" title="">Analysis 7.8</a>); </p> </li> <li> <p>instrumental vaginal delivery (RR 1.02, 95% CI 0.76 to 1.37; one trial, 395 women, <a href="./references#CD006901-fig-0107" title="">Analysis 7.5</a>); </p> </li> <li> <p>meconium‐stained liquor (RR 0.86, 95% CI 0.32 to 2.28; one trial, 66 women, <a href="./references#CD006901-fig-0108" title="">Analysis 7.6</a>); </p> </li> <li> <p>Apgar score less than seven at five minutes (RR 0.55, 95% CI 0.15 to 1.98; two trials, 504 women, <a href="./references#CD006901-fig-0109" title="">Analysis 7.7</a>); </p> </li> <li> <p>Neonatal intensive care unit admission (RR 0.88, 95% CI 0.43 to 1.78; three trials, 571 babies, <a href="./references#CD006901-fig-0115" title="">Analysis 7.13</a>); </p> </li> <li> <p>postpartum haemorrhage (RR 0.69, 95% CI 0.12 to 3.98; one trial, 110 women, <a href="./references#CD006901-fig-0113" title="">Analysis 7.11</a>); </p> </li> <li> <p>serious maternal complications (RR 0.35, 95% CI 0.01 to 8.30; one trial, 110 women, <a href="./references#CD006901-fig-0114" title="">Analysis 7.12</a>). </p> </li> </ol> </p> <p>There was evidence of an increase in the rates of nausea (RR 1.79, 95% CI 1.10 to 2.93; one study, 385 women, <a href="./references#CD006901-fig-0111" title="">Analysis 7.9</a>) and an increase in the rates of headache (RR 8.79, 95% CI 5.75 to 13.45; two studies, 493 women, <a href="./references#CD006901-fig-0112" title="">Analysis 7.10</a>) when induction was undertaken using NO. </p> <p>None of the following secondary outcomes were reported and analysed: cervix unfavourable/unchanged after 12 to 24 hours; uterine rupture; neonatal encephalopathy; perinatal death; disability in childhood; maternal death; woman not satisfied; caregiver not satisfied; neonatal infection; neonatal antibiotics; chorioamnionitis; endometritis; maternal antibiotics; additional induction agents required; initiation of cervical ripening to delivery interval (in days). </p> </section> <section id="CD006901-sec-0082"> <h5 class="title">Clinical subgroups</h5> <p>The results for all of the secondary outcomes were the same in the clinical subgroups analysed: </p> <p> <ol id="CD006901-list-0022"> <li> <p>unfavourable cervix (<a href="./references#CD006901-fig-0118" title="">Analysis 8.3</a> to <a href="./references#CD006901-fig-0126" title="">Analysis 8.11</a>); </p> </li> <li> <p>intact membranes and unfavourable cervix (<a href="./references#CD006901-fig-0129" title="">Analysis 9.3</a> to <a href="./references#CD006901-fig-0134" title="">Analysis 9.8</a>); </p> </li> <li> <p>primiparae (<a href="./references#CD006901-fig-0138" title="">Analysis 10.4</a> to <a href="./references#CD006901-fig-0143" title="">Analysis 10.9</a>); </p> </li> <li> <p>all primiparae and unfavourable cervix (<a href="./references#CD006901-fig-0146" title="">Analysis 11.3</a> to <a href="./references#CD006901-fig-0151" title="">Analysis 11.8</a>); </p> </li> <li> <p>all primiparae, intact membranes, unfavourable cervix (<a href="./references#CD006901-fig-0154" title="">Analysis 12.3</a> to <a href="./references#CD006901-fig-0159" title="">Analysis 12.8</a>). </p> </li> </ol> </p> </section> <section id="CD006901-sec-0083"> <h5 class="title">Subgroup analysis</h5> <p>There was no evidence of any difference between the different types of NO donor used (glyceral trinitrate; isosorbide mononitrate; isosorbide dinitrate) for any of the secondary outcomes analysed. </p> </section> </section> <section id="CD006901-sec-0084"> <h4 class="title">Comparison 3: Nitric oxide versus intracervical prostaglandins (two studies, 442 women)</h4> <section id="CD006901-sec-0085"> <h5 class="title">Primary outcomes</h5> <p>One study (<a href="./references#CD006901-bbs2-0009" title="KadianND . Comparison of nitric oxide donor isosorbide dinitrate (IDN) and dinoprostone for cervical ripening before induction of labor at term. BJOG: an international journal of obstetrics and gynaecology2008;115(s1):76. ">Kadian 2008</a>), reported a reduction in the number of women who had not achieved a vaginal delivery within 24 hours when induction was undertaken with NO donors in comparison to intracervical prostaglandins (RR 0.63, 95% CI 0.47 to 0.86; one trial, 400 women, <a href="./references#CD006901-fig-0160" title="">Analysis 13.1</a>). This result should be interpreted with caution as the information was extracted from an abstract only and a full report of the study is awaited. No differences were observed between groups for uterine hyperstimulation with FHR changes (RR 0.33, 95% CI 0.01 to 7.74; one trial, 42 women, <a href="./references#CD006901-fig-0161" title="">Analysis 13.2</a>) or serious neonatal morbidity/perinatal death (RR 0.33, 95% CI 0.01 to 7.74; one trial, 42 women, <a href="./references#CD006901-fig-0163" title="">Analysis 13.4</a>). Fewer women in the NO donor group underwent a caesarean section in comparison to women who received intracervical prostaglandins (RR 0.63, 95% CI 0.44 to 0.90; two trials, 442 women, <a href="./references#CD006901-fig-0162" title="">Analysis 13.3</a>). No study reported on the outcome serious maternal morbidity or death. </p> </section> <section id="CD006901-sec-0086"> <h5 class="title">Clinical subgroups</h5> <p>The results for two of the primary outcomes, uterine hyperstimulation with FHR changes and serious neonatal morbidity/perinatal death, were the same in the clinical subgroups analysed: </p> <p> <ol id="CD006901-list-0023"> <li> <p>unfavourable cervix (<a href="./references#CD006901-fig-0171" title="">Analysis 14.2</a>; <a href="./references#CD006901-fig-0173" title="">Analysis 14.4</a>); </p> </li> <li> <p>intact membranes and unfavourable cervix (<a href="./references#CD006901-fig-0181" title="">Analysis 15.2</a>; <a href="./references#CD006901-fig-0183" title="">Analysis 15.4</a>); </p> </li> <li> <p>primiparae (<a href="./references#CD006901-fig-0190" title="">Analysis 16.1</a>; <a href="./references#CD006901-fig-0192" title="">Analysis 16.3</a>); </p> </li> <li> <p>all primiparae and unfavourable cervix (<a href="./references#CD006901-fig-0199" title="">Analysis 17.1</a>; <a href="./references#CD006901-fig-0201" title="">Analysis 17.3</a>); </p> </li> <li> <p>all primiparae, intact membranes, unfavourable cervix (<a href="./references#CD006901-fig-0208" title="">Analysis 18.1</a>; <a href="./references#CD006901-fig-0210" title="">Analysis 18.3</a>). </p> </li> </ol> </p> <p>For caesarean section, there were no differences between groups according to the clinical subgroups, although only one study was included in any clinical subgroup: </p> <p> <ol id="CD006901-list-0024"> <li> <p>unfavourable cervix (<a href="./references#CD006901-fig-0172" title="">Analysis 14.3</a>); </p> </li> <li> <p>intact membranes and unfavourable cervix (<a href="./references#CD006901-fig-0182" title="">Analysis 15.3</a>); </p> </li> <li> <p>primiparae (<a href="./references#CD006901-fig-0191" title="">Analysis 16.2</a>); </p> </li> <li> <p>all primiparae and unfavourable cervix (<a href="./references#CD006901-fig-0200" title="">Analysis 17.2</a>); </p> </li> <li> <p>all primiparae, intact membranes, unfavourable cervix (<a href="./references#CD006901-fig-0209" title="">Analysis 18.2</a>). </p> </li> </ol> </p> </section> <section id="CD006901-sec-0087"> <h5 class="title">Subgroup analysis</h5> <p>There were too few studies to determine whether there was evidence of a difference between the different types of NO donor for caesarean section (<a href="./references#CD006901-fig-0162" title="">Analysis 13.3</a>). It was not possible to perform subgroup analysis for any other primary outcomes. </p> </section> <section id="CD006901-sec-0088"> <h5 class="title">Secondary outcomes</h5> <p>There were no differences observed between groups for any of the following outcomes:</p> <p> <ol id="CD006901-list-0025"> <li> <p>cervix unfavourable/unchanged after 12 to 24 hours (RR 1.29, 95% CI 0.59 to 2.81; one trial, 42 women, <a href="./references#CD006901-fig-0164" title="">Analysis 13.5</a>); </p> </li> <li> <p>oxytocin augmentation (RR 0.89, 95% CI 0.43 to 1.85; one trial, 42 women, <a href="./references#CD006901-fig-0165" title="">Analysis 13.6</a>); </p> </li> <li> <p>uterine hyperstimulation without FHR changes (RR 0.14, 95% CI 0.01 to 2.61; one trial, 42 women, <a href="./references#CD006901-fig-0166" title="">Analysis 13.7</a>); </p> </li> <li> <p>instrumental vaginal delivery (RR 1.00, 95% CI 0.07 to 14.95; one trial, 42 women, <a href="./references#CD006901-fig-0167" title="">Analysis 13.8</a>); </p> </li> <li> <p>perinatal death (RR 0.33, 95% CI 0.01 to 7.74)(RR 0.33, 95% CI 0.01 to 7.74; one trial, 42 women, <a href="./references#CD006901-fig-0168" title="">Analysis 13.9</a>). </p> </li> </ol> </p> <p>The only difference observed related to maternal side effects of headache. Nitric oxide when compared to intracervical prostaglandins resulted in an increase in maternal headache (RR 10.00, 95% CI 1.40 to 71.32; one study, 42 women; <a href="./references#CD006901-fig-0169" title="">Analysis 13.10</a>). </p> <p>None of the following secondary outcomes were reported and analysed: uterine rupture; epidural analgesia; meconium‐stained liquor; Apgar score less than seven at five minutes; neonatal intensive care unit admission; neonatal encephalopathy; disability in childhood; postpartum haemorrhage; serious maternal complications; maternal death; woman not satisfied; caregiver not satisfied; neonatal infection; neonatal antibiotics; chorioamnionitis; endometritis; maternal antibiotics; additional induction agents required; initiation of cervical ripening to delivery interval (in days). </p> </section> <section id="CD006901-sec-0089"> <h5 class="title">Clinical subgroups</h5> <p>The results for all secondary outcomes did not change when analysed in clinical subgroups:</p> <p> <ol id="CD006901-list-0026"> <li> <p>unfavourable cervix (<a href="./references#CD006901-fig-0174" title="">Analysis 14.5</a>; <a href="./references#CD006901-fig-0175" title="">Analysis 14.6</a>; <a href="./references#CD006901-fig-0176" title="">Analysis 14.7</a>; <a href="./references#CD006901-fig-0177" title="">Analysis 14.8</a>; <a href="./references#CD006901-fig-0178" title="">Analysis 14.9</a>; <a href="./references#CD006901-fig-0179" title="">Analysis 14.10</a>); </p> </li> <li> <p>intact membranes and unfavourable cervix (<a href="./references#CD006901-fig-0184" title="">Analysis 15.5</a>; <a href="./references#CD006901-fig-0185" title="">Analysis 15.6</a>; <a href="./references#CD006901-fig-0186" title="">Analysis 15.7</a>; <a href="./references#CD006901-fig-0187" title="">Analysis 15.8</a>; <a href="./references#CD006901-fig-0188" title="">Analysis 15.9</a>; <a href="./references#CD006901-fig-0189" title="">Analysis 15.10</a>); </p> </li> <li> <p>primiparae (<a href="./references#CD006901-fig-0193" title="">Analysis 16.4</a>; <a href="./references#CD006901-fig-0194" title="">Analysis 16.5</a>; <a href="./references#CD006901-fig-0195" title="">Analysis 16.6</a>; <a href="./references#CD006901-fig-0196" title="">Analysis 16.7</a>; <a href="./references#CD006901-fig-0197" title="">Analysis 16.8</a>; <a href="./references#CD006901-fig-0198" title="">Analysis 16.9</a>); </p> </li> <li> <p>all primiparae and unfavourable cervix (<a href="./references#CD006901-fig-0202" title="">Analysis 17.4</a>; <a href="./references#CD006901-fig-0203" title="">Analysis 17.5</a>; <a href="./references#CD006901-fig-0204" title="">Analysis 17.6</a>; <a href="./references#CD006901-fig-0205" title="">Analysis 17.7</a>; <a href="./references#CD006901-fig-0206" title="">Analysis 17.8</a>; <a href="./references#CD006901-fig-0207" title="">Analysis 17.9</a>); </p> </li> <li> <p>all primiparae, intact membranes, unfavourable cervix (<a href="./references#CD006901-fig-0211" title="">Analysis 18.4</a>; <a href="./references#CD006901-fig-0212" title="">Analysis 18.5</a>; <a href="./references#CD006901-fig-0213" title="">Analysis 18.6</a>; <a href="./references#CD006901-fig-0214" title="">Analysis 18.7</a>; <a href="./references#CD006901-fig-0215" title="">Analysis 18.8</a>; <a href="./references#CD006901-fig-0216" title="">Analysis 18.9</a>). </p> </li> </ol> </p> </section> <section id="CD006901-sec-0090"> <h5 class="title">Subgroup analysis</h5> <p>There were not enough data to carry out planned subgroup analysis.</p> </section> </section> <section id="CD006901-sec-0091"> <h4 class="title">Comparison 4: Nitric oxide versus vaginal misoprostol (seven studies, 917 women)</h4> <section id="CD006901-sec-0092"> <h5 class="title">Primary outcomes</h5> <p>There was a reduction in the rate of uterine hyperstimulation with FHR changes when induction was conducted with NO compared with vaginal misoprostol (RR 0.07, 95% CI 0.01 to 0.37; three trials, 281 women, <a href="./references#CD006901-fig-0218" title="">Analysis 19.2</a>). There were no differences in caesarean section rates (RR 1.00, 95% CI 0.82 to 1.21; 6 studies; 761 women <a href="./references#CD006901-fig-0219" title="">Analysis 19.3</a>), and no cases of serious neonatal morbidity/perinatal death were reported (<a href="./references#CD006901-fig-0220" title="">Analysis 19.4</a>). The primary outcomes vaginal delivery not achieved within 24 hours and serious maternal morbidity or death were not reported in any of the studies. </p> </section> <section id="CD006901-sec-0093"> <h5 class="title">Clinical subgroups</h5> <p>Results were largely similar across clinical subgroups:</p> <p> <ol id="CD006901-list-0027"> <li> <p>unfavourable cervix (<a href="./references#CD006901-fig-0235" title="">Analysis 20.1</a>; <a href="./references#CD006901-fig-0236" title="">Analysis 20.2</a>; <a href="./references#CD006901-fig-0237" title="">Analysis 20.3</a>); </p> </li> <li> <p>intact membranes and unfavourable cervix (<a href="./references#CD006901-fig-0248" title="">Analysis 21.1</a>; <a href="./references#CD006901-fig-0249" title="">Analysis 21.2</a>; <a href="./references#CD006901-fig-0250" title="">Analysis 21.3</a>); </p> </li> <li> <p>primiparae (<a href="./references#CD006901-fig-0260" title="">Analysis 22.2</a>; <a href="./references#CD006901-fig-0261" title="">Analysis 22.3</a>; <a href="./references#CD006901-fig-0262" title="">Analysis 22.4</a>); </p> </li> <li> <p>all primiparae and unfavourable cervix (<a href="./references#CD006901-fig-0273" title="">Analysis 23.1</a>; <a href="./references#CD006901-fig-0274" title="">Analysis 23.2</a>; <a href="./references#CD006901-fig-0275" title="">Analysis 23.3</a>); </p> </li> <li> <p>all primiparae, intact membranes, unfavourable cervix (<a href="./references#CD006901-fig-0285" title="">Analysis 24.1</a>; <a href="./references#CD006901-fig-0286" title="">Analysis 24.2</a>; <a href="./references#CD006901-fig-0287" title="">Analysis 24.3</a>). </p> </li> </ol> </p> </section> <section id="CD006901-sec-0094"> <h5 class="title">Subgroup analysis</h5> <p>There was no evidence of any difference between the different types of NO donor used (glyceral trinitrate; isosorbide mononitrate; isosorbide dinitrate) for any of the primary outcomes analysed. </p> </section> <section id="CD006901-sec-0095"> <h5 class="title">Secondary outcomes</h5> <p>There was an increase in cervix unchanged/unfavourable when induction with NO was compared with vaginal misoprostol (RR 3.43, 95% CI 2.07 to 5.66; two trials, 151 women, <a href="./references#CD006901-fig-0221" title="">Analysis 19.5</a>). </p> <p>There was an increase in the need for oxytocin augmentation with NO induction compared with vaginal misoprostol (RR 2.67, 95% CI 1.31 to 5.45; seven trials, 767 women, <a href="./references#CD006901-fig-0222" title="">Analysis 19.6</a>). However, there was evidence of significant heterogeneity between the studies despite the use of a random‐effects model (Heterogeneity: Tau² = 0.84; Chi² = 108.82, df = 6 (P &lt; .00001): I² = 94%). Uterine hyperstimulation without FHR was lower in the NO group in comparison to the vaginal misoprostol group (RR 0.06, 95% CI 0.01 to 0.32; three trials, 367 women, <a href="./references#CD006901-fig-0223" title="">Analysis 19.7</a>), as was meconium‐stained liquor (RR 0.29, 95% CI 0.13 to 0.65; two trials, 260 women, <a href="./references#CD006901-fig-0226" title="">Analysis 19.10</a>), Apgar score less than seven at five minutes (RR 0.16, 95% CI 0.07 to 0.38; six trials, 777 women, <a href="./references#CD006901-fig-0227" title="">Analysis 19.11</a>) and analgesia requirements (RR 0.26, 95% CI 0.13 to 0.49; one trial, 130 women, <a href="./references#CD006901-fig-0233" title="">Analysis 19.17</a>). </p> <p>NO was associated with an increase in maternal headache when compared with vaginal misoprostol for induction of labour (RR 10.98, 95% CI 4.05 to 29.73; four trials, 341 women, <a href="./references#CD006901-fig-0231" title="">Analysis 19.15</a>). </p> <p>No differences between groups were observed for instrumental vaginal delivery (RR 1.10, 95% CI 0.07 to 16.43; one trial, 44 women, <a href="./references#CD006901-fig-0225" title="">Analysis 19.9</a>), neonatal intensive care unit admission (RR 0.19, 95% CI 0.09 to 0.43; four trials, 587 women, <a href="./references#CD006901-fig-0228" title="">Analysis 19.12</a>), or postpartum haemorrhage (RR 1.33, 95% CI 0.57 to 3.06; four trials, 587 women, <a href="./references#CD006901-fig-0232" title="">Analysis 19.16</a>). There were no cases of perinatal death reported in the two studies that reported it (<a href="./references#CD006901-fig-0229" title="">Analysis 19.13</a>). </p> <p>None of the following secondary outcomes were reported and analysed: uterine rupture; epidural analgesia; neonatal encephalopathy; disability in childhood; serious maternal complications; maternal death; caregiver not satisfied; neonatal infection; neonatal antibiotics; chorioamnionitis; endometritis; maternal antibiotics; additional induction agents required. Initiation of cervical ripening to delivery interval was reported in three trials, <a href="./references#CD006901-bbs2-0010" title="KrishnamurthyR , PallaveeP , GhoseS . Evaluation of isosorbide mononitrate for preinduction of cervical ripening: A randomized placebo‐controlled trial. Journal of Family and Reproductive Health2015;9:75‐81. ">Krishnamurthy 2015</a>, <a href="./references#CD006901-bbs2-0011" title="MovahedF , SeyedE , PakniatH , IranipourM , YazdiZ . Comparison of the effects of transcervical catheter, laminaria and isosorbide mononitrate on cervical ripening. Journal of Babol University of Medical Sciences2016;18(3):19‐24. ">Movahed 2016</a> and <a href="./references#CD006901-bbs2-0016" title="RazaqA . Isosorbide mononitrate versus misoprostol for cervical ripening. Al‐Kindy College Medical Journal2011;8(1):69‐74. ">Razaq 2011</a>, but data were presented in mean minutes (<a href="./references#CD006901-bbs2-0010" title="KrishnamurthyR , PallaveeP , GhoseS . Evaluation of isosorbide mononitrate for preinduction of cervical ripening: A randomized placebo‐controlled trial. Journal of Family and Reproductive Health2015;9:75‐81. ">Krishnamurthy 2015</a>; <a href="./references#CD006901-bbs2-0011" title="MovahedF , SeyedE , PakniatH , IranipourM , YazdiZ . Comparison of the effects of transcervical catheter, laminaria and isosorbide mononitrate on cervical ripening. Journal of Babol University of Medical Sciences2016;18(3):19‐24. ">Movahed 2016</a>) and hours (<a href="./references#CD006901-bbs2-0016" title="RazaqA . Isosorbide mononitrate versus misoprostol for cervical ripening. Al‐Kindy College Medical Journal2011;8(1):69‐74. ">Razaq 2011</a>), respectively rather than days as specified for this review and so has not been analysed. Women not satisfied were described in <a href="./references#CD006901-bbs2-0006" title="GuhaK , FatemaA , BiswasPK , HaqueE . Isosorbide mononitrate versus misoprostol for cervical ripening and induction of labour at term. Mymensingh Medical Journal : Mmj2015;24(2):346‐51. ">Guha 2015</a>. Due to lack of clarity of how this outcome was reported (the percentages of women reporting satisfaction levels add up to over 100%), the data were not used in the analysis. </p> </section> <section id="CD006901-sec-0096"> <h5 class="title">Clinical subgroups</h5> <p>Result were largely similar across clinical subgroups:</p> <p> <ol id="CD006901-list-0028"> <li> <p>unfavourable cervix (<a href="./references#CD006901-fig-0238" title="">Analysis 20.4</a>; <a href="./references#CD006901-fig-0239" title="">Analysis 20.5</a>; <a href="./references#CD006901-fig-0240" title="">Analysis 20.6</a>; <a href="./references#CD006901-fig-0241" title="">Analysis 20.7</a>; <a href="./references#CD006901-fig-0242" title="">Analysis 20.8</a>; <a href="./references#CD006901-fig-0243" title="">Analysis 20.9</a>; <a href="./references#CD006901-fig-0244" title="">Analysis 20.10</a>; <a href="./references#CD006901-fig-0245" title="">Analysis 20.11</a>; <a href="./references#CD006901-fig-0246" title="">Analysis 20.12</a>; <a href="./references#CD006901-fig-0247" title="">Analysis 20.13</a>); </p> </li> <li> <p>intact membranes and unfavourable cervix (<a href="./references#CD006901-fig-0251" title="">Analysis 21.4</a>; <a href="./references#CD006901-fig-0252" title="">Analysis 21.5</a>; <a href="./references#CD006901-fig-0253" title="">Analysis 21.6</a>; <a href="./references#CD006901-fig-0254" title="">Analysis 21.7</a>; <a href="./references#CD006901-fig-0255" title="">Analysis 21.8</a>; <a href="./references#CD006901-fig-0256" title="">Analysis 21.9</a>; <a href="./references#CD006901-fig-0257" title="">Analysis 21.10</a>); </p> </li> <li> <p>primiparae (<a href="./references#CD006901-fig-0263" title="">Analysis 22.5</a>; <a href="./references#CD006901-fig-0264" title="">Analysis 22.6</a>; <a href="./references#CD006901-fig-0265" title="">Analysis 22.7</a>; <a href="./references#CD006901-fig-0268" title="">Analysis 22.10</a>; <a href="./references#CD006901-fig-0270" title="">Analysis 22.12</a>); </p> </li> <li> <p>all primiparae and unfavourable cervix (<a href="./references#CD006901-fig-0275" title="">Analysis 23.3</a>; <a href="./references#CD006901-fig-0276" title="">Analysis 23.4</a>; <a href="./references#CD006901-fig-0277" title="">Analysis 23.5</a>; <a href="./references#CD006901-fig-0278" title="">Analysis 23.6</a>; <a href="./references#CD006901-fig-0281" title="">Analysis 23.9</a>; <a href="./references#CD006901-fig-0283" title="">Analysis 23.11</a>); </p> </li> <li> <p>all primiparae, intact membranes, unfavourable cervix (<a href="./references#CD006901-fig-0288" title="">Analysis 24.4</a>; <a href="./references#CD006901-fig-0289" title="">Analysis 24.5</a>; <a href="./references#CD006901-fig-0290" title="">Analysis 24.6</a>; <a href="./references#CD006901-fig-0293" title="">Analysis 24.9</a>; <a href="./references#CD006901-fig-0295" title="">Analysis 24.11</a>). </p> </li> </ol> </p> </section> <section id="CD006901-sec-0097"> <h5 class="title">Subgroup analysis</h5> <p>There was no evidence of any difference between the different types of NO donor used (glyceral trinitrate; isosorbide mononitrate; isosorbide dinitrate) for any of the secondary outcomes analysed. </p> </section> </section> <section id="CD006901-sec-0098"> <h4 class="title">Comparison 5: Nitric oxide versus intracervical catheter (two studies, 155 women)</h4> <section id="CD006901-sec-0099"> <h5 class="title">Analyses 25 to 30</h5> <p>One study (<a href="./references#CD006901-bbs2-0011" title="MovahedF , SeyedE , PakniatH , IranipourM , YazdiZ . Comparison of the effects of transcervical catheter, laminaria and isosorbide mononitrate on cervical ripening. Journal of Babol University of Medical Sciences2016;18(3):19‐24. ">Movahed 2016</a>) did not contribute any data. </p> </section> <section id="CD006901-sec-0100"> <h5 class="title">Primary outcomes</h5> <p>There was no evidence on any difference between the effects of NO and the use of a Foley catheter for induction of labour for caesarean section (RR 1.00, 95% CI 0.39 to 2.59; one trial, 80 women, <a href="./references#CD006901-fig-0297" title="">Analysis 25.1</a>). None of the other primary outcomes were reported: vaginal delivery not achieved within 24 hours; uterine hyperstimulation with FHR changes; serious neonatal morbidity or perinatal death or; or serious maternal morbidity or death. </p> </section> <section id="CD006901-sec-0101"> <h5 class="title">Clinical subgroups</h5> <p>Since there was only one study in this comparison with one outcome (caesarean section), the results were the same for the one outcome analysed. </p> </section> <section id="CD006901-sec-0102"> <h5 class="title">Subgroup analysis</h5> <p>It was not possible to carry out subgroup analysis with a single study.</p> </section> <section id="CD006901-sec-0103"> <h5 class="title">Secondary outcomes</h5> <p>There was evidence of an increase in the use of oxytocin augmentation when comparing NO donors to the use of a Foley catheter for induction of labour (RR 1.65, 95% CI 1.17 to 2.32; one trial, 80 women, <a href="./references#CD006901-fig-0298" title="">Analysis 25.2</a>). Additionally there was evidence of an increase in the rates of maternal headache in association with NO donors when compared to Foley catheter (RR 3.33, 95% CI 0.99 to 11.22; one trial, 80 women, <a href="./references#CD006901-fig-0306" title="">Analysis 25.10</a>). There was no evidence of a difference in maternal satisfaction between the use of NO donors or Foley catheter for induction of labour (RR 1.75, 95% CI 0.56 to 5.51; one trial, 80 women, participants, <a href="./references#CD006901-fig-0308" title="">Analysis 25.12</a>). </p> <p>There were no differences observed between groups for any of the following outcomes:</p> <p> <ol id="CD006901-list-0029"> <li> <p>oxytocin augmentation (RR 1.65, 95% CI 1.17 to 2.32; one trial, 80 women, <a href="./references#CD006901-fig-0298" title="">Analysis 25.2</a>); </p> </li> <li> <p>uterine rupture (not estimable as no events in either group, <a href="./references#CD006901-fig-0299" title="">Analysis 25.3</a>); </p> </li> <li> <p>epidural analgesia (RR 1.00, 95% CI 0.39 to 2.59; one trial, 80 women, <a href="./references#CD006901-fig-0300" title="">Analysis 25.4</a>); </p> </li> <li> <p>instrumental vaginal delivery (RR 0.80, 95% CI 0.23 to 2.76; one trial, 80 women, <a href="./references#CD006901-fig-0301" title="">Analysis 25.5</a>); </p> </li> <li> <p>meconium‐stained liquor (RR 2.00, 95% CI 0.19 to 21.18; one trial, 80, <a href="./references#CD006901-fig-0302" title="">Analysis 25.6</a>); </p> </li> <li> <p>Apgar score less than seven at five minutes (RR 1.67, 95% CI 0.95 to 2.93; one trial, 80 women, <a href="./references#CD006901-fig-0303" title="">Analysis 25.7</a>); </p> </li> <li> <p>neonatal intensive care unit admission (RR 2.50, 95% CI 0.51 to 12.14; one trial, 80 women, <a href="./references#CD006901-fig-0304" title="">Analysis 25.8</a>); </p> </li> <li> <p>maternal side effects (nausea and vomiting) (RR 3.00, 95% CI 0.33 to 27.63; one trial, 80 women, <a href="./references#CD006901-fig-0305" title="">Analysis 25.9</a>); </p> </li> <li> <p>postpartum haemorrhage (RR 2.00, 95% CI 0.90 to 4.43; one trial, 80 women, <a href="./references#CD006901-fig-0307" title="">Analysis 25.11</a>); </p> </li> <li> <p>other maternal side effect (puerperal pyrexia) (RR 0.42, 95% CI 0.16 to 1.07; one trial, 80 women, <a href="./references#CD006901-fig-0309" title="">Analysis 25.13</a>). </p> </li> </ol> </p> <p>None of the following secondary outcomes were reported and analysed: cervix unfavourable/unchanged after 12 to 24 hours; uterine hyperstimulation without FHR changes; neonatal encephalopathy; perinatal death; disability in childhood; serious maternal complications; maternal death; caregiver not satisfied; neonatal infection; neonatal antibiotics; chorioamnionitis; endometritis; maternal antibiotics. </p> </section> <section id="CD006901-sec-0104"> <h5 class="title">Clinical subgroups</h5> <p>Since there was only one study in this comparison and the results were the same for all clinical subgroups. </p> </section> <section id="CD006901-sec-0105"> <h5 class="title">Subgroup analysis</h5> <p>It was not possible to carry out subgroup analysis with a single study.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006901-sec-0106" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006901-sec-0106"></div> <section id="CD006901-sec-0107"> <h3 class="title" id="CD006901-sec-0107">Summary of main results</h3> <p> <ol id="CD006901-list-0030"> <li> <p>Nitric oxide (NO) donors reduce the proportion of women with an unfavourable cervix at 12 to 24 hours when compared to placebo for induction of labour. </p> </li> <li> <p>NO donors increase the proportion of women with an unfavourable cervix at 12 to 24 hours when compared to vaginal misoprostol. </p> </li> <li> <p>NO donors when compared to placebo, vaginal or intracervical prostaglandins, vaginal misoprostol and intracervical Foley catheter resulted in a higher rate of maternal headache when used for induction of labour. </p> </li> <li> <p>Induction of labour with NO donors resulted in a greater proportion of women remaining undelivered at 24 to 48 hours when compared with vaginal or intracervical prostaglandins. </p> </li> <li> <p>NO donors were associated with a reduction in the rate of uterine hyperstimulation with fetal heart rate (FHR) changes when compared with vaginal misoprostol for induction of labour. </p> </li> <li> <p>NO donors when compared to intracervical prostaglandins resulted in fewer women undergoing a caesarean section. </p> </li> <li> <p>NO donors were associated with a reduction in the rate of uterine hyperstimulation without FHR changes when compared with placebo or vaginal misoprostol. </p> </li> <li> <p>There was no evidence of any difference between NO donors and Foley catheter for any of the reported outcomes, apart from an increase in headache with NO donors. </p> </li> </ol> </p> <p>There are very limited data available to compare NO donors to any other induction agent. There is evidence to suggest that NO is more effective in causing cervical ripening in comparison to placebo however, these results needs further evaluation as this did not affect the induction to delivery interval or delivery outcomes in this comparison. Vaginal misoprostol appears to be more effective than NO donors for induction of labour. </p> <p>In two studies, we noted the use of a complex intervention in the form of vaginal prostaglandin along with NO donor in some women (<a href="./references#CD006901-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a>; <a href="./references#CD006901-bbs2-0002" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. NormanJ . Pharmacokinetics of nitric oxide donors administered per vaginam in the third trimester of pregnancy. National Research Register (www.controlled‐trials.com) (accessed 26 July 2001). ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27:30‐5. ">Bollapragada 2009</a>). In both of these studies, the use of additional induction agents was determined by the response of the cervix following initial treatment with NO donors or placebo. If the cervix remained unfavourable (as defined by the authors), then vaginal prostaglandin was administered. If the cervix was favourable then additional vaginal prostaglandin E2 (PGE2) was not used. Hence for a proportion of these women a complex intervention was used. It is difficult to determine the effect of NO donor alone on the favourability of cervix in these studies. </p> <p>It is therefore possible that the true effect of NO donors would be better evaluated through a trial comparing NO donors plus vaginal PGE2 versus other interventions. </p> </section> <section id="CD006901-sec-0108"> <h3 class="title" id="CD006901-sec-0108">Overall completeness and applicability of evidence</h3> <p>There are limited data within the trials on the whole; furthermore, there are limited numbers of studies within each comparison group, making interpretation difficult. There are insufficient data to understand if we have a complete view of the effect of NO donor use in the cervical ripening. </p> <p>As mentioned earlier in the review, NO donors work primarily to promote cervical ripening, hence the comparison to other, more traditional induction of labour agents may not be appropriate. The outcomes used to evaluate these agents look at the entire journey from the first stages of induction through to delivery. Furthermore, many of the recent studies looking at the use of NO donors have been performed within an outpatient setting where most standard ripening agents are not routinely used at present. </p> </section> <section id="CD006901-sec-0109"> <h3 class="title" id="CD006901-sec-0109">Quality of the evidence</h3> <p>The risk of bias was found to be low in the majority of studies for all domains. The more recent trials were found to be at the lowest risk of bias. The quality of the evidence was assessed using the GRADE approach for the five primary outcomes for the comparison of nitric oxide donors versus placebo/no intervention (see <a href="./full#CD006901-tbl-0001">summary of findings Table for the main comparison</a>). The evidence was assessed as being low for vaginal delivery not achieved in 24 hours, uterine hyperstimulation with FHR changes, and serious maternal morbidity. The main reason for downgrading the evidence for these outcomes was due to concerns over imprecision (few events, small sample sizes and wide confidence intervals) and because most of the data were from single studies. The evidence was assessed as being of moderate quality for caesarean section and was downgraded due to limitations in design (high risk of bias for allocation concealment, selective outcome reporting and blinding). </p> </section> <section id="CD006901-sec-0110"> <h3 class="title" id="CD006901-sec-0110">Potential biases in the review process</h3> <p>We attempted to minimise bias during the review process by having three people assess the eligibility of studies, assess risk of bias and extract data with a third person involved to check or review each area. We attempted to be as inclusive as possible in our search. </p> </section> <section id="CD006901-sec-0111"> <h3 class="title" id="CD006901-sec-0111">Agreements and disagreements with other studies or reviews</h3> <p>There have been no formal systematic reviews of the use of NO donors compared to other induction agents. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006901-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006901-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/full#CD006901-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006901-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/full#CD006901-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD006901-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 3 Caesarean section." data-id="CD006901-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 4 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 4 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 5 Serious maternal morbidity or death." data-id="CD006901-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 5 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 6 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 6 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 7 Oxytocin augmentation." data-id="CD006901-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 7 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 8 Uterine hyperstimulation without FHR changes." data-id="CD006901-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 8 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 9 Epidural analgesia." data-id="CD006901-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 9 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 10 Instrumental vaginal delivery." data-id="CD006901-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 10 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 11 Meconium‐stained liquor." data-id="CD006901-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 11 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 12 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 12 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 13 Neonatal intensive care unit admission." data-id="CD006901-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 13 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 14 Perinatal death." data-id="CD006901-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 14 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 15 Maternal side effects (all)." data-id="CD006901-fig-0017" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 15 Maternal side effects (all). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 16 Maternal side effects (nausea)." data-id="CD006901-fig-0018" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 16 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 17 Maternal side effects (headache)." data-id="CD006901-fig-0019" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 17 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 18 Maternal side effects (vomiting)." data-id="CD006901-fig-0020" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 18 Maternal side effects (vomiting). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 19 Maternal side effects (diarrhoea)." data-id="CD006901-fig-0021" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 19 Maternal side effects (diarrhoea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 20 Postpartum haemorrhage." data-id="CD006901-fig-0022" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 20 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 21 Women not satisfied." data-id="CD006901-fig-0023" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 21 Women not satisfied. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 22 Additional induction agents used." data-id="CD006901-fig-0024" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 (1.1) Nitric oxide donors versus placebo/no intervention (all women), Outcome 22 Additional induction agents used. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD006901-fig-0025" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0026" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 3 Caesarean section." data-id="CD006901-fig-0027" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 4 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0028" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 4 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0029" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 6 Oxytocin augmentation." data-id="CD006901-fig-0030" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 6 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 7 Uterine hyperstimulation without FHR changes." data-id="CD006901-fig-0031" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 7 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 8 Epidural analgesia." data-id="CD006901-fig-0032" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 8 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 9 Instrumental vaginal delivery." data-id="CD006901-fig-0033" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 9 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 10 Meconium‐stained liquor." data-id="CD006901-fig-0034" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 10 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 11 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0035" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 11 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 12 Neonatal intensive care unit admission." data-id="CD006901-fig-0036" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 12 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 13 Perinatal death." data-id="CD006901-fig-0037" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 13 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 14 Maternal side effects (nausea)." data-id="CD006901-fig-0038" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 14 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 15 Maternal side effects (headache)." data-id="CD006901-fig-0039" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.15</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 15 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 16 Postpartum haemorrhage." data-id="CD006901-fig-0040" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.16</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 16 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-002-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-002-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 17 Additional induction agents used." data-id="CD006901-fig-0041" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.17</div> <div class="figure-caption"> <p>Comparison 2 (1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix), Outcome 17 Additional induction agents used. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-002-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD006901-fig-0042" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0043" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 3 Caesarean section." data-id="CD006901-fig-0044" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 4 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0045" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 4 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0046" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 6 Oxytocin augmentation." data-id="CD006901-fig-0047" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 6 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 7 Uterine hyperstimulation without FHR changes." data-id="CD006901-fig-0048" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 7 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 8 Epidural analgesia." data-id="CD006901-fig-0049" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 8 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 9 Instrumental vaginal delivery." data-id="CD006901-fig-0050" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 9 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 10 Meconium‐stained liquor." data-id="CD006901-fig-0051" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 10 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 11 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0052" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 11 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 12 Neonatal intensive care unit admission." data-id="CD006901-fig-0053" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 12 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 13 Perinatal death." data-id="CD006901-fig-0054" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 13 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 14 Maternal side effects (nausea)." data-id="CD006901-fig-0055" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 14 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 15 Maternal side effects (headache)." data-id="CD006901-fig-0056" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.15</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 15 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 16 Postpartum haemorrhage." data-id="CD006901-fig-0057" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.16</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 16 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-003-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-003-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 17 Additional induction agents used." data-id="CD006901-fig-0058" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.17</div> <div class="figure-caption"> <p>Comparison 3 (1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix), Outcome 17 Additional induction agents used. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-003-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD006901-fig-0059" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0060" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 3 Caesarean section." data-id="CD006901-fig-0061" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 4 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0062" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 4 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0063" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 6 Oxytocin augmentation." data-id="CD006901-fig-0064" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 6 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 7 Epidural analgesia." data-id="CD006901-fig-0065" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 7 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 8 Instrumental vaginal delivery." data-id="CD006901-fig-0066" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 8 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 9 Meconium‐stained liquor." data-id="CD006901-fig-0067" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 9 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-004-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-004-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 10 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0068" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 10 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-004-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-004-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 11 Neonatal intensive care unit admission." data-id="CD006901-fig-0069" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.11</div> <div class="figure-caption"> <p>Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 11 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-004-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-004-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 12 Perinatal death." data-id="CD006901-fig-0070" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.12</div> <div class="figure-caption"> <p>Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 12 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-004-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-004-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 13 Maternal side effects (nausea)." data-id="CD006901-fig-0071" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.13</div> <div class="figure-caption"> <p>Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 13 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-004-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-004-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 14 Maternal side effects (headache)." data-id="CD006901-fig-0072" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.14</div> <div class="figure-caption"> <p>Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 14 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-004-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-004-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 15 Additional induction agents used." data-id="CD006901-fig-0073" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.15</div> <div class="figure-caption"> <p>Comparison 4 (1.4) Nitric oxide donors versus placebo/no intervention (all primiparae), Outcome 15 Additional induction agents used. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-004-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD006901-fig-0074" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0075" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 3 Caesarean section." data-id="CD006901-fig-0076" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 4 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0077" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 4 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0078" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 6 Oxytocin augmentation." data-id="CD006901-fig-0079" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 6 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 7 Epidural analgesia." data-id="CD006901-fig-0080" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 7 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 8 Instrumental vaginal delivery." data-id="CD006901-fig-0081" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 8 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 9 Meconium‐stained liquor." data-id="CD006901-fig-0082" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 9 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 10 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0083" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 10 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-005-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-005-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 11 Neonatal intensive care unit admission." data-id="CD006901-fig-0084" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 11 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-005-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-005-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 12 Perinatal death." data-id="CD006901-fig-0085" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.12</div> <div class="figure-caption"> <p>Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 12 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-005-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-005-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 13 Maternal side effects (nausea)." data-id="CD006901-fig-0086" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.13</div> <div class="figure-caption"> <p>Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 13 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-005-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-005-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 14 Maternal side effects (headache)." data-id="CD006901-fig-0087" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.14</div> <div class="figure-caption"> <p>Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 14 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-005-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-005-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 15 Additional induction agents used." data-id="CD006901-fig-0088" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.15</div> <div class="figure-caption"> <p>Comparison 5 (1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix), Outcome 15 Additional induction agents used. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-005-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD006901-fig-0089" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 2 Caesarean section." data-id="CD006901-fig-0090" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 3 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0091" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 3 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0092" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 5 Oxytocin augmentation." data-id="CD006901-fig-0093" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 5 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 6 Epidural analgesia." data-id="CD006901-fig-0094" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 6 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-006-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-006-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 7 Instrumental vaginal delivery." data-id="CD006901-fig-0095" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 7 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-006-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-006-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 8 Meconium‐stained liquor." data-id="CD006901-fig-0096" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 8 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-006-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-006-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 9 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0097" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 9 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-006-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-006-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 10 Neonatal intensive care unit admission." data-id="CD006901-fig-0098" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.10</div> <div class="figure-caption"> <p>Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 10 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-006-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-006-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 11 Perinatal death." data-id="CD006901-fig-0099" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.11</div> <div class="figure-caption"> <p>Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 11 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-006-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-006-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 12 Maternal side effects (nausea)." data-id="CD006901-fig-0100" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.12</div> <div class="figure-caption"> <p>Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 12 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-006-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-006-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 13 Maternal side effects (headache)." data-id="CD006901-fig-0101" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.13</div> <div class="figure-caption"> <p>Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 13 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-006-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-006-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 14 Additional induction agents used." data-id="CD006901-fig-0102" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.14</div> <div class="figure-caption"> <p>Comparison 6 (1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix), Outcome 14 Additional induction agents used. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-006-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD006901-fig-0103" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0104" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 3 Uterine hyperstimulation without FHR changes." data-id="CD006901-fig-0105" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 3 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 4 Caesarean section." data-id="CD006901-fig-0106" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 4 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 5 Instrumental vaginal delivery." data-id="CD006901-fig-0107" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 5 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-007-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-007-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 6 Meconium‐stained liquor." data-id="CD006901-fig-0108" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 6 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-007-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-007-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0109" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.7</div> <div class="figure-caption"> <p>Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 7 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-007-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-007-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 8 Epidural analgesia." data-id="CD006901-fig-0110" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.8</div> <div class="figure-caption"> <p>Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 8 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-007-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-007-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 9 Maternal side effects (nausea)." data-id="CD006901-fig-0111" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.9</div> <div class="figure-caption"> <p>Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 9 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-007-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-007-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 10 Maternal side effects (headache)." data-id="CD006901-fig-0112" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.10</div> <div class="figure-caption"> <p>Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 10 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-007-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-007-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 11 Postpartum haemorrhage." data-id="CD006901-fig-0113" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.11</div> <div class="figure-caption"> <p>Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 11 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-007-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-007-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 12 Serious maternal complications." data-id="CD006901-fig-0114" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.12</div> <div class="figure-caption"> <p>Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 12 Serious maternal complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-007-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-007-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 13 Neonatal intensive care unit admission." data-id="CD006901-fig-0115" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.13</div> <div class="figure-caption"> <p>Comparison 7 (2.1) Nitric oxide donors versus vaginal prostaglandins (all women), Outcome 13 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-007-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0116" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 2 Caesarean section." data-id="CD006901-fig-0117" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0118"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 3 Uterine hyperstimulation without FHR changes." data-id="CD006901-fig-0118" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 3 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0118">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 4 Epidural analgesia." data-id="CD006901-fig-0119" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 4 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 5 Instrumental vaginal delivery." data-id="CD006901-fig-0120" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 5 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0121"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-008-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-008-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 6 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0121" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.6</div> <div class="figure-caption"> <p>Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 6 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0121">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0122"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-008-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-008-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 7 Neonatal intensive care unit admission." data-id="CD006901-fig-0122" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.7</div> <div class="figure-caption"> <p>Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 7 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0122">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0123"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-008-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-008-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 8 Maternal side effects (nausea)." data-id="CD006901-fig-0123" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.8</div> <div class="figure-caption"> <p>Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 8 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0123">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0124"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-008-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-008-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 9 Maternal side effects (headache)." data-id="CD006901-fig-0124" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.9</div> <div class="figure-caption"> <p>Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 9 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0124">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0125"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-008-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-008-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 10 Postpartum haemorrhage." data-id="CD006901-fig-0125" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.10</div> <div class="figure-caption"> <p>Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 10 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0125">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0126"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-008-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-008-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 11 Serious maternal complications." data-id="CD006901-fig-0126" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.11</div> <div class="figure-caption"> <p>Comparison 8 (2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix), Outcome 11 Serious maternal complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0126">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-008-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0127"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0127" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0127">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0128"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 2 Caesarean section." data-id="CD006901-fig-0128" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0128">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0129"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 3 Epidural analgesia." data-id="CD006901-fig-0129" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 3 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0129">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0130"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 4 Instrumental vaginal delivery." data-id="CD006901-fig-0130" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 4 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0130">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0131"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-009-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-009-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 5 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0131" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 5 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0131">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0132"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-009-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-009-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 6 Neonatal intensive care unit admission." data-id="CD006901-fig-0132" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 6 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0132">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0133"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-009-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-009-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 7 Maternal side effects (nausea)." data-id="CD006901-fig-0133" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.7</div> <div class="figure-caption"> <p>Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 7 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0133">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0134"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-009-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-009-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 8 Maternal side effects (headache)." data-id="CD006901-fig-0134" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.8</div> <div class="figure-caption"> <p>Comparison 9 (2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix), Outcome 8 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0134">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-009-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0135"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD006901-fig-0135" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0135">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0136"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0136" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0136">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0137"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 3 Caesarean section." data-id="CD006901-fig-0137" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0137">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0138"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-010-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-010-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 4 Epidural analgesia." data-id="CD006901-fig-0138" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 4 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0138">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0139"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-010-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-010-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 5 Instrumental vaginal delivery." data-id="CD006901-fig-0139" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.5</div> <div class="figure-caption"> <p>Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 5 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0139">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0140"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-010-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-010-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 6 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0140" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.6</div> <div class="figure-caption"> <p>Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 6 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0140">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0141"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-010-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-010-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 7 Neonatal intensive care unit admission." data-id="CD006901-fig-0141" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.7</div> <div class="figure-caption"> <p>Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 7 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0141">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0142"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-010-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-010-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 8 Maternal side effects (nausea)." data-id="CD006901-fig-0142" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.8</div> <div class="figure-caption"> <p>Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 8 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0142">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0143"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-010-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-010-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 9 Maternal side effects (headache)." data-id="CD006901-fig-0143" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.9</div> <div class="figure-caption"> <p>Comparison 10 (2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae), Outcome 9 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0143">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-010-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0144"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0144" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0144">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0145"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 2 Caesarean section." data-id="CD006901-fig-0145" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0145">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0146"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-011-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-011-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 3 Epidural analgesia." data-id="CD006901-fig-0146" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 3 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0146">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0147"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-011-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-011-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 4 Instrumental vaginal delivery." data-id="CD006901-fig-0147" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.4</div> <div class="figure-caption"> <p>Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 4 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0147">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0148"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-011-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-011-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 5 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0148" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.5</div> <div class="figure-caption"> <p>Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 5 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0148">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0149"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-011-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-011-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 6 Neonatal intensive care unit admission." data-id="CD006901-fig-0149" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.6</div> <div class="figure-caption"> <p>Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 6 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0149">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0150"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-011-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-011-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 7 Maternal side effects (nausea)." data-id="CD006901-fig-0150" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.7</div> <div class="figure-caption"> <p>Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 7 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0150">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0151"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-011-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-011-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 8 Maternal side effects (headache)." data-id="CD006901-fig-0151" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.8</div> <div class="figure-caption"> <p>Comparison 11 (2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix), Outcome 8 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0151">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-011-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0152"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-012-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-012-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0152" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0152">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0153"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-012-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-012-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 2 Caesarean section." data-id="CD006901-fig-0153" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0153">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0154"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-012-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-012-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 3 Epidural analgesia." data-id="CD006901-fig-0154" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 3 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0154">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0155"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-012-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-012-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 4 Instrumental vaginal delivery." data-id="CD006901-fig-0155" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.4</div> <div class="figure-caption"> <p>Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 4 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0155">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0156"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-012-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-012-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 5 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0156" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.5</div> <div class="figure-caption"> <p>Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 5 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0156">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0157"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-012-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-012-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 6 Neonatal intensive care unit admission." data-id="CD006901-fig-0157" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.6</div> <div class="figure-caption"> <p>Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 6 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0157">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0158"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-012-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-012-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 7 Maternal side effects (nausea)." data-id="CD006901-fig-0158" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.7</div> <div class="figure-caption"> <p>Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 7 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0158">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0159"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-012-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-012-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 8 Maternal side effects (headache)." data-id="CD006901-fig-0159" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.8</div> <div class="figure-caption"> <p>Comparison 12 (2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix), Outcome 8 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0159">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-012-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0160"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-013-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-013-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD006901-fig-0160" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0160">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0161"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-013-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-013-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0161" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0161">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0162"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-013-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-013-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 3 Caesarean section." data-id="CD006901-fig-0162" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.3</div> <div class="figure-caption"> <p>Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0162">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0163"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-013-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-013-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 4 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0163" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.4</div> <div class="figure-caption"> <p>Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 4 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0163">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0164"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-013-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-013-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0164" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.5</div> <div class="figure-caption"> <p>Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0164">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0165"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-013-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-013-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 6 Oxytocin augmentation." data-id="CD006901-fig-0165" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.6</div> <div class="figure-caption"> <p>Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 6 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0165">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0166"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-013-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-013-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 7 Uterine hyperstimulation without FHR changes." data-id="CD006901-fig-0166" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.7</div> <div class="figure-caption"> <p>Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 7 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0166">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0167"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-013-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-013-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 8 Instrumental vaginal delivery." data-id="CD006901-fig-0167" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.8</div> <div class="figure-caption"> <p>Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 8 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0167">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0168"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-013-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-013-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 9 Perinatal death." data-id="CD006901-fig-0168" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.9</div> <div class="figure-caption"> <p>Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 9 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0168">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0169"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-013-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-013-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 10 Maternal side effects (headache)." data-id="CD006901-fig-0169" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.10</div> <div class="figure-caption"> <p>Comparison 13 (3.1) Nitric oxide donors versus intracervical prostaglandins (all women), Outcome 10 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0169">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-013-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0170"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-014-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-014-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD006901-fig-0170" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0170">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0171"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-014-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-014-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0171" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.2</div> <div class="figure-caption"> <p>Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0171">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0172"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-014-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-014-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 3 Caesarean section." data-id="CD006901-fig-0172" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.3</div> <div class="figure-caption"> <p>Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0172">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0173"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-014-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-014-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 4 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0173" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.4</div> <div class="figure-caption"> <p>Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 4 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0173">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0174"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-014-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-014-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0174" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.5</div> <div class="figure-caption"> <p>Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0174">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0175"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-014-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-014-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 6 Oxytocin augmentation." data-id="CD006901-fig-0175" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.6</div> <div class="figure-caption"> <p>Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 6 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0175">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0176"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-014-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-014-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 7 Uterine hyperstimulation without FHR changes." data-id="CD006901-fig-0176" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.7</div> <div class="figure-caption"> <p>Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 7 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0176">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0177"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-014-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-014-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 8 Instrumental vaginal delivery." data-id="CD006901-fig-0177" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.8</div> <div class="figure-caption"> <p>Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 8 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0177">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0178"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-014-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-014-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 9 Perinatal death." data-id="CD006901-fig-0178" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.9</div> <div class="figure-caption"> <p>Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 9 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0178">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0179"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-014-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-014-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 10 Maternal side effects (headache)." data-id="CD006901-fig-0179" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.10</div> <div class="figure-caption"> <p>Comparison 14 (3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix), Outcome 10 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0179">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-014-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0180"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-015-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-015-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD006901-fig-0180" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0180">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0181"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-015-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-015-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0181" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0181">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0182"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-015-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-015-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 3 Caesarean section." data-id="CD006901-fig-0182" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.3</div> <div class="figure-caption"> <p>Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0182">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0183"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-015-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-015-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 4 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0183" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.4</div> <div class="figure-caption"> <p>Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 4 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0183">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0184"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-015-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-015-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0184" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.5</div> <div class="figure-caption"> <p>Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0184">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0185"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-015-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-015-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 6 Oxytocin augmentation." data-id="CD006901-fig-0185" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.6</div> <div class="figure-caption"> <p>Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 6 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0185">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0186"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-015-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-015-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 7 Uterine hyperstimulation without FHR changes." data-id="CD006901-fig-0186" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.7</div> <div class="figure-caption"> <p>Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 7 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0186">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0187"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-015-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-015-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 8 Instrumental vaginal delivery." data-id="CD006901-fig-0187" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.8</div> <div class="figure-caption"> <p>Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 8 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0187">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0188"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-015-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-015-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 9 Perinatal death." data-id="CD006901-fig-0188" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.9</div> <div class="figure-caption"> <p>Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 9 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0188">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0189"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-015-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-015-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 10 Maternal side effects (headache)." data-id="CD006901-fig-0189" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.10</div> <div class="figure-caption"> <p>Comparison 15 (3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes), Outcome 10 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0189">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-015-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0190"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-016-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-016-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0190" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0190">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0191"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-016-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-016-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 2 Caesarean section." data-id="CD006901-fig-0191" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.2</div> <div class="figure-caption"> <p>Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0191">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0192"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-016-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-016-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 3 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0192" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.3</div> <div class="figure-caption"> <p>Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 3 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0192">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0193"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-016-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-016-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0193" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.4</div> <div class="figure-caption"> <p>Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0193">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0194"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-016-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-016-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 5 Oxytocin augmentation." data-id="CD006901-fig-0194" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.5</div> <div class="figure-caption"> <p>Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 5 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0194">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0195"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-016-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-016-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 6 Uterine hyperstimulation without FHR changes." data-id="CD006901-fig-0195" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.6</div> <div class="figure-caption"> <p>Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 6 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0195">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0196"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-016-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-016-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 7 Instrumental vaginal delivery." data-id="CD006901-fig-0196" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.7</div> <div class="figure-caption"> <p>Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 7 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0196">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0197"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-016-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-016-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 8 Perinatal death." data-id="CD006901-fig-0197" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.8</div> <div class="figure-caption"> <p>Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 8 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0197">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0198"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-016-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-016-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 9 Maternal side effects (headache)." data-id="CD006901-fig-0198" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.9</div> <div class="figure-caption"> <p>Comparison 16 (3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae), Outcome 9 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0198">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-016-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0199"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-017-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-017-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0199" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0199">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0200"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-017-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-017-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 2 Caesarean section." data-id="CD006901-fig-0200" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.2</div> <div class="figure-caption"> <p>Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0200">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0201"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-017-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-017-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 3 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0201" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.3</div> <div class="figure-caption"> <p>Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 3 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0201">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0202"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-017-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-017-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0202" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.4</div> <div class="figure-caption"> <p>Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0202">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0203"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-017-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-017-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 5 Oxytocin augmentation." data-id="CD006901-fig-0203" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.5</div> <div class="figure-caption"> <p>Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 5 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0203">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0204"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-017-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-017-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 6 Uterine hyperstimulation without FHR changes." data-id="CD006901-fig-0204" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.6</div> <div class="figure-caption"> <p>Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 6 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0204">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0205"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-017-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-017-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 7 Instrumental vaginal delivery." data-id="CD006901-fig-0205" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.7</div> <div class="figure-caption"> <p>Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 7 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0205">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0206"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-017-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-017-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 8 Perinatal death." data-id="CD006901-fig-0206" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.8</div> <div class="figure-caption"> <p>Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 8 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0206">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0207"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-017-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-017-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 9 Maternal side effects (headache)." data-id="CD006901-fig-0207" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.9</div> <div class="figure-caption"> <p>Comparison 17 (3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix), Outcome 9 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0207">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-017-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0208"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-018-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-018-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0208" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.1</div> <div class="figure-caption"> <p>Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0208">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0209"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-018-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-018-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 2 Caesarean section." data-id="CD006901-fig-0209" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.2</div> <div class="figure-caption"> <p>Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0209">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0210"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-018-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-018-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 3 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0210" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.3</div> <div class="figure-caption"> <p>Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 3 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0210">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0211"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-018-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-018-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0211" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.4</div> <div class="figure-caption"> <p>Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0211">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0212"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-018-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-018-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 5 Oxytocin augmentation." data-id="CD006901-fig-0212" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.5</div> <div class="figure-caption"> <p>Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 5 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0212">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0213"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-018-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-018-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 6 Uterine hyperstimulation without FHR changes." data-id="CD006901-fig-0213" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.6</div> <div class="figure-caption"> <p>Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 6 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0213">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0214"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-018-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-018-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 7 Instrumental vaginal delivery." data-id="CD006901-fig-0214" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.7</div> <div class="figure-caption"> <p>Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 7 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0214">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0215"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-018-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-018-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 8 Perinatal death." data-id="CD006901-fig-0215" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.8</div> <div class="figure-caption"> <p>Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 8 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0215">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0216"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-018-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-018-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 9 Maternal side effects (headache)." data-id="CD006901-fig-0216" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.9</div> <div class="figure-caption"> <p>Comparison 18 (3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes), Outcome 9 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0216">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-018-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0217"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD006901-fig-0217" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.1</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0217">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0218"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0218" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.2</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0218">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0219"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 3 Caesarean section." data-id="CD006901-fig-0219" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.3</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0219">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0220"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 4 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0220" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.4</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 4 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0220">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0221"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0221" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.5</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0221">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0222"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 6 Oxytocin augmentation." data-id="CD006901-fig-0222" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.6</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 6 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0222">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0223"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 7 Uterine hyperstimulation without FHR changes." data-id="CD006901-fig-0223" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.7</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 7 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0223">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0224"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 8 Epidural analgesia." data-id="CD006901-fig-0224" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.8</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 8 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0224">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0225"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 9 Instrumental vaginal delivery." data-id="CD006901-fig-0225" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.9</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 9 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0225">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0226"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 10 Meconium‐stained liquor." data-id="CD006901-fig-0226" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.10</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 10 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0226">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0227"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 11 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0227" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.11</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 11 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0227">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0228"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 12 Neonatal intensive care unit admission." data-id="CD006901-fig-0228" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.12</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 12 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0228">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0229"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 13 Perinatal death." data-id="CD006901-fig-0229" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.13</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 13 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0229">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0230"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 14 Maternal side effects (nausea)." data-id="CD006901-fig-0230" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.14</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 14 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0230">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0231"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 15 Maternal side effects (headache)." data-id="CD006901-fig-0231" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.15</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 15 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0231">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0232"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 16 Postpartum haemorrhage." data-id="CD006901-fig-0232" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.16</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 16 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0232">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0233"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 17 Analgesia requirement." data-id="CD006901-fig-0233" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.17</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 17 Analgesia requirement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0233">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0234"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-019-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-019-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 18 Additional induction agents required." data-id="CD006901-fig-0234" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.18</div> <div class="figure-caption"> <p>Comparison 19 (4.1) Nitric oxide donors versus vaginal misoprostol (all women), Outcome 18 Additional induction agents required. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0234">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-019-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0235"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-020-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-020-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0235" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.1</div> <div class="figure-caption"> <p>Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0235">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0236"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-020-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-020-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 2 Caesarean section." data-id="CD006901-fig-0236" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.2</div> <div class="figure-caption"> <p>Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0236">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0237"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-020-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-020-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 3 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0237" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.3</div> <div class="figure-caption"> <p>Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 3 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0237">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0238"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-020-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-020-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0238" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.4</div> <div class="figure-caption"> <p>Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0238">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0239"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-020-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-020-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 5 Oxytocin augmentation." data-id="CD006901-fig-0239" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.5</div> <div class="figure-caption"> <p>Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 5 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0239">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0240"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-020-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-020-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 6 Uterine hyperstimulation without FHR changes." data-id="CD006901-fig-0240" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.6</div> <div class="figure-caption"> <p>Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 6 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0240">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0241"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-020-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-020-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 7 Instrumental vaginal delivery." data-id="CD006901-fig-0241" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.7</div> <div class="figure-caption"> <p>Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 7 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0241">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0242"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-020-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-020-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 8 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0242" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.8</div> <div class="figure-caption"> <p>Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 8 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0242">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0243"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-020-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-020-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 9 Neonatal intensive care unit admission." data-id="CD006901-fig-0243" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.9</div> <div class="figure-caption"> <p>Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 9 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0243">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0244"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-020-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-020-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 10 Perinatal death." data-id="CD006901-fig-0244" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.10</div> <div class="figure-caption"> <p>Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 10 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0244">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0245"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-020-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-020-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 11 Maternal side effects (nausea)." data-id="CD006901-fig-0245" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.11</div> <div class="figure-caption"> <p>Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 11 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0245">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0246"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-020-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-020-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 12 Maternal side effects (headache)." data-id="CD006901-fig-0246" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.12</div> <div class="figure-caption"> <p>Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 12 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0246">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0247"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-020-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-020-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 13 Postpartum haemorrhage." data-id="CD006901-fig-0247" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.13</div> <div class="figure-caption"> <p>Comparison 20 (4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix), Outcome 13 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0247">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-020-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0248"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-021-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-021-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0248" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.1</div> <div class="figure-caption"> <p>Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0248">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0249"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-021-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-021-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 2 Caesarean section." data-id="CD006901-fig-0249" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.2</div> <div class="figure-caption"> <p>Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0249">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0250"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-021-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-021-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 3 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0250" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.3</div> <div class="figure-caption"> <p>Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 3 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0250">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0251"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-021-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-021-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0251" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.4</div> <div class="figure-caption"> <p>Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0251">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0252"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-021-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-021-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 5 Oxytocin augmentation." data-id="CD006901-fig-0252" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.5</div> <div class="figure-caption"> <p>Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 5 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0252">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0253"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-021-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-021-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 6 Instrumental vaginal delivery." data-id="CD006901-fig-0253" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.6</div> <div class="figure-caption"> <p>Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 6 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0253">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0254"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-021-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-021-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0254" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.7</div> <div class="figure-caption"> <p>Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 7 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0254">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0255"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-021-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-021-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 8 Perinatal death." data-id="CD006901-fig-0255" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.8</div> <div class="figure-caption"> <p>Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 8 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0255">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0256"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-021-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-021-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 9 Maternal side effects (nausea)." data-id="CD006901-fig-0256" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.9</div> <div class="figure-caption"> <p>Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 9 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0256">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0257"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-021-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-021-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 10 Maternal side effects (headache)." data-id="CD006901-fig-0257" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.10</div> <div class="figure-caption"> <p>Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 10 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0257">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0258"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-021-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-021-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 11 Postpartum haemorrhage." data-id="CD006901-fig-0258" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.11</div> <div class="figure-caption"> <p>Comparison 21 (4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix), Outcome 11 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0258">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-021-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0259"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-022-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-022-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD006901-fig-0259" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.1</div> <div class="figure-caption"> <p>Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0259">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0260"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-022-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-022-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0260" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.2</div> <div class="figure-caption"> <p>Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0260">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0261"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-022-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-022-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 3 Caesarean section." data-id="CD006901-fig-0261" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.3</div> <div class="figure-caption"> <p>Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0261">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0262"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-022-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-022-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 4 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0262" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.4</div> <div class="figure-caption"> <p>Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 4 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0262">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0263"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-022-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-022-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0263" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.5</div> <div class="figure-caption"> <p>Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0263">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0264"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-022-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-022-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 6 Oxytocin augmentation." data-id="CD006901-fig-0264" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.6</div> <div class="figure-caption"> <p>Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 6 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0264">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0265"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-022-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-022-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 7 Instrumental vaginal delivery." data-id="CD006901-fig-0265" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.7</div> <div class="figure-caption"> <p>Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 7 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0265">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0266"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-022-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-022-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 8 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0266" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.8</div> <div class="figure-caption"> <p>Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 8 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0266">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0267"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-022-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-022-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 9 Neonatal intensive care unit admission." data-id="CD006901-fig-0267" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.9</div> <div class="figure-caption"> <p>Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 9 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0267">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0268"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-022-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-022-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 10 Perinatal death." data-id="CD006901-fig-0268" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.10</div> <div class="figure-caption"> <p>Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 10 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0268">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0269"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-022-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-022-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 11 Maternal side effects (nausea)." data-id="CD006901-fig-0269" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.11</div> <div class="figure-caption"> <p>Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 11 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0269">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0270"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-022-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-022-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 12 Maternal side effects (headache)." data-id="CD006901-fig-0270" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.12</div> <div class="figure-caption"> <p>Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 12 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0270">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0271"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-022-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-022-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 13 Postpartum haemorrhage." data-id="CD006901-fig-0271" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.13</div> <div class="figure-caption"> <p>Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 13 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0271">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0272"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-022-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-022-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 14 Additional induction agents required." data-id="CD006901-fig-0272" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.14</div> <div class="figure-caption"> <p>Comparison 22 (4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae), Outcome 14 Additional induction agents required. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0272">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-022-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0273"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-023-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-023-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0273" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.1</div> <div class="figure-caption"> <p>Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0273">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0274"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-023-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-023-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 2 Caesarean section." data-id="CD006901-fig-0274" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.2</div> <div class="figure-caption"> <p>Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0274">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0275"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-023-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-023-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 3 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0275" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.3</div> <div class="figure-caption"> <p>Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 3 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0275">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0276"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-023-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-023-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0276" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.4</div> <div class="figure-caption"> <p>Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0276">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0277"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-023-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-023-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 5 Oxytocin augmentation." data-id="CD006901-fig-0277" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.5</div> <div class="figure-caption"> <p>Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 5 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0277">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0278"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-023-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-023-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 6 Instrumental vaginal delivery." data-id="CD006901-fig-0278" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.6</div> <div class="figure-caption"> <p>Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 6 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0278">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0279"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-023-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-023-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0279" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.7</div> <div class="figure-caption"> <p>Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 7 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0279">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0280"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-023-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-023-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 8 Neonatal intensive care unit admission." data-id="CD006901-fig-0280" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.8</div> <div class="figure-caption"> <p>Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 8 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0280">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0281"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-023-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-023-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 9 Perinatal death." data-id="CD006901-fig-0281" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.9</div> <div class="figure-caption"> <p>Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 9 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0281">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0282"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-023-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-023-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 10 Maternal side effects (nausea)." data-id="CD006901-fig-0282" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.10</div> <div class="figure-caption"> <p>Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 10 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0282">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0283"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-023-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-023-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 11 Maternal side effects (headache)." data-id="CD006901-fig-0283" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.11</div> <div class="figure-caption"> <p>Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 11 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0283">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0284"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-023-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-023-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 12 Postpartum haemorrhage." data-id="CD006901-fig-0284" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.12</div> <div class="figure-caption"> <p>Comparison 23 (4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix), Outcome 12 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0284">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-023-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0285"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-024-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-024-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD006901-fig-0285" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.1</div> <div class="figure-caption"> <p>Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0285">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0286"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-024-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-024-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 2 Caesarean section." data-id="CD006901-fig-0286" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.2</div> <div class="figure-caption"> <p>Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0286">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0287"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-024-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-024-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 3 Serious neonatal morbidity/perinatal death." data-id="CD006901-fig-0287" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.3</div> <div class="figure-caption"> <p>Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 3 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0287">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0288"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-024-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-024-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD006901-fig-0288" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.4</div> <div class="figure-caption"> <p>Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 4 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0288">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0289"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-024-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-024-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 5 Oxytocin augmentation." data-id="CD006901-fig-0289" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.5</div> <div class="figure-caption"> <p>Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 5 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0289">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0290"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-024-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-024-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 6 Instrumental vaginal delivery." data-id="CD006901-fig-0290" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.6</div> <div class="figure-caption"> <p>Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 6 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0290">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0291"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-024-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-024-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0291" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.7</div> <div class="figure-caption"> <p>Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 7 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0291">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0292"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-024-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-024-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 8 Neonatal intensive care unit admission." data-id="CD006901-fig-0292" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.8</div> <div class="figure-caption"> <p>Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 8 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0292">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0293"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-024-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-024-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 9 Perinatal death." data-id="CD006901-fig-0293" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.9</div> <div class="figure-caption"> <p>Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 9 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0293">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0294"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-024-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-024-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 10 Maternal side effects (nausea)." data-id="CD006901-fig-0294" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.10</div> <div class="figure-caption"> <p>Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 10 Maternal side effects (nausea). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0294">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0295"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-024-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-024-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 11 Maternal side effects (headache)." data-id="CD006901-fig-0295" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.11</div> <div class="figure-caption"> <p>Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 11 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0295">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0296"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-024-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-024-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 12 Postpartum haemorrhage." data-id="CD006901-fig-0296" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.12</div> <div class="figure-caption"> <p>Comparison 24 (4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix), Outcome 12 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0296">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-024-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0297"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-025-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-025-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 1 Caesarean section." data-id="CD006901-fig-0297" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.1</div> <div class="figure-caption"> <p>Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 1 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0297">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0298"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-025-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-025-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 2 Oxyocin augmentation." data-id="CD006901-fig-0298" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.2</div> <div class="figure-caption"> <p>Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 2 Oxyocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0298">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0299"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-025-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-025-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 3 Uterine rupture." data-id="CD006901-fig-0299" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.3</div> <div class="figure-caption"> <p>Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 3 Uterine rupture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0299">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0300"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-025-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-025-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 4 Epidural analgesia." data-id="CD006901-fig-0300" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.4</div> <div class="figure-caption"> <p>Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 4 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0300">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0301"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-025-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-025-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 5 Instrumental vaginal delivery." data-id="CD006901-fig-0301" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.5</div> <div class="figure-caption"> <p>Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 5 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0301">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0302"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-025-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-025-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 6 Meconium‐stained liquor." data-id="CD006901-fig-0302" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.6</div> <div class="figure-caption"> <p>Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 6 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0302">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0303"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-025-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-025-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0303" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.7</div> <div class="figure-caption"> <p>Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 7 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0303">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0304"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-025-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-025-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 8 Neonatal intensive care unit admission." data-id="CD006901-fig-0304" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.8</div> <div class="figure-caption"> <p>Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 8 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0304">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0305"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-025-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-025-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 9 Maternal side effects (nausea and vomiting)." data-id="CD006901-fig-0305" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.9</div> <div class="figure-caption"> <p>Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 9 Maternal side effects (nausea and vomiting). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0305">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0306"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-025-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-025-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 10 Maternal side effects (headache)." data-id="CD006901-fig-0306" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.10</div> <div class="figure-caption"> <p>Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 10 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0306">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0307"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-025-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-025-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 11 Postpartum haemorrhage." data-id="CD006901-fig-0307" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.11</div> <div class="figure-caption"> <p>Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 11 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0307">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0308"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-025-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-025-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 12 Women not satisfied." data-id="CD006901-fig-0308" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.12</div> <div class="figure-caption"> <p>Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 12 Women not satisfied. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0308">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0309"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-025-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-025-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 13 Other maternal side effect (puerperal pyrexia)." data-id="CD006901-fig-0309" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.13</div> <div class="figure-caption"> <p>Comparison 25 (5.1) Nitric oxide versus intracervical Foley catheter (all women), Outcome 13 Other maternal side effect (puerperal pyrexia). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0309">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-025-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0310"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-026-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-026-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 1 Caesarean section." data-id="CD006901-fig-0310" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.1</div> <div class="figure-caption"> <p>Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 1 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0310">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0311"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-026-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-026-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 2 Oxyocin augmentation." data-id="CD006901-fig-0311" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.2</div> <div class="figure-caption"> <p>Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 2 Oxyocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0311">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0312"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-026-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-026-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 3 Uterine rupture." data-id="CD006901-fig-0312" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.3</div> <div class="figure-caption"> <p>Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 3 Uterine rupture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0312">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0313"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-026-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-026-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 4 Epidural analgesia." data-id="CD006901-fig-0313" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.4</div> <div class="figure-caption"> <p>Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 4 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0313">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0314"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-026-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-026-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 5 Instrumental vaginal delivery." data-id="CD006901-fig-0314" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.5</div> <div class="figure-caption"> <p>Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 5 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0314">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0315"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-026-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-026-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 6 Meconium‐stained liquor." data-id="CD006901-fig-0315" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.6</div> <div class="figure-caption"> <p>Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 6 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0315">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0316"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-026-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-026-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0316" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.7</div> <div class="figure-caption"> <p>Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 7 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0316">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0317"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-026-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-026-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 8 Neonatal intensive care unit admission." data-id="CD006901-fig-0317" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.8</div> <div class="figure-caption"> <p>Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 8 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0317">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0318"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-026-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-026-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 9 Maternal side effects (nausea and vomiting)." data-id="CD006901-fig-0318" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.9</div> <div class="figure-caption"> <p>Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 9 Maternal side effects (nausea and vomiting). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0318">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0319"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-026-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-026-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 10 Maternal side effects (headache)." data-id="CD006901-fig-0319" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.10</div> <div class="figure-caption"> <p>Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 10 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0319">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0320"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-026-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-026-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 11 Postpartum haemorrhage." data-id="CD006901-fig-0320" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.11</div> <div class="figure-caption"> <p>Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 11 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0320">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0321"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-026-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-026-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 12 Women not satisfied." data-id="CD006901-fig-0321" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.12</div> <div class="figure-caption"> <p>Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 12 Women not satisfied. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0321">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0322"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-026-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-026-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 13 Other maternal side effect (puerperal pyrexia)." data-id="CD006901-fig-0322" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.13</div> <div class="figure-caption"> <p>Comparison 26 (5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix), Outcome 13 Other maternal side effect (puerperal pyrexia). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0322">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-026-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0323"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-027-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-027-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 1 Caesarean section." data-id="CD006901-fig-0323" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.1</div> <div class="figure-caption"> <p>Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 1 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0323">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0324"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-027-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-027-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 2 Oxyocin augmentation." data-id="CD006901-fig-0324" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.2</div> <div class="figure-caption"> <p>Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 2 Oxyocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0324">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0325"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-027-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-027-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 3 Uterine rupture." data-id="CD006901-fig-0325" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.3</div> <div class="figure-caption"> <p>Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 3 Uterine rupture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0325">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0326"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-027-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-027-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 4 Epidural analgesia." data-id="CD006901-fig-0326" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.4</div> <div class="figure-caption"> <p>Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 4 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0326">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0327"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-027-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-027-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 5 Instrumental vaginal delivery." data-id="CD006901-fig-0327" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.5</div> <div class="figure-caption"> <p>Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 5 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0327">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0328"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-027-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-027-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 6 Meconium‐stained liquor." data-id="CD006901-fig-0328" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.6</div> <div class="figure-caption"> <p>Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 6 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0328">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0329"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-027-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-027-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0329" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.7</div> <div class="figure-caption"> <p>Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 7 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0329">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0330"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-027-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-027-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 8 Neonatal intensive care unit admission." data-id="CD006901-fig-0330" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.8</div> <div class="figure-caption"> <p>Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 8 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0330">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0331"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-027-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-027-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 9 Maternal side effects (nausea and vomiting)." data-id="CD006901-fig-0331" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.9</div> <div class="figure-caption"> <p>Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 9 Maternal side effects (nausea and vomiting). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0331">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0332"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-027-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-027-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 10 Maternal side effects (headache)." data-id="CD006901-fig-0332" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.10</div> <div class="figure-caption"> <p>Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 10 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0332">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0333"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-027-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-027-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 11 Postpartum haemorrhage." data-id="CD006901-fig-0333" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.11</div> <div class="figure-caption"> <p>Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 11 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0333">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0334"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-027-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-027-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 12 Women not satisfied." data-id="CD006901-fig-0334" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.12</div> <div class="figure-caption"> <p>Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 12 Women not satisfied. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0334">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0335"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-027-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-027-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 13 Other maternal side effect (puerperal pyrexia)." data-id="CD006901-fig-0335" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.13</div> <div class="figure-caption"> <p>Comparison 27 (5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix), Outcome 13 Other maternal side effect (puerperal pyrexia). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0335">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-027-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0336"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-028-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-028-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 1 Caesarean section." data-id="CD006901-fig-0336" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 28.1</div> <div class="figure-caption"> <p>Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 1 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0336">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0337"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-028-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-028-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 2 Oxyocin augmentation." data-id="CD006901-fig-0337" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 28.2</div> <div class="figure-caption"> <p>Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 2 Oxyocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0337">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0338"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-028-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-028-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 3 Uterine rupture." data-id="CD006901-fig-0338" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 28.3</div> <div class="figure-caption"> <p>Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 3 Uterine rupture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0338">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0339"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-028-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-028-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 4 Epidural analgesia." data-id="CD006901-fig-0339" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 28.4</div> <div class="figure-caption"> <p>Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 4 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0339">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0340"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-028-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-028-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 5 Instrumental vaginal delivery." data-id="CD006901-fig-0340" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 28.5</div> <div class="figure-caption"> <p>Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 5 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0340">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0341"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-028-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-028-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 6 Meconium‐stained liquor." data-id="CD006901-fig-0341" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 28.6</div> <div class="figure-caption"> <p>Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 6 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0341">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0342"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-028-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-028-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0342" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 28.7</div> <div class="figure-caption"> <p>Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 7 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0342">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0343"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-028-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-028-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 8 Neonatal intensive care unit admission." data-id="CD006901-fig-0343" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 28.8</div> <div class="figure-caption"> <p>Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 8 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0343">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0344"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-028-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-028-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 9 Maternal side effects (nausea and vomiting)." data-id="CD006901-fig-0344" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 28.9</div> <div class="figure-caption"> <p>Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 9 Maternal side effects (nausea and vomiting). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0344">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0345"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-028-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-028-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 10 Maternal side effects (headache)." data-id="CD006901-fig-0345" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 28.10</div> <div class="figure-caption"> <p>Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 10 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0345">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0346"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-028-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-028-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 11 Postpartum haemorrhage." data-id="CD006901-fig-0346" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 28.11</div> <div class="figure-caption"> <p>Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 11 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0346">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0347"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-028-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-028-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 12 Women not satisfied." data-id="CD006901-fig-0347" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 28.12</div> <div class="figure-caption"> <p>Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 12 Women not satisfied. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0347">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0348"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-028-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-028-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 13 Other maternal side effect (puerperal pyrexia)." data-id="CD006901-fig-0348" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 28.13</div> <div class="figure-caption"> <p>Comparison 28 (5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS), Outcome 13 Other maternal side effect (puerperal pyrexia). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0348">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-028-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0349"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-029-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-029-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 1 Caesarean section." data-id="CD006901-fig-0349" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.1</div> <div class="figure-caption"> <p>Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 1 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0349">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0350"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-029-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-029-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 2 Oxyocin augmentation." data-id="CD006901-fig-0350" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.2</div> <div class="figure-caption"> <p>Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 2 Oxyocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0350">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0351"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-029-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-029-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 3 Uterine rupture." data-id="CD006901-fig-0351" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.3</div> <div class="figure-caption"> <p>Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 3 Uterine rupture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0351">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0352"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-029-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-029-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 4 Epidural analgesia." data-id="CD006901-fig-0352" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.4</div> <div class="figure-caption"> <p>Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 4 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0352">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0353"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-029-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-029-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 5 Instrumental vaginal delivery." data-id="CD006901-fig-0353" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.5</div> <div class="figure-caption"> <p>Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 5 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0353">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0354"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-029-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-029-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 6 Meconium‐stained liquor." data-id="CD006901-fig-0354" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.6</div> <div class="figure-caption"> <p>Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 6 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0354">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0355"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-029-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-029-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0355" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.7</div> <div class="figure-caption"> <p>Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 7 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0355">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0356"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-029-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-029-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 8 Neonatal intensive care unit admission." data-id="CD006901-fig-0356" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.8</div> <div class="figure-caption"> <p>Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 8 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0356">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0357"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-029-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-029-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 9 Maternal side effects (nausea and vomiting)." data-id="CD006901-fig-0357" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.9</div> <div class="figure-caption"> <p>Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 9 Maternal side effects (nausea and vomiting). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0357">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0358"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-029-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-029-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 10 Maternal side effects (headache)." data-id="CD006901-fig-0358" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.10</div> <div class="figure-caption"> <p>Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 10 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0358">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0359"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-029-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-029-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 11 Postpartum haemorrhage." data-id="CD006901-fig-0359" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.11</div> <div class="figure-caption"> <p>Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 11 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0359">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0360"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-029-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-029-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 12 Women not satisfied." data-id="CD006901-fig-0360" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.12</div> <div class="figure-caption"> <p>Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 12 Women not satisfied. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0360">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0361"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-029-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-029-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 13 Other maternal side effect (puerperal pyrexia)." data-id="CD006901-fig-0361" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.13</div> <div class="figure-caption"> <p>Comparison 29 (5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix), Outcome 13 Other maternal side effect (puerperal pyrexia). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0361">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-029-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0362"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-030-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-030-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 1 Caesarean section." data-id="CD006901-fig-0362" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.1</div> <div class="figure-caption"> <p>Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 1 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0362">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0363"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-030-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-030-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 2 Oxyocin augmentation." data-id="CD006901-fig-0363" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.2</div> <div class="figure-caption"> <p>Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 2 Oxyocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0363">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0364"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-030-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-030-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 3 Uterine rupture." data-id="CD006901-fig-0364" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.3</div> <div class="figure-caption"> <p>Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 3 Uterine rupture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0364">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0365"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-030-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-030-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 4 Epidural analgesia." data-id="CD006901-fig-0365" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.4</div> <div class="figure-caption"> <p>Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 4 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0365">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0366"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-030-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-030-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 5 Instrumental vaginal delivery." data-id="CD006901-fig-0366" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.5</div> <div class="figure-caption"> <p>Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 5 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0366">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0367"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-030-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-030-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 6 Meconium‐stained liquor." data-id="CD006901-fig-0367" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.6</div> <div class="figure-caption"> <p>Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 6 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0367">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0368"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-030-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-030-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD006901-fig-0368" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.7</div> <div class="figure-caption"> <p>Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 7 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0368">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0369"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-030-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-030-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 8 Neonatal intensive care unit admission." data-id="CD006901-fig-0369" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.8</div> <div class="figure-caption"> <p>Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 8 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0369">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0370"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-030-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-030-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 9 Maternal side effects (nausea and vomiting)." data-id="CD006901-fig-0370" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.9</div> <div class="figure-caption"> <p>Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 9 Maternal side effects (nausea and vomiting). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0370">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0371"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-030-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-030-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 10 Maternal side effects (headache)." data-id="CD006901-fig-0371" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.10</div> <div class="figure-caption"> <p>Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 10 Maternal side effects (headache). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0371">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0372"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-030-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-030-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 11 Postpartum haemorrhage." data-id="CD006901-fig-0372" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.11</div> <div class="figure-caption"> <p>Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 11 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0372">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0373"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-030-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-030-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 12 Women not satisfied." data-id="CD006901-fig-0373" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.12</div> <div class="figure-caption"> <p>Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 12 Women not satisfied. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0373">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006901-fig-0374"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/urn:x-wiley:14651858:media:CD006901:CD006901-CMP-030-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_t/tCD006901-CMP-030-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 13 Other maternal side effect (puerperal pyrexia)." data-id="CD006901-fig-0374" src="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.13</div> <div class="figure-caption"> <p>Comparison 30 (5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix), Outcome 13 Other maternal side effect (puerperal pyrexia). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-fig-0374">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/media/CDSR/CD006901/image_n/nCD006901-CMP-030-13.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006901-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Nitric oxide donors versus placebo for cervical ripening and induction of labour</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Nitric oxide donors for cervical ripening and induction of labour</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> pregnant women undergoing cervical ripening and induction of labour<br/> <b>Setting:</b> outpatient and inpatient settings in India, UK, Sweden, Sri Lanka, France and Iran <br/> <b>Intervention:</b> nitric oxide donors<br/> <b>Comparison:</b> placebo/no intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo/no intervention (all women)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with (1.1) Nitric oxide donors</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal delivery not achieved in 24 hours</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.97<br/> (0.83 to 1.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>238<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>711 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>689 per 1000<br/> (590 to 817) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Uterine hyperstimulation with FHR changes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.09<br/> (0.01 to 1.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>300<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3 per 1000<br/> (1 to 54) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.99<br/> (0.88 to 1.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2624<br/> (9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>280 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>277 per 1000<br/> (246 to 311) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious neonatal morbidity/perinatal death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.61<br/> (0.08 to 33.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1712<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>5 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000<br/> (0 to 39) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious maternal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1362<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were no events for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>FHR:</b> Fetal heart rate; <b>RCT:</b> randomised controlled trial; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Only one study with few events, small sample size and wide confidence interval. </p> <p><sup>2</sup> High risk of bias for allocation concealment and blinding. </p> <p><sup>3</sup> Only two studies with few or no events, small sample size and wide confidence interval. </p> <p><sup>4</sup> High risk of bias for allocation concealment, blinding and selective outcome reporting. </p> <p><sup>5</sup> Confidence intervals do not overlap (opposite directions of effect) and I<sup>2</sup> = 48%. </p> <p><sup>6</sup> Only two studies with few events and wide confidence intervals. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Nitric oxide donors versus placebo for cervical ripening and induction of labour</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/full#CD006901-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">(1.1) Nitric oxide donors versus placebo/no intervention (all women)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.83, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2624</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.88, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1712</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [0.08, 33.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>762</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.67, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Standard release</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>659</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.69, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Slow release</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.49, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1916</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.84, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.00, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.82, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.83, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>699</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.69, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.54, 2.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>873</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.47, 1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1712</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Maternal side effects (all) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.82 [2.49, 3.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1782</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.44 [1.47, 4.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2085</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.59 [3.97, 10.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Maternal side effects (vomiting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.42 [1.54, 3.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Maternal side effects (diarrhoea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.95, 2.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1562</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.90, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Women not satisfied <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.82, 1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Additional induction agents used <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.58, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 Standard release</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2077</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.58, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 Slow release</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.49, 0.82]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">(1.1) Nitric oxide donors versus placebo/no intervention (all women)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">(1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.83, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.82, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>557</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.73, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>554</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.82, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.00, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.82, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>473</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.68, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>699</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.69, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>850</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.42, 2.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>873</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.57, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.06 [1.22, 3.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>723</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.04 [5.13, 9.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.57, 2.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Additional induction agents used <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>413</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.57, 0.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">(1.2) Nitric oxide donors versus placebo/no intervention (all women, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">(1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.83, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>754</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.77, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.61, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>454</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.79, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.00, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.82, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.61, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.67, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>750</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.27, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>750</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.42, 1.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.18 [0.82, 5.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>620</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.27 [2.47, 34.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.55, 2.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Additional induction agents used <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.70, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">(1.3) Nitric oxide donors versus placebo/no intervention (all women, intact membranes, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">(1.4) Nitric oxide donors versus placebo/no intervention (all primiparae)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.83, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>683</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.89, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>357</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.77, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.89, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.82, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>450</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.66, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.70, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>450</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.97 [0.50, 7.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>450</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.53, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.73, 2.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.10 [1.97, 8.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Additional induction agents used <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.70, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">(1.4) Nitric oxide donors versus placebo/no intervention (all primiparae)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">(1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.83, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>683</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.89, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>357</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.77, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.89, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.82, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>450</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.66, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.70, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>450</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.97 [0.50, 7.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>450</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.53, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.73, 2.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.73 [2.56, 5.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Additional induction agents used <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.70, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">(1.5) Nitric oxide donors versus placebo/no intervention (all primiparae, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">(1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.83, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.87, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.42, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.88, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.82, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.61, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.68, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.25, 8.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.58, 2.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.73, 2.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.24 [2.18, 4.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Additional induction agents used <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.70, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">(1.6) Nitric oxide donors versus placebo/no intervention (all primiparae, intact membranes, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">(2.1) Nitric oxide donors versus vaginal prostaglandins (all women)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.47, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.47, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>508</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.01, 4.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.01, 4.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>571</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.78, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.59, 1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.80, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Isosorbide Dinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.44, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.76, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.76, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.32, 2.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Isosorbide Dinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.32, 2.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>504</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.15, 1.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.15, 2.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.91, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.91, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [1.10, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [1.10, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>493</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.79 [5.75, 13.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.4 [0.65, 201.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.73 [5.68, 13.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.12, 3.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.12, 3.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Serious maternal complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>571</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.43, 1.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Isosorbide Dinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.45, 1.93]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">(2.1) Nitric oxide donors versus vaginal prostaglandins (all women)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">(2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>508</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.01, 4.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.01, 4.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>505</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.82, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.59, 1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.80, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.91, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.91, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.76, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.76, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>504</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.15, 1.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.15, 2.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>505</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.43, 1.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.45, 1.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [1.10, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [1.10, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>493</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.79 [5.75, 13.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.4 [0.65, 201.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.73 [5.68, 13.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.12, 3.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.12, 3.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Serious maternal complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.30]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">(2.2) Nitric oxide donors versus vaginal prostaglandins (all women, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">(2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.80, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.80, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.91, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.91, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.76, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.76, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.15, 2.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.15, 2.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.45, 1.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.45, 1.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [1.10, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [1.10, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.73 [5.68, 13.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.73 [5.68, 13.41]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">(2.3) Nitric oxide donors versus vaginal prostaglandins (all women, intact membranes, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">(2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.47, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.47, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>795</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.68, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>795</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.68, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.91, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.91, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.76, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.76, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.15, 2.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.15, 2.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.45, 1.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.45, 1.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [1.10, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [1.10, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.73 [5.68, 13.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.73 [5.68, 13.41]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">(2.4) Nitric oxide donors versus vaginal prostaglandins (all primiparae)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">(2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.80, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.80, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.91, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.91, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.76, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.76, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.15, 2.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.15, 2.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.45, 1.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.45, 1.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [1.10, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [1.10, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.73 [5.68, 13.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.73 [5.68, 13.41]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">(2.5) Nitric oxide donors versus vaginal prostaglandins (all primiparae, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">(2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.80, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.80, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.91, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.91, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.76, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.76, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.15, 2.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.15, 2.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.45, 1.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.45, 1.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [1.10, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [1.10, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.73 [5.68, 13.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.73 [5.68, 13.41]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">(2.6) Nitric oxide donors versus vaginal prostaglandins (all primiparae, intact membranes, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">(3.1) Nitric oxide donors versus intracervical prostaglandins (all women)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.47, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Isosorbide dinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.47, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>442</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.44, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Isosorbide dinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.38, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.43, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.59, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.59, 2.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.43, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.43, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.0 [1.40, 71.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.0 [1.40, 71.32]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">(3.1) Nitric oxide donors versus intracervical prostaglandins (all women)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">(3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.47, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Isosorbide dinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.47, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.43, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.43, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.59, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.59, 2.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.43, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.43, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.0 [1.40, 71.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.0 [1.40, 71.32]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">(3.2) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">(3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.47, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Isosorbide dinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.47, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.43, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.43, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.59, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.59, 2.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.43, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.43, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.0 [1.40, 71.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.0 [1.40, 71.32]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">(3.3) Nitric oxide donors versus intracervical prostaglandins (all women, unfavourable cervix, intact membranes)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">(3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.43, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.43, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.59, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.59, 2.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.43, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.43, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.0 [1.40, 71.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.0 [1.40, 71.32]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">(3.4) Nitric oxide donors versus intracervical prostaglandins (all primiparae)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">(3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.43, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.43, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.59, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.59, 2.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.43, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.43, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.0 [1.40, 71.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.0 [1.40, 71.32]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">(3.5) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">(3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.43, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.43, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.59, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.59, 2.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.43, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.43, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.0 [1.40, 71.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Glyceryl trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.0 [1.40, 71.32]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">(3.6) Nitric oxide donors versus intracervical prostaglandins (all primiparae, unfavourable cervix, intact membranes)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">(4.1) Nitric oxide donors versus vaginal misoprostol (all women)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.33 [1.62, 17.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.33 [1.62, 17.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.01, 0.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.01, 4.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.01, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>761</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.82, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.47, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>587</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.84, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Isosorbide Dinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.37, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.43 [2.07, 5.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.46 [0.89, 6.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.78 [2.12, 6.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>767</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.67 [1.31, 5.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.55, 2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>593</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.57 [1.84, 6.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Isosorbide Dinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [1.11, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.01, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.01, 0.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Isosorbide Dinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.01, 3.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.45, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.45, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.07, 16.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.07, 16.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.13, 0.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Isosorbide Dinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.00, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.15, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>777</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.07, 0.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Isosorbide Dinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>647</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.07, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>587</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.09, 0.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>587</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.09, 0.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>647</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.63, 2.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>647</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.63, 2.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.98 [4.05, 29.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.48 [1.35, 22.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.46 [2.69, 67.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3 Isosorbide Dinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>24.25 [1.47, 401.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>587</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.57, 3.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>587</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.57, 3.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Analgesia requirement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.13, 0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.13, 0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Additional induction agents required <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.67 [5.44, 51.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.67 [5.44, 51.09]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">(4.1) Nitric oxide donors versus vaginal misoprostol (all women)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">(4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 0.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.01, 4.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.00, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.66, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.47, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.63, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.43 [2.07, 5.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.46 [0.89, 6.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.78 [2.12, 6.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>357</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.24 [1.23, 8.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.55, 2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.35 [1.32, 14.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.00, 0.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.00, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.07, 16.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.07, 16.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.03, 0.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.03, 0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.07, 0.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.07, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.35, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.35, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.01 [3.11, 26.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.48 [1.35, 22.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.46 [2.69, 67.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.25, 8.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.25, 8.61]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">(4.2) Nitric oxide donors versus vaginal misoprostol (all women, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">(4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.01, 4.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.01, 4.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.53, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.47, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.47, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.46 [0.89, 6.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.46 [0.89, 6.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.15 [2.29, 4.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.55, 2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.64 [2.57, 5.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.07, 16.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.07, 16.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.02, 0.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.02, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.22, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.22, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.09 [2.90, 28.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.48 [1.35, 22.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.0 [2.26, 113.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.18, 21.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.18, 21.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">(4.3) Nitric oxide donors versus vaginal misoprostol (all women, intact membranes, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">(4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.33 [1.62, 17.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.33 [1.62, 17.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.01, 4.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.01, 4.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.76, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.47, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.76, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Isosorbide Mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.46 [0.89, 6.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.46 [0.89, 6.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>340</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.27 [2.27, 4.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.55, 2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.86 [2.56, 5.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.07, 16.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.07, 16.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.01, 0.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.01, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.06, 0.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.06, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.37, 1.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.37, 1.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.48 [1.35, 22.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.48 [1.35, 22.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.50, 3.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.50, 3.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Additional induction agents required <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.67 [5.44, 51.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.67 [5.44, 51.09]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">(4.4) Nitric oxide donors versus vaginal misoprostol (all primiparae)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 23.</span> <span class="table-title">(4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.01, 4.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.01, 4.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.53, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.47, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Isosorbide monotrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.47, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.46 [0.89, 6.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.46 [0.89, 6.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.38 [2.77, 6.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.55, 2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.36 [3.57, 11.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.07, 16.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.07, 16.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.00, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.00, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.07, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.07, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.3 [0.09, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.3 [0.09, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.48 [1.35, 22.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.48 [1.35, 22.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.18, 21.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.18, 21.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 23.</span> <span class="table-title">(4.5) Nitric oxide donors versus vaginal misoprostol (all primiparae, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0024">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0025"> <div class="table-heading"><span class="table-label">Comparison 24.</span> <span class="table-title">(4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.01, 4.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.01, 4.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.53, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.47, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.47, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.46 [0.89, 6.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.46 [0.89, 6.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.38 [2.77, 6.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.55, 2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.36 [3.57, 11.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.07, 16.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.07, 16.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.00, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.00, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.07, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.07, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maternal side effects (nausea) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.3 [0.09, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.3 [0.09, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.48 [1.35, 22.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Glyceryl Trinitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.48 [1.35, 22.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.18, 21.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Isosorbide mononitrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.18, 21.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 24.</span> <span class="table-title">(4.6) Nitric oxide donors versus vaginal misoprostol (all primiparae, intact membranes, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0025">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0026"> <div class="table-heading"><span class="table-label">Comparison 25.</span> <span class="table-title">(5.1) Nitric oxide versus intracervical Foley catheter (all women)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Oxyocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [1.17, 2.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.23, 2.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.19, 21.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.95, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.5 [0.51, 12.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Maternal side effects (nausea and vomiting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.33, 27.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.33 [0.99, 11.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.90, 4.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Women not satisfied <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.56, 5.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Other maternal side effect (puerperal pyrexia) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.16, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 25.</span> <span class="table-title">(5.1) Nitric oxide versus intracervical Foley catheter (all women)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0026">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0027"> <div class="table-heading"><span class="table-label">Comparison 26.</span> <span class="table-title">(5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Oxyocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [1.17, 2.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.23, 2.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.19, 21.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.95, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.5 [0.51, 12.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Maternal side effects (nausea and vomiting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.33, 27.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.33 [0.99, 11.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.90, 4.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Women not satisfied <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.56, 5.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Other maternal side effect (puerperal pyrexia) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.16, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 26.</span> <span class="table-title">(5.2) Nitric oxide versus intracervical Foley catheter (all women, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0027">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0028"> <div class="table-heading"><span class="table-label">Comparison 27.</span> <span class="table-title">(5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Oxyocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [1.17, 2.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.23, 2.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.19, 21.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.95, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.5 [0.51, 12.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Maternal side effects (nausea and vomiting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.33, 27.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.33 [0.99, 11.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.90, 4.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Women not satisfied <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.56, 5.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Other maternal side effect (puerperal pyrexia) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.16, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 27.</span> <span class="table-title">(5.3) Nitric oxide versus intracervical Foley catheter (all women, intact membranes, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0028">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0029"> <div class="table-heading"><span class="table-label">Comparison 28.</span> <span class="table-title">(5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Oxyocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [1.17, 2.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.23, 2.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.19, 21.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.95, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.5 [0.51, 12.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Maternal side effects (nausea and vomiting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.33, 27.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.33 [0.99, 11.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.90, 4.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Women not satisfied <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.56, 5.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Other maternal side effect (puerperal pyrexia) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.16, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 28.</span> <span class="table-title">(5.4) Nitric oxide versus intracervical Foley catheter (all women, previous CS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0029">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0030"> <div class="table-heading"><span class="table-label">Comparison 29.</span> <span class="table-title">(5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Oxyocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [1.17, 2.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.23, 2.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.19, 21.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.95, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.5 [0.51, 12.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Maternal side effects (nausea and vomiting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.33, 27.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.33 [0.99, 11.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.90, 4.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Women not satisfied <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.56, 5.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Other maternal side effect (puerperal pyrexia) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.16, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 29.</span> <span class="table-title">(5.5) Nitric oxide versus intracervical Foley catheter (all women, previous cs, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0030">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006901-tbl-0031"> <div class="table-heading"><span class="table-label">Comparison 30.</span> <span class="table-title">(5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Oxyocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [1.17, 2.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.23, 2.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.19, 21.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.95, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.5 [0.51, 12.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Maternal side effects (nausea and vomiting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.33, 27.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maternal side effects (headache) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.33 [0.99, 11.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.90, 4.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Women not satisfied <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.56, 5.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Other maternal side effect (puerperal pyrexia) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.16, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 30.</span> <span class="table-title">(5.6) Nitric oxide versus intracervical Foley catheter (all women, previous cs, intact membranes, unfavourable cervix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006901.pub3/references#CD006901-tbl-0031">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006901.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD006901-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD006901-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006901-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="ja#CD006901-note-0004">日本語</a> </li> <li class="section-language"> <a class="" href="ru#CD006901-note-0002">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006901\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006901\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006901\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006901\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006901\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=f00EizoA&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006901.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006901.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006901.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006901.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006901.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727769115"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006901.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727769119"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006901.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eb413faeb9368',t:'MTc0MDcyNzc3MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 